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Chapter 1 
GENERAL INTRODUCTION 
Introduction 
Hiere is a lot of evidence indicating that Adult Respiratory Distress Syndrome (ARDS) 
and Multiple Organ Failure (MOF) are the result of one common pathophysiological 
pathway (1-3). Respiratory failure merely is the first organ failure apparent in the 
sequence of events leading to MOF and therefore is of special interest (4). The MOF 
syndrome was first recognised as an entity by Tilney et al. (1973), who described the 
post-operative course of patients with ruptured abdominal aortic aneurysms (5). Later 
Baue (1975) wrote a famous editorial on the syndrome of sequential and progressive 
failure of function of several organ systems, finally resulting in death (6). MOF has 
become the syndrome of the last decades. It actually is a consequence of the succes-
sful resuscitation of critically ill and severely traumatized patients with up to date 
intensive care treatment. In fact, in this way intensive care medicine has created its 
own disease (7). 
From a historical point of view, every era has known its own medical limitations. Acute 
blood loss was the main cause of death in World War I. After prevention and treat-
ment of this type of shock during the World War II and the late fifties, renal insufficien-
cy appeared to be the major limiting factor for survival. During the Vietnam conflict 
increased administration of large amounts of crystalloids prevented acute renal failure, 
but now survival of patients was limited by the development of ARDS (the so called 
"Da Nung-lung"). Later in the seventies, when increasing numbers of patients survived 
ARDS - because of adequate mechanical ventilation with positive end expiratory 
pressure (PEEP) - the limiting problem was not a single organ failure anymore, but a 
complex of sequential organ failures: MOF (9,10). 
ARDS and MOF are responsible for more than 70% of the ventilator days spent in the 
intensive care unit (ICU) (4,8). Today MOF represents the number 1 cause of death in 
a surgical ICU and is responsible for 50% to 80% of all surgical ICU deaths (9). The 
costs are estimated to exceed $ 150,000 per MOF patient in the USA. 
Clinical presentation of ARDS and MOF 
The sequence of events leading to ARDS and MOF is best illustrated by several 
extensive clinical case reports. 
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Case 1 
Patient Ρ was a 48-year-old man, who was admitted to another hospital, because of 
acute abdominal discomfort and severe shock (systolic blood pressure 80 mmHg and 
pulse rate 140/minute). Since one day he had developed jaundice and had produced 
dark coloured urine and discoloured stools. Blood analysis showed a marked 
hyperamylasemia and hypocalcemia. Severe acute pancreatitis was diagnosed and 
because of respiratory failure and renal insufficiency the patient was transferred to our 
hospital. 
An explorative laparotomy was performed: a severe hemorrhagic necrotizing pancrea­
titis was present throughout the whole pancreas; the retroperitoneal space was 
extensively infiltrated from the diaphragm into the pelvis and a high number of calcium 
deposits were found intra-abdominally. The galbladder was filled with stones and 
sludge. A cholecystectomy and additional choledochotomy with drainage were carried 
out. 
On admission to the ICU, the man was hemodynamically stable with no need for 
vasoactive agents. Mechanical ventilation was continued with a Fi02 of 50% and 6 cm 
H,0 PEEP, resulting in normal blood gasses. Urine production was about 30 ml/hour. 
The third day a second look operation was performed and necrotic tissue was 
removed. Bacterial cultures of material taken during the first operation were negative, 
while necrosis of the second laparotomy appeared to be infected with Escherichia 
coli. Over the next days the patient developed a progressive renal failure (creatinine > 
600 μπΊοΙ/Ι and BUN > 50 mmol/l) and hemodialysis was necessary. 
On day 6 the pulmonary function deteriorated further: with an FiO, of 60% and 10 cm 
Η,Ο PEEP the Pa02 was only 8.6 kPa. A chest X-ray showed diffuse bilateral patchy 
infiltrates and ARDS was diagnosed. In this period increasing amounts of Dopamine" 
were necessary to maintain an adequate systolic blood pressure. Meanwhile, from day 
1 to 4, the patient's positive fluid balance had exceeded 10 liters, while central venous 
pressure was normal. The patient had developed a generalized edema and his central 
body temperature varied from 36.8°C to 39.2°C. After the first operation the initially 
raised bilirubine levels -due to biliary obstruction- had decreased. From day 5 
however, bilirubine levels started to increase again together with transaminases. 
Jaundice was present. During the whole ICU admission the patient was on total 
parenteral nutrition. At day 5 a hemorrhagic gastritis was diagnosed. On days 8 and 
10, respectively, a third and fourth laparotomy for removal of necrotic tissue were 
performed. From day 5 on several blood cultures grew E.coli, as well as Pseudom­
onas species. 
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In the seond week the patient further deteriorated with diminished cerebral responsi­
veness and increasing cardiovascular instability. Platelet count was decreasing (at day 
12 below 30,000 χ 1071) and the initial leukocytosis (21,400 χ 1071) changed into a 
leukopenia at day 12: 2,100 χ 1071. At day 16 the man had several arhythmic episo­
des and bradycardia with persisting low systolic blood presurres. Cerebral responsi­
veness was further diminished and his pupils were anisocoric and showed only a 
slight reaction to light. At day 17 the patient died of irreversible shock. Permission for 
post mortem examination was not obtained. 
Case 2 (11) 
Patient Τ was an 18-year-old man, who was hit by a car when riding his bicycle. He 
was admitted to another hospital in severe shock (systolic blood pressure < 70 
mmHg). A left-sided tension hemopneumothorax and 6 fractured ribs were diagnosed, 
together with a hemoperitoneum, an unstable pelvic fracture and a fracture of the left 
scapula. Blood loss through a thoracostomy tube was so extensive that a thoracoto­
my had to be performed for hemostasis. Explorative laparotomy revealed a laceration 
of the inferior mesenteric artery and an extensive retroperitoneal hematoma. The 
artery was ligated and no significant ischemia of the large bowel resulted. The blood 
pressure returned to normal and an adequate diuresis followed. Seven liters of blood 
were administered during the first 24 hours. 
Subsequently the patient was carefully observed, while breathing spontaneously. Two 
days later, however, the man developed progressive pulmonary insufficiency requiring 
mechanical ventilation. Because of this the patient was transferred to our hospital. On 
admission, a left-sided pneumothorax was relieved by a new thoracostomy tube. 
Because of hemodynamic instability a second laparotomy was performed and the 
spleen was removed because of a ruptured subcapsular hemotoma. Complete 
inspection of the abdomen revealed no further abnormalities. The displaced pelvic 
fracture was then reduced by suspension in a hammock sling and traction to one leg. 
After admission to the ICU, mechanical ventilation with Fi02 of 100% and 20 cm H20 
PEEP was necessary to obtain a Pa02 of 8.0 kPa. Intravenous hyperalimentation was 
started. During the following 5 days, Fi02 could progressively be diminished to 40% 
and PEEP to 12 cm H20. The platelet count remained below 50,000 χ 1071 during the 
next 7 days. From then on the leukocyte count slowly increased from 12,000 χ 1071 to 
70,000 χ 1071. Central body temperatures were between 37.2°C and 39.8°C. 
At day 10, bacterial cultures of sputum grew E.coli, which was also cultured in the 
urine at day 12. Pus from an infected maxillary sinus also contained E.coli. Weaning 
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from the ventilator was not possible. In the third and fourth week sputum cultures 
revealed multi-resistent E.coli, together with Klebsiella pneumoniae and Pseudomonas 
aeruginosa. Blood cultures remained negative until day 42, when Staphylococcus 
epidermide was cultured. Extensive pulmonary fibrosis resulted in hypertension with 
cardiopulmonary failure, not responding to treatment with digitalis. Progressive renal 
failure developed at the end of week 3, necessitating hemodialysis. Jaundice develo­
ped with increasing levels of bilirubine and transaminases. At 7 weeks a tender mass 
could be felt in the right subcostal area, and acalculous cholecystitis was confirmed 
ultrasonographically. Other disorders found in the patient included spontaneous 
hemorrhage from the rectum, lungs, trachea, nose and ears, requiring blood transfusi­
ons, bilateral otitis media needing paracentesis, ulceration and spontaneous perforati­
on of the cornea, despite adequate local care and extensive herpes zoster. Because 
of the "destroyed lung" operation for the acalculous cholecystitis was not performed 
and the patient subsequently died 58 days after the injury. 
At post mortem examination, there was extensive consolidation of both lungs, which 
weigthed 1200 g and 990 g. The kidneys were large and swollen. The liver weigth was 
2580 g. An acute phlegmonous necrotizing cholecystitis was present with recent 
perforation and biliary peritonitis. A bile trombus was present in the cystic duct. The 
major intra- and extra-hepatic bile ducts were patent and of normal calibre. Microsco­
py of the liver demonstrated biliary stasis, mainly with pericentral localization. Multiple 
petechiae were seen in the gastric mucosa, the bladder mucosa and subepicardial^. 
Case 3 
Patient A was a 74 year old man, who was seen at the emergency department, 
because of acute abdominal tenderness and moderate shock (systolic blood pressure 
90 mmHg and pulse rate 120/minute). Analysis of blood taken on admission showed 
a lactate concentration of 6800 //mol/l, hemoglobine concentration of 6.5 mmol/l, 
Creatinin 130 μπιοΙ/Ι, platelet count of 187 χ 1071, leukocyte count of 22,800 χ 1071. 
with the following arterial blood gas analysis: P02 12.2 kPa, PCO, 4.1 kPa, pH 7.35, 
НСОэ 16.8 mmol/l and base excess - 7.0 mmol/l. 
A ruptured abdominal aortic aneurysm was diagnosed and an emergency laparotomy 
was carried out without delay. The aorta was cross-clamped infrarenally and the 
aneurysm was repaired with an inlay graft. The whole operation took 145 minutes and 
total blood loss was 4.5 liters. By use of a cell saver, 1000 ml of homologous blood 
could be returned to the patient, together with 8 units of autologous blood. 
The post-operative course was complicated by an insufficient arterial blood supply to 
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both legs. Therefore a bilateral arterial embolectomy had to be performed, three hours 
after the initial operation. The peripheral circulation could be restored adequately and 
a four compartment fasciotomy was carried out bilaterally to prevent compartment 
syndromes. During this procedure, two more units of packed cells were transfused. 
On admission to the ICU the patient was hemodynamically stable, with a systolic 
blood pressure of 170 mmHg, pulse rate of 100/minute and central venous pressure 
of 5 cm Η,Ο, with intravenous Dopamin" administration in renal dosage. Central core 
temperature was 32,3°C. At that moment urine production was more than 200 ml/hour. 
Mechanical ventilation was performed with Fi02 of 40% and 2 cm Η,Ο PEEP, resulting 
in а РаО
г
 of 15.0 kPa. Over the next few hours urine production diminished and 24 
hours postoperatively the patient was practically anurie (urine production less than 5 
ml/hour), probably due to acute tubular necrosis. 
At day 2, the use of vasopressor agents had to be increased to maintain the systolic 
blood pressure between 130 and 140 mmHg; central venous pressure was normal (10 
cm H20), but the pulmonary condition deteriorated: with a Fi02 of 55% and 8 cm H,0 
PEEP, PaOj was only 8.2 kPa. A chest X-ray showed bilateral patchy infiltrates, 
features compatible with the diagnosis ARDS. From days 1 to 4 the patient's positive 
fluid balance exceeded 12 liters and generalized edema was present. Because serum 
Creatinin rose above 400 //mol/l and BUN above 24 mmol/l hemodialysis was started. 
Bacteriologie cultures of blood, sputum and urine did not reveal any microorganism. 
Except for the prophylactic use of a cephalosporin peri-operatively, no other antibiotic 
drug was used at that time. 
The patient's condition remained unchanged until day 9. Cultures of sputum showed 
Serratia marcescens and ß-hemolytic streptococci. At day 10, a blood culture grew S. 
marcescens and antibiotic treatment was started. At day 14 a wound abscess was 
diagnosed and drainage performed (cultures: S. marcescens). These two weeks cen-
tral body temperature remained below 38°C. Meanwhile the leukocyte count rose 
progressively from 12,000 to above 24,000 χ IO8/! and bilirubin levels rose above 200 
μηηοΙ/Ι. Clinical jaundice was present. 
At day 19 the patient had several episodes of bradycardia, while cardiac output was 
over 8 l/minute (cardiac index > 4,0). At that day a relaparotomy was performed for 
the search of a "septic" focus. Because of acalculous cholecystitis a cholecystectomy 
had to be performed. Postoperatively the patient seemed more stable, the use of 
vasopressive agents could be diminished and no episodes of bradycardia occured. At 
day 23, because of the suspicion of a renewed intra-abdominal sepsis, a second 
relaparotomy was carried out. However, the operation did not reveal any abnormal 
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infectious focus. Up to this period S. marcescens grew in all cultures, while at day 23 
P. aeruginosa could also be cultured from the dialysis fluid. 
Over the next days the patient deteriorated further, requiring maximal support of the 
cardiovascular system by various vasoactive medication, pulmonary support with 
mechanical ventilation (FiO, 60%, 10 cm H 2 0 PEEP), renal support by dialysis, need of 
parenteral feeding because of gastro-intestinal failure with ileus, liver failure with 
jaundice, leukocytosis and trombopenia, and diminished cerebral responsiveness. 
After consultation of the patient's family, it was decided not to resuscitate further. The 
patient subsequently succumbed at day 31. Post mortem autopsy was refused. 
Comment 
Although the three cases represent different etiologic entities (acute pancreatitis/in­
flammation, multiple trauma/extensive tissue injury, hemorrhagic shock/ischemia-
reperfusion injury) all three ended in progressive failure of several organ systems. 
In all three patients acute pulmonary failure played an early role. In two patients (P 
and A) acute renal failure was already present in the early stage, while in patient Τ 
renal insufficiency developed in the third week. 
During the first days these patients developed a marked positive fluid balance and 
had an appearance of total body edema. This was not caused by cardiac failure 
(normal venous pressures and high cardiac output), but probably by a generalized 
increased micro-vascular permeability. 
Liver failure occured next, which was mainly indicated by the rising (unconjugated) 
bilirubin levels. Obviously, patient Ρ presented with initial liver failure, due to obstructi­
on of the biliary tract which also caused the pancreatitis, but after a tendency to 
normalize, a secondary liver failure appeared at the end of the first week. 
All three patients also showed increasing cardiovascular instability, mainly expressed 
by the increasing need for vaso-active medication to maintain an adequate systolic 
blood pressure. 
In all patients the function of the gastro-intestinal tract deteriorated, resulting in ileus 
and in the necessity of total parenteral nutrition. Patient Ρ developed hemorrhagic 
gastritis and patients Τ and A acalculous cholecystitis. 
The hematologic and clotting systems subsequently deteriorated, as indicated by the 
leukocytosis or leukopenia, trombopenia and general bleeding disorders (patient T). 
The impairment and dysregulation of the immunological functions is demonstrated by 
the various types of infections that developed. Logically, in patient Ρ the necrotic 
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tissue was infected very rapidly. But in patients Τ and A bacteria could not be cultured 
from sputum, urine, blood or other body fluids before the beginning of the second 
week. 
In general patients developing MOF frequently show dysregulation of the central and 
peripheral neurological functions, although it is difficult to evaluate these functions in 
sedated patients at an ICU. The Glasgow Coma Scale can be very helpful! in this 
respect (see apppendix). 
In summary, the patients described above showed a progressive and sequential 
failure of seven organ systems, including the pulmonary, renal, cardiovascular, 
hepatic, gastro-intestinal, hematologic-immunologic, and neurological system with the 
clinical signs of generalized inflammation i.e. 'rubor' (generalized vasodilatation), 'calor' 
(fever), 'tumor' (generalized edema), and 'functio laesa' (MOF). Based on these obser­
vations Goris et al. developed the MOF score to grade the severity of organ failure 
(12) (see appendix). 
It should be noticed that, although the systemic responses are similar among patients 
developing MOF, the exact sequence of organ failures can be influenced by the 
patient's acute disease process or physiological reserve (9). 
Incidence and severity grading of ARDS and MOF. 
Data on the incidence of ARDS and MOF and of their respective mortality are 
confusing. This is mainly caused by the use of different definitions of ARDS and MOF 
and the wide range of patient populations studied. Patient populations generally 
known to be at risk for development of ARDS and MOF are: patients with sepsis 
(infection - septic shock), with multiple trauma or extensive burn wounds, after major 
elective surgery, with severe pancreatitis, or with hemorrhagic shock, such as due to 
ruptured aneurysms or with ongoing blood loss needing multiple blood transfusions. 
Within these different patient groups, the reported incidence of ARDS and MOF may 
vary from 5% in trauma patients to 65% in septic patients (13,14). 
The relationship between MOF and mortality can be illustrated by studying the 
number of organs that have failed. Mortality of a single organ failure has been repor­
ted to vary from 16 - 40%, two organ failures 57 - 60%, three organ failures 80 - 85% 
and four or more organ failures 88 - 100% (12-15), while the length of time a patient 
suffered from organ failure has also been demonstrated to correlate with mortality 
(15). To compare different reports and studies on ARDS and MOF consensus about 
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the definition of these syndromes is necessary. 
Since Ashbaugh and coworkers in 1967 described the first patients with this type of 
acute pulmonary failure (16) this entity has been recognized throughout the world (16-
18). Yet, there still exists controversy concerning a satisfactory definition of this 
syndrome. In general it has been called ARDS or "acute respiratory failure due to non-
cardiogenic pulmonary edema" (16). Recently, it has been proposed to rename it to 
"Acute Lung Injury" (19). 
Current definitions rely mostly on the following features: 
1. Hypoxemia, measured either by the Pa02 / FiO, ratio or by the alveolar -
arterial oxygen quotient, and the necessity for PEEP ventilation to maintain an 
acceptable Pa02, 
2. Diffuse bilateral röntgenographic infiltrates on the chest X-rays, 
3. Decreased pulmonary compliance (though almost never measured), 
4. Normal pulmonary capillary wedge presssure (values vary from less than 12 
mm Hg to less than 18 mm Hg), 
5. Pulmonary shunting (shunt fraction higher than 15% or 20%), and 
6. A clinical condition associated with the risk for development of ARDS. 
Other definitions use the necessity of mechanical ventilation for more than a certain 
number of days and grade the intensity of ventilatory support by using various Pa02 / 
FiOs / PEEP indexes (3,16,20,21). 
MOF has been defined as a syndrome consisting of the sequential failure of two or 
more organ systems in patients with clinical signs of "sepsis" (10). Originally, the term 
sepsis implied the systemic, clinical response arising from infection. Confusion 
developed when the term was also used for patients with this clinical syndrome, but 
without clear signs of infection or bacterial invasion. An additional source of confusion 
was the use of various other terms, such as bacteremia, septicemia, septic syndrome, 
septic shock. Recently, a consensus conference held by the American College of 
Chest Physicians and Society of Critical Care Medicine proposed the use of the term 
Systemic Inflammatory Response Syndrome (SIRS) to describe the inflammatory 
reaction of the organism, independent of its cause (22). It would therefore be better to 
decribe MOF as a frequent complication and late consequence of SIRS. 
The organ systems involved in definitions of MOF are usually the ventilatory (ARDS), 
cardiovascular, renal, hepatic, gastro-intestinal, coagulation, hematological, immune, 
central nervous, metabolic and musculoskeletal systems. The grading of severity of 
19 
these organ failures varies in the same way as outlined before for ARDS. Many 
scoring systems have been published to grade the severity of organ dysfunction, one 
sometimes being a slight modification of another. 
The following is a list of parameters that are mostly used to grade the intensity of dys­
function of a specified organ system (2,9,12-14,23-37): 
(for ventilatory system see ARDS), 
Cardiovascular: systolic blood pressure or mean arterial pressure, pulse rate, cardiac 
output or cardiac index, cardiac filling pressure, decreased ejection fraction, arhythmi-
as, use of vaso-active drugs, myocardial infarction, need for reanimation. 
Renal: urine output, body urea nitrogen, serum creatinine, serum potassium, creatini-
ne-clearance, effect of diuretics, requirement for dialysis, ultra- or hemofiltration. 
Hepatic: rise of enzymes, such as alkaline phosphatase or transaminases, serum bili­
rubine, ketone body ratio, serum ammonia, serum albumin. 
Gastro-intestinal: stress ulcer (by endoscopy or necessity of blood transfusion), ileus 
(gastric retention fluid or intolerance to enteral feeding), acalculous cholecystitis, 
pancreatitis, raise of serum or urine amylase, enterocolitis, bowel perforation, mesen­
teric vein trombosis. 
Central nervous: polyneuropathy, pathological reflexes, mental state, progressive 
coma, Glasgow Coma Scale. 
Coagulation: platelets, serum fibrinogen and fibrinogen split products, serum 
antitrombine III, clotting time, requirement of fresh frozen plasma, disseminated 
intravascular coagulation. 
Hematologic: platelets, leukocytes, hematocrit, P50 ( PO, when 50% of the hemoglo­
bin is oxygenated). 
Immunologic: В and Τ cell function, skin tests (delayed hypersensitivity test). 
Metabolic / musculoskeletal: occurence of decubitus, weigth loss, hyperglycemia or 
need of insuline, ketone body ratio, aminoacid-, carbohydrate-, and fat metabolism. 
Next to these more or less organ specific parameters, some scoring systems use 
additive data such as central temperature, serum electrolytes (calcium, sodium, 
potassium) or hemoglobin or total protein concentration, number of positive blood 
cultures, local effects of tissue infection and metabolic acidosis (compensated or not) 
(23-25,29,35,36). 
The variability in criteria used to define organ failure causes the confusion about the 
exact data on the incidence and prevalence of ARDS and MOF. 
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Morphology of AROS and MOF 
It is worthwhile to consider the morphologic alterations seen in different organs 
involved in ARDS and MOF. We will discuss morphological changes of organs 
reported in autopsy studies of patients succumbed after trauma and information 
gathered from organs studied after experimental hypovolemic - traumatic shock or 
experimentally induced ARDS and MOF (36-43). An important finding is the general 
increase of organ weights and swollen appearance of these organs found in patients 
dying of ARDS and MOF, compared to "normal" values of organ weights obtained 
from other autopsies (39). 
For the lung the most prominent features associated with ARDS or early lung failure 
are the sequestration, aggregation and degranulation of polymorphonuclear granulo-
cytes (PMNs) in the pulmonary microcirculation. This leads to damage of the pulmo-
nary capillary endothelium and alveolo - capillary membrane, with interstitial edema 
and protein-rich fluid migrating into the alveolar space. In a later stage, fibrin depositi-
on and platelet accumulation take place, leading to progressive and diffuse fibrosis. 
Also monocyte invasion occurs, more extensively so in patients developing MOF. 
Morphologic changes seen in the liver after injury or shock also consist of accumulati-
on and aggregation of PMNs, endothelial cell and Kupffer cell swelling, impairment of 
sinusoidal function and focal areas of hepatocyte necrosis. The latter changes increa-
se in severity with the length of survival after injury. 
In the kidneys PMN accumulation has also been observed in the glomeruli, whereas 
the tubuli showed vacuolar nephrotubulopathy. Endothelial cell swelling with bleb 
formation can occur, leading to blocking of the intravascular spaces. 
In the heart increased numbers of PMNs have been found occassionally, concomitant 
with interstitial and cellular edema. Focal cellular necrosis has also been demonstrated 
and increasingly so in patients dying late after trauma. 
In the spleen an excessive number of PMNs and macrophages can be found, next to 
depletion of red and white pulpa. Pathologists attributed these findings to "sepsis", 
though these features also occurred in patients who died within 24 hours after trauma, 
without clinical signs of infection. 
The intestines, after a period of trauma or shock (low flow syndrome), macroscopical-
ly show hemorrhagic mucosal damage. Microscopically there is mucosal edema 
formation, necrosis, loss of epithelium, interstitial hemorrhage, and edema, features 
that are also observed in the intestines of patients dying of MOF (44). 
Skeletal muscle after a period of shock and reperfusion shows markedly increased 
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endothelial cell swelling, however without increased accumulation of PMNs. 
After septic shock extensive perivascular edema with PMN infiltration is found in the 
brain (45). 
Many of the above mentioned alterations in various organs could also be observed in 
experimental circumstances, such as after infusion of complement activated plasma 
with additional hypoxia in rabbits, after intraperitoneal injection of zymosan in rats and 
mice, after hemorrhagic shock in rabbits, after endotoxin administration in rats or after 
cecal ligature and puncture in sheep (46-50). 
The morphologic alterations observed share several common findings: 1. endothelial 
cell damage and generalized edema formation, and 2. the presence of PMN infiltration 
(except in the musculoskeletal system). These features are compatible with a generali-
zed inflammatory reaction with microvascular injury (14,38,39). 
Oxygen metabolism in relation to ARDS and MOF 
Circulatory failure (shock) and especially insufficient peripheral circulation result in a 
reduction of oxygen supply to the cells. This oxygen supply is vital, as 95% of the 
energy generated by the body normally originates from aerobic pathways (51). In 
conditions associated with sepsis, trauma or extensive surgery, oxygen demand may 
be elevated. However, it has been demonstrated, e.g. in fully resuscitated trauma 
patients, that although oxygen supply was normal or even above normal, oxygen 
consumption was decreased (52). It has also been shown that in these patients 
oxygen consumption depends on oxygen supply, a condition called pathologic 
oxygen-supply-dependency (53). This process has been attributed to an impaired 
oxygen extraction and is associated with "hidden tissue hypoxia", causing deteriorati-
on of organ functions leading to MOF (54). In patients with ARDS such supply-
dependency has also been demonstrated (55). 
When oxygen supply decreases below a critical threshold, excess lactate is generated 
(56). Many clinical studies have indicated that blood lactate levels are increased in 
circulatory failure and are directly correlated with the severity of shock (57). In septic 
shock, lactate reliably predicts outcome (57). In ARDS oxygen extraction is low, 
despite a supra-normal oxygen supply, while lactic acidosis is present (59). 
When, after a period of shock, ischemia and hypoxia, tissues are reperfused, they will 
also be reoxygenated. During hypoxia, ATP is broken down to hypoxanthine. Mean-
while an enzyme system is activated, leading to the production of xanthine oxidase, 
which after reoxygenation converts hypoxanthine into xanthine (urate). During this 
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process highly reactive oxygen free radicals are produced (60). These oxygen free 
radicals will induce the oxydation of plasma membrane associated arachidonic add 
by the lipoxygenase and cycloxygenase pathways, resulting in an excess production 
of metabolites, such as lipid peroxides, prostaglandins and tromboxanes (60). The 
process of ischemia and reperfusion has also been shown to be associated with 
impaired oxygen extraction (51). The involvement of oxygen free radicals in the 
pathogenesis of ARDS is suggested by the finding of increased levels of Н
г
О
г
 in the 
expired breath and increased carbon exhalation in patients with ARDS (61,62). 
Ischemia, resulting in tissue hypoxia, may ultimately lead to cell destruction. The 
intestine is highly susceptible to splanchnic ischemia, which can very rapidly lead to 
mucosal damage and finally transmural infarction (63). The adequacy of this mucosal 
oxygenation can be investigated indirectly by pH measurement of the mucosa. This 
pHi (intramucosal pH) determination, using an intraluminal^ placed balloon catheter 
permeable to C02, is called tonometry (64). Tonometry has been demonstrated to be 
usefull in monitoring ICU patients to guide therapy (65) and to provide predictive 
information towards the development of complications, such as sepsis and MOF, in 
patients after cardiac or abdominal aortic operations (64,66). 
Role of humoral and cellular systems in ARDS and MOF 
The primary reaction of the organism to any type of tissue damage can be summari­
zed as an inflammatory response. Experimental and clinical evidence indicates that 
activation of humoral systems precedes activation of cellular systems (38). The various 
local interacting humoral systems (complement, coagulation, fibrinolytic and kinin-
kallikrein) in turn are potent activators of circulating inflammatory cells, such as PMNs 
and monocytes. 
The complement system can be activated by either the classical or the alternative 
pathway. Both routes lead to conversion of C3 to C3a, which is a very strong 
anaphylatoxin (67,68). Next in the cascade is the production of C5a (from C5) and 
terminal complement complexes, which are an assembly of C5b to C9. The level of 
complement activation has been positively correlated to severity of trauma (69,70), 
while in patients with established ARDS higher levels of activated complement pro­
ducts could be demonstrated compared with patients without ARDS (68,71). Continu­
ous infusion of complement activated plasma with additional hypoxia in the rabbit, 
resulted not only in ARDS-like changes in the lungs, but also in a generalized 
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inflammatory response in many other organs, such as the liver, kidneys, spleen and 
heart (46). In another report it was shown that complement activation positively 
correlated to the first signs of MOF (72). 
The generation of complement activated products (C3a and C5a) leads to the activa-
tion of PMNs, which aggregate and stick to endothelial cells. This process accounts 
for the PMN margination, resulting in pulmonary leukostasis seen in ARDS and the 
early leukopenia observed at the onset of sepsis or immediately after hypovolemic-
traumatic shock (73,74). Adherence of PMNs to the endothelium appears to create an 
inflammatory microenvironment in which numerous active substances are released, 
such as proteolytic enzymes (elastase), vaso-active substances (platelet activating fac-
tor, leukotrienes, prostaglandins), wound hormones (granulocyte macrophage -
colony stimulating factor) and oxygen free radicals. These substances lead to 
endothelial damage, thus creating microvascular injury, resulting in increased permea-
bility with edema formation (7,38). 
Especially elastase seems to be a factor of direct relevance in this type of tissue 
injury. Experimental administration of elastase results in elevated pulmonary vascular 
resistance, decreased cardiac output, pulmonary leukostasis, disseminated intravas-
cular coagulation and increased venous oxygen content (75). In many studies a 
positive correlation between plasma elastase levels (measured as the elastase-a1-
antiprotease inhibitor complex) and severity of trauma, sepsis, ARDS and MOF could 
be demonstrated (76-79). Some authors even reported elastase levels to be predictive 
for subsequent ARDS and MOF (76,78). Free circulating elastase might harm endot-
helial tissue in remote organs, thereby contributing to the development of MOF. 
In response to inflammatory stimuli, human PMNs produce large amounts of oxygen 
free radicals, importantly more than bovine, ovine or porcine PMNs (80). The hydroxyl 
radical probably is the most important oxidant involved in PMN-induced endothelial 
cell injury (81). Thus, the cell damage observed in the post-traumatic or post-ischemi-
a/reperfusion period is aggravated by the contribution of oxygen free radicals 
produced by activated PMNs (38). 
After chemoattraction to the inflammatory scene, circulating monocytes differentiate 
locally into macrophages. Fixed tissue macrophages are present in most tissues, such 
as the liver (Kupffer cells, comprising 70% of the total population of fixed macropha-
ges), brain (glia cells), kidneys (mesangial cells), or peritoneum, lung and spleen. 
Monocytes and macrophages in turn also are activated by C5a and a score of signals 
from PMNs (82). Other strong activators of macrophages are tissue hypoxia and 
endotoxin (82). Upon stimulation, macrophages may release large amounts of 
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secretory products, including pro-inflammatory (such as cytokines), anti-inflammatory, 
immunosuppresive or pro-coagulatory substances (83). In contrast to PMNs, it appa­
rently takes several days after activation to develop the full inflammatory capacity of 
macrophages (83). 
Neopterin is a stable inactive end product of macrophage metabolism and neopterin 
levels reflect macrophage activity (84). As neopterin is cleared from the circulation in a 
creatinin-like manner it probably is more correct to use the neopterin/creatinin ratio, 
when using neopterin as a marker of macrophage activity (76,84). Increased plasma 
neopterin concentrations have been associated with poor outcome in patients with 
viral infection (including AIDS), auto-immune disease, graft vs host reaction, and 
multiple trauma and sepsis (76,85). 
Recently the role of cytokines · such as tumor necrosis factor (TNFa), interleukine-1Q 
and -6 (IL-113 and IL-6) - in the inflammatory process has been subject of extensive 
study. Monocytes (macrophages) and endothelial cells are the primary source of 
these cytokines, but many other cells involved in the inflammatory reaction such as 
fibroblasts, Τ and В cells and various mesenchymal cells also produce cytokines (86). 
Of course cytokines have various beneficial effects and cannot only be detrimental to 
the host. For example, they are essential for normal antimicrobial and immune activity, 
wound healing and optimal substrate mobilisation (9). The understanding of cytokine 
effects is complicated by several factors: 
* the cytokine cascade is characterized by many feedback loops, in which cytoki­
nes can modulate each other; 
* combinations of cytokines can be inhibitory, additive or synergistic; 
* cytokine producing cells may be primed or just tolerant to new triggers; 
* the sequence of cytokine release influences the target cells, and 
* cytokine effects are dose related (9). 
Until now of all cytokines IL-113, TNFa and IL-6 have been well studied in the clinical 
setting. Elevated levels have been demonstrated in patients with sepsis, after trauma 
or burn injury, shock, inflammation in the absence of infection and even in chronic 
diseases (87-93). There is ample evidence that TNFa appears to be a key messenger 
in activating and orchestrating the "septic" or inflammatory response (9,38). Admi­
nistration of TNFa induces a cascade of factors that modulate multiple humoral 
systems, resulting in organ damage closely mimicking MOF (94). 
IL-6 has been shown to correlate positively with the severity of injury and its levels are 
more closely tied to soft tissue trauma than the other cytokines (88,95,96). IL-6 is the 
main regulator of the acute phase response in human adult hepatocytes, which 
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release acute phase proteins, including С reactive protein (CRP) (97). CRP levels have 
also been shown to correlate well with the severity of injury or the magnitude of 
surgical intervention (95,98) and were predictable of subsequent MOF in one study of 
multiple trauma patients (76). 
Bacteriological aspects of MOF 
By the late 1970s, surgeons started to think of MOF as a septic syndrome. Many of 
the critically ill surgical patients had occult, usually intra-abdominal infections and MOF 
came to be regarded as the external expression of an occult septic focus and as an 
indicator for abdominal exploration. In 1980, Fry et al. (27) published the results of 553 
patients who underwent emergency operations, 38 of whom had developed MOF. 
Thirty four (89%) of these patients showed signs of infections and the authors con­
cluded that infection and its systemic manifestations were the most crucial factor in 
the evolution of MOF in patients after surgery. The first investigators to describe ARDS 
noticed that these patients often died of sepsis (99) and in a necropsy study of 
patients with lethal ARDS, infection was found in 46 of 47 patients (100). As time went 
on, however, it was found that increasing numbers of patients were explored in whom 
no abscess could be found intra-abdominally, even though florid MOF was evident 
(101). 
In 1980, Meakins et al. (102) described a group of patients who manifested the 
characteristic clinical findings of sepsis, yet who had persistently negative blood 
cultures. This phenomenon was then termed 'non-bacterial clinical sepsis'. Several 
studies, especially on multiple trauma patients, showed that the relation between 
infection, sepsis and MOF is not so evident. Goris et al. (12) documented that a focus 
of uncontrolled infection was present in only 31 (56%) of 55 severely injured patients 
with MOF. Border (103) found negative blood cultures in two thirds and no septic 
focus in one third of his patients with MOF following trauma. Fowler et ai. (104) 
reported that 49 (56%) of 88 patients with ARDS did not show signs of infection. In an 
excellent study of 100 multiple trauma patients Waydhas et al. (75) concluded that in 
about one quarter of patients with MOF infection did not play a role at any time, and 
that in those patients with infection three quarter showed early onset of MOF long 
before infection started. In addition, nine (9%) patients suffered from sepsis, but did 
not develop any organ dysfunction at all. 
There appear to be no essential clinical, biochemical or morphological differences 
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between patients with non-bacterial sepsis (or SIRS) (22) and patients with bacterial 
sepsis (12,105,106). It has been demonstrated that the correlation of sepsis scores to 
mortality depends only on organ failure data, not on bacteriologie data (107). In 
patients at risk of or with ARDS/MOF, bacterial invasion occurs relatively late and 
infection is often caused by organisms of relatively low virulence, such as Staphy-
lococcus epidermidis and Candida species (12,108). In these circumstances the fin-
ding of bacteremia actually may be an expression of failed host defenses, rather than 
of infection in the traditional sense (9). 
The apparent paradox why no septic focus can be identified clinically or at autopsy in 
more than 30% of bacteremic patients, led to the concept of the gut being the source 
of translocating bacteria and thus being the 'motor' of MOF (9,109). 
The gut and Its association with MOF 
Under normal conditions the splanchnic circulation receives about 30% of the cardiac 
output and contains approximately one-third of the total circulating blood volume 
(110). Hypovolemic or cardiogenic shock results in a profound splanchnic vasospasm, 
generating an effective autotransfusion to the systemic circulation. However, the 
resulting splanchnic ischemia may lead to mucosal damage throughout the whole 
intestine, finally resulting in transmural infarction (63). It has been suggested that the 
gastro-intestinal tract is not only a target organ in critical illness, but that it may have a 
more active role in the pathogenesis of MOF (109). This is attributed to the presence 
of large amounts of bacteria and endotoxins in the bowel. 
Living bacteria have been shown to cross the intact intestinal mucosal barrier and to 
appear in mesenteric lymph nodes, peritoneal fluid and other organs. This process is 
called bacterial translocation and it has been demonstrated to occur under a variety of 
conditions, such as hemorrhagic shock, severe burns, pancreatitis, severe inflammati-
on, abdominal abscesses and after endotoxin administration (9,111-115). 
Endotoxins are lipopolysaccharide compounds of the outer membrane of Gram-
negative bacteria. They can cause numerous deleterious biological effects and are 
thought to be responsible for the detrimental changes observed in Gram-negative 
septic shock (116). Michie et al. (64) showed that endotoxin and TNFa induce similar 
metabolic responses in human beings, resulting in organ damage. Under pathological 
circumstances endotoxin can penetrate the mucosal barrier, leading to portal and 
systemic endotoxemia (117,118). 
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Since bacteria and endotoxin can play a significant role in the initiation and perpetuati-
on of the inflammatory cascade, the gut barrier function seems to be important. As 
discussed above, conditions such as trauma and shock may lead to mucosal damage 
by splanchnic ischemia, which in turn may result in loss of barrier function. Alterations 
of intestinal permeability have been demonstrated to occur under various pathological 
conditions (for review see chapter 8). Some authors reported an association between 
increased intestinal permeability, endotoxemia, bacterial translocation and infectious 
complications (114,119,120). However, Alexander et al. (118) elegantly demonstrated 
that the process of microbial and endotoxin translocation is different from the 
absorption of for instance inert sugars, which are frequently used in investigations on 
intestinal permeability. Nevertheless, it is often suggested that the finding of increased 
intestinal permeability will probably also mean bacterial and endotoxin translocation 
and thus contribute to the development of MOF (9,99,121). 
In this respect data on selective decontamination of the gastro-intestinal tract are 
interesting. This procedure aims to selectively eradicate the Enterobacteriaceae -
organisms most likely to translocate -, while leaving intact the more harmless anaero-
bes to prevent bacterial overgrowth of pathogens (122). Selective decontamination 
has resulted in an impressive decrease in incidence of nosocomial infections in ICU 
patients, but sofar it has not been demonstrated conclusively to be effective in the 
prevention of MOF (123). 
Pathophysiological theories on the mechanisms leading to ARDS and MOF 
Based on the observations discussed in the previous paragraphs several hypotheses 
about the pathophysiological mechanisms leading to ARDS/MOF have been develo-
ped. Some of these theories can be summarized as follows (9,10,99,124): 
* Sepsis theory. Invading bacteria or their toxic products, such as endotoxin or 
exotoxin are thought to be the primary cause that trigger the cascade leading to 
ARDS/MOF. It remains a matter of debate, however, whether patients with ARDS/MOF 
die from bacterial infection, or just with infection. 
* The gut as "the motor of MOF". Intestinal^ derived bacteria and endotoxins serve 
as a trigger to initiate, perpetuate or exacerbate the "septic" state. There is of course 
an overlap with the first hypothesis. This theory yields an attractive explanation for the 
fact that in a lot of patients with clinical signs of sepsis and lethal MOF no bacterial 
focus can be found. However, the clinical relevance of the role of bacterial trans-
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location and endotoxemia - both extensively demonstrated experimentally - is yet to 
be elucidated. 
* Microcirculatorv hypothesis. Organ dysfunction is related to ischemia or microvascu-
lar-endothelial injury. This includes the mechanism of inadequate tissue and cellular 
oxygen delivery (125), ischemia-reperfusion injury (38,60), and tissue injury due to 
endothelial-leukocyte interactions (126). There are many overlapping points in this 
hypothesis with the following two theories (9). An important clinical observation that 
supports this theory is that circulatory shock with resulting tissue hypoxia is one of the 
most common clinical events that precedes MOF (6,9). In addition, autopsy data show 
evidence of diffuse microvascular injury in patients with lethal MOF (39). 
* Uncontrolled inflammatory response by an excessive and prolonged activation or 
stimulation of humoral and cellular systems. In this theory the activation of humoral 
and cellular inflammatory systems is exaggerated and out of control. Teleologically, 
inflammation is intended to be a local process, but after an overwhelming stimulus a 
systemic activation of inflammatory cells and thus a systemic spill-over of inflammatory 
products and mediators may be present. This may then lead to whole body inflamma-
tion with damage to remote organs not primarily involved in the primary injury (4,7,12). 
The macrophage is thought to play a major role in this process (127). 
* Two hit phenomenon. An initial insult primes the host such that on a second 
subsequent event the host's response is greatly amplified, resulting in an autodestruc-
tive inflammatory response. In fact, this represents a combination of the hypotheses 
mentioned above. 
At the moment there is no consensus what key factor is responsible for the final 
common pathophysiological pathway observed in the development of ARDS and 
MOF. But, whatever theory or mechanism fits this key role, there is agreement that a 
cascade of events precedes MOF. In addition, it is important to realize that ARDS and 
MOF are entities that represent a pathophysiologic continuum of progressively 
increasing severity. 
According to Goris (4) we can schematically represent this proces in time by discrimi-
nating several events (or stimuli or triggers) that can be graded by scoring systems. 
Each event can be characterized by increased levels of circulating biochemical sub-
stances, which are then called markers of that event. 
If these substances are actively involved in the development or triggering of a next 
event by inducing damage to otherwise healthy tissues they are mediators of that 
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process. If increased amounts of mediators are detected prior to subsequent ARDS 
and MOF, these substances then are predictors of ARDS and MOF. 
For example, elastase - a protease released by activated PMNs - can cause damage 
to proteins, such as elastin, and mediates endothelial cell injury. Elevated serum 
elastase levels have been shown to correlate well with injury severity and the final 
development of ARDS and MOF. Thus, elastase is a marker of PMN activity and 
trauma severity, a mediator for endothelial injury and a predictor of ARDS and MOF 
(7). 
To fully analyze the sequence of events, the following procedures should be perfor-
med. 
* A time scale should be set to separate cause from effect. 
* Primary insults have to be identified and graded according to severity, such as 
the severity of trauma, shock, pancreatitis, peritonitis. 
* The physiological responses to these primary events need to be graded also, 
for instance by APACHE II score, Glasgow Coma Scale, or sepsis scores (see 
appendix). 
* Body fluids, mainly blood, should be sampled sequentially to detect substances 
that could serve as markers, mediators or even as predictors. 
* Finally, parameters adequately defining organ function are necessary, and 
scoring systems to quantify the degree of organ (dys)function during follow up 
of the patient's clinical course. 
With this concept and on the basis of the literature (3,4,10,38,44,99), we constructed 
figure 1.1, which is a diagram showing the interrelations of several events, risk factors, 
scoring systems, (potential) markers, mediators and predictors in relation to the 
development of ARDS and MOF. Instead of a fixed time scale we used levels that 
range from the initial level 1 (primary, causative event) to the final level 7, being the 
effect, viz. ARDS, MOF and/or death. 
Questions and aim of the study. 
The aim of this thesis was to further delineate several components of the aforementio-
ned levels of the cascade resulting in ARDS and MOF. The accent was put on clinical 
observations and determinations in patients known to be at risk of ARDS and MOF, 
such as patients with severe trauma, in hemorrhagic shock due to a ruptured 
abdominal aneurysm, undergoing major elective vascular surgery, or with severe 
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pancreatitis. We were especially interested in these patients, because they primary 
have a non-bacterial challenge, allowing to study the time-relation between primary 
event, inflammatory response, evential occurring infection-endotoxemia-sepsis and 
subsequent complications, such as ARDS/MOF. 
The following three main issues and various connected questions will be addressed in 
the respective chapters: 
1. What is the role of scoring systems, grading the severity of trauma, disease 
and organ dysfunction in relation to subseguent ARDS/MOF ? (level 1 to 7). 
a. What is the (predictive) value of several scoring systems towards final outcome, 
i.e. either ARDS, MOF or death. Do disease-specific scoring systems (e.g. for 
pancreatitis) provide more information about outcome than non-specific scoring 
systems, like the APACHE II score? (chapter 2) 
b. Is there a difference between anatomical severity grading and physiological 
response grading concerning the predictive value for outcome after severe 
trauma? (chapter 3) 
с What is the difference in prognostic information of severity of disease classifica­
tion systems, like the APACHE II score, and organ failure scoring systems, like 
the MOF score? (chapters 2 and 3) 
2. What is the relation of various circulating products of the inflammatory cascade 
with subseguent ARDS/MOF ? (level 1, 3 and 4). 
a. The predictive value of lactate concentrations in multiple trauma patients 
towards subsequent ARDS/MOF. (chapter 2) 
b. Evaluation of complement activation, acute phase reaction, eicosanoid producti­
on and PMN and macrophage activation after multiple trauma, (chapter 4) 
с Cytokine production after multiple trauma, hemorrhagic shock and major 
vascular surgery, (chapter 5) 
d. Serum lipofuscin concentrations as indicator of lipid peroxidation following 
severe trauma and acute and elective major vascular surgery, (chapter 6) 
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Figure 1.1 
* = asterisks indicate parameters that are evaluated in this thesis. 
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3. What is the role of the gut in relation to the development of ARDS/MOF with 
emphasis on its barrier function (intestinal permeability) ? (level 1, 2 and 5). 
a. Does endotoxemia occur after severe trauma or major vascular surgery? If so, 
is there evidence that endotoxin plays a key role in the cascade leading to 
ARDS and MOF? (chapters 7 and 9) 
b. Is intestinal permeability altered after multiple trauma, hemorrhagic shock or 
major vascular surgery? (chapters 9 and 10) What is the value of intestinal 
permeability in relation to bacterial translocation and subsequent complicati­
ons? (chapter 8) Does altered intestinal permeability relate to subsequent 
ARDS and MOF? (chapters 8, 9 ,10) 
с What information is provided by measurements that give an indication of the 
splanchnic ischemic insult (gastric tonometry) in multiple trauma patients? Does 
the latter measurement correlate with changes in intestinal permeability? 
(chapter 11) 
In the general discussion (chapter 12) we will address the question whether our 
clinical studies provide evidence that ARDS and MOF are the result of an overwhel­
ming generalized autodestructive inflammatory response of the host to the primary 
insult. 
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Abstract 
Between 1980 and 1990, 39 patients, admitted to the ICU of the St. Radboud Universi-
ty Hospital, Nijmegen, were surgically treated for acute hemorrhagic necrotizing 
pancreatitis (AHNP). 
Five scoring systems were retrospectively investigated for the prediction of severity 
and outcome: Ranson score, Imrie score, APACHE II, MOF score and SSS. 
Twenty-two of the patients died (56%). The survivors were significantly younger than 
the non-survivors, of whom 68% died within 3 weeks of admission to the Intensive 
Care Unit (ICU). Stay in the ICU was significantly longer ICU in the former group. 
Sensitivity in prediction of death was best with the APACHE II score > 9 (96%) and 
Ranson score > 3 (95%). Of the five scores the MOF score > 4 gave the best 
equilibration between sensitivity (73%) and specificity (76%) and the strongest 
prediction of lethal outcome (80%). 
Although the independent factor age had low sensitivity (55%) it showed the highest 
specificity (88%) and prediction of death (86%). 
APACHE II score is concluded to be the best for grading the severity of disease on 
admission to the ICU, while the MOF score is best for monitoring the degree of organ 
dysfunction and the intensity of supportive treatment. 
Introduction 
Acute pancreatitis presents a broad clinical spectrum ranging from a mild disorder to 
a fulminant lethal disease resulting in multi-organ failure and death. Mortality rates 
reported in large series of acute pancreatitis range from less than 3% to 10% (1-5). 
The actual mortality rate even may be higher as cases diagnosed at necropsy are not 
included in most series (6). In patients with acute hemorrhagic necrotizing pancreatitis 
(AHNP) mortality varies from 30% to 90% depending on the extent of necrosis of the 
(peri-)pancreatic tissue and the severity of organ failures (2,7,8). Sepsis and MOF still 
are the main cause of death in this group of patients (2). 
Surgical treatment is indicated in AHNP when the patient's condition deteriorates. In 
one case series AHNP was fatal in 100% of patients without, and 63% of those with 
surgical treatment (9). To accurately evaluate the effects of therapeutic intervention, 
therefore, it is of the utmost importance to grade the severity of pancreatitis and to 
identify potential non-survivors. In the present study, we retrospectively investigated 
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several scoring systems for predicting outcome in 39 patients with laparotomy proven 
AHNP. 
Scoring systems (see appendix, chapter 14) 
The widely accepted APACHE II system was originally devised for classification of 
severity in acute diseases and to predicting hospital mortality among cases admitted 
to ICU (10). The system has of three components, viz. an acute physiology score, that 
can be influenced by therapeutic interventions; and non-dynamic components such as 
age and chronic health evaluation. The system is well suited for the stratification of 
patients and comparison of treatment methods. Although it was not designed for 
following the clinical course, many studies showed it to be usefull for monitoring this 
course and the response to therapy (3,4). Nevertheless the score may improve while 
the number and intensity of therapeutic interventions increase. 
The Ranson (11,12) and Imrie (13,14) scoring systems were evolved for evaluating 
acute pancreatitis. They respectively comprise 11 and nine clinical and biochemical 
criteria collected within 48 hours from the onset of the disease and permit identifica-
tion of patients with mild or severe pancreatitis. Mortality was shown to increase with 
the numbers of positive criteria. The scores consist of factors as age, specific 
pancreatitis linked parameters (i.e. serum calcium and glucose levels), and criteria of 
remote organ dysfunction like pulmonary (arterial p02), renal (BUN), and liver (serum 
LOH and AST levels) function parameters. The scores indicate the severity at onset of 
the disease and are not intended for monitoring the clinical course. 
The Sepsis Severity Score (SSS) (15) was developed to grade the severity of sepsis 
at any given time and to permit follow up of the patient's progress. Its four compo-
nents are: local effects of tissue infection, pyrexia, secondary effects of sepsis and 
laboratory data. As both the cause and the effects of sepsis are used to compute the 
total score, some conditions are scored multiply, e.g. a positive bloodculture with fever 
and leucocytosis. Furthermore "secondary effects of sepsis" and "laboratory data" 
concern mainly alterations in the function of several organ systems (liver, kidney, CNS 
and blood), but do not include data from the most important sources such as the 
pulmonary, cardiovascular and gastro-intestinal organ systems. 
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The Multiple Organ Failure score (MOF score) (16). was developed to grade the 
function of the seven main organ systems: the pulmonary, cardiovascular, hepatic, 
renal, nervous, hematologic and gastro-intestinal system. It comprises a three-point 
scale. The score can be used at any time and is well suited for following the clinical 
course during ICU treatment. Included in the score are laboratory data, a few clinical 
diagnoses and the number and intensity of several therapeutic interventions neces-
sary to support organ functions. 
Patients and methods 
During a ten year period (1980-1990) 39 patients with AHNP were admitted and 
treated in the departments of General Surgery and Intensive Care. This selected 
group of patients required mechanical ventilation for more than 24 hours because of 
respiratory failure: 22 had been referred from other hospitals for intensive care 
treatment. AHNP was diagnosed at the first laparotomy in all patients. At the time of 
the initial hospital admission the severity of acute pancreatitis was defined according 
to Ranson and Imrie criteria. 
On the day of ICU admission patients were scored using the APACHE II system. MOF 
score and SSS were determined daily. For each patient these latter scores were 
calculated to give an average for the entire ICU-stay and also for the first four days of 
ICU-stay. Survivors were defined as patients discharged alive from the hospital and 
non-survivors as those who died from AHNP or its complications during hospitali-
zation. 
Differences between groups were tested using the Mann - Whitney U-test. Correlati-
ons were calculated using the Spearman's correlation coefficients. Probability values 
of less than 0.05 were regarded as significant. 
Results 
Twenty-two (56%) of the 39 patients died. Mortality among primarily treated patients in 
our ICU was 59% and 55% patients referred from elsewhere (table 2.2). The median 
age of survivors was 40 years and of non-survivors 57 years (p=0.0048). Of the 17 
patients aged over 55 years survived only two survived. 
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ТаЫе2.2 
Age and sex of 39 patients with AHNP. 
8 Survivor· 
1 Non-eurvlvor· 
1Totai 
number of 
patients 
17 
22 
39 
Sex 
(female/male) 
7/10 
6/16 
13/26 
Age 
40(19-69) 
57 (24-63)** 
Referred 
10 
12
 I 
22 I 
** : ρ = 0.0048 
The average Ranson score for survivors was 3.5 and for non-survivors 4.6 (p = 
0.037), while the respective Imrie averages were 2.7 and 4.0 (p = 0.021) (table 2.3). 
On ICU admission APACHE II scores averaged 9.8 (12-17) in the survivors and 14.1 
(7-24) in the non-survivors (P < 0.001). When the contribution of age points to the 
APACHE II score was excluded, these figures became 8.9 (5-15) and 11.0 (4-21), 
respectively (p = 0.057). The factor age in APACHE II, thus, contributed significantly in 
prediction of outcome in AHNP. 
Table 2.3 
Number of positive criteria according to Hanson et al. and Imrie et al. in 39 patients with AHNP. 
Difference between groups according to Ranson: ρ = 0.037, and according to Imrie: ρ = 0.021. 
Ranson: 
I 
I Survivors (n=17) 
I (mean 3.5) 
Non-survivors (0=22) 
(mean 4.6) 
0 
-
-
1 
1 
-
2 
3 
1 
3 
6 
6 
4 
2 
5 
5 
4 
3 
6 
1 
2 
ì 7 
-
5 
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Inule: 
Ι 
Survhrora (π=17) 
(mean 2.7) 
Non-survlvora (η=22) 
(mean 4.0) 
0 
1 
-
1 
3 
1 
2 
7 
3 
3 
1 
4 
4 
2 
7 
5 
3 
2 
6 
-
3 
2 7 
-
2 
The stay ¡η the ICU was significantly shorter for non-survivors than for survivors (mean 
21 days versus 51 days, ρ = 0014). Of the non-survivors, 68% died during the first 3 
weeks of ICU admission, while during this same period only two of the 17 survivors 
could be discharged from the ICU. 
A good correlation was found between the MOF score and SSS (Spearman's 
corr.coef. r = 0.65, ρ < 0.001). 
The average daily values of MOF score and SSS for the entire ICU-stay significantly 
differed between survivors and non-survivors (p < 0.001) (table 2.4A). The average for 
the first 4 days of ICU-stay (table 2.4B) showed significant intergroup difference for 
MOF score (p = 0.012), but only an indication of significance for SSS (p = 0.054). 
Table 2.4 
Average MOF scores and SSS (median - range) 'm 39 patients with AHNP. 
Table 2.4A: For the entire ICU-stay. ** = ρ < 0.001 
Survivors (n=17) 
Non-survivors (n=22) 
MOF score 
2.0(1.2-3.5) 
4.5(1.7-8.2)** 
SSS 
12.3 (7.2 - 17.3) 
20.4(11.9-27.6)** 
Table 2.4B: For the first 4 days in ICU. * : ρ 0.012, and (*) : ρ = 0.054 
Survivors (n=17) 
Non-survivors (n=22) 
MOF score 
3.0 (0.8 - 6.8) 
4.7 (1.3 - 8.0)* 
I ' 1. I I - . . — . ! _ . . , I . . 
SSS 
16.5(9.0-28.0) 
21.8 (10.3 -27.0)(*) 
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Table 2.5 summarizes the sensitivity, specificity and the positive and negative p-
redictive values. In figure 2.1 the average MOF score of the first four days is plotted 
versus age: 16 of 20 patients (80%) with an average MOF score г 4 died. Of the 
patients older than 60 years, only the patient with the lowest MOF score (1.5) 
survived. 
When clinical deterioration occurred, relaparotomy was performed for debridement or 
to search for a septic focus. Excluding the reoperations for technical reasons like 
wound closure or restoration of bowel continuity, all patients underwent one or more 
(1-13) relaparotomies, averaging 4.8 in the non-survivors and 6.2 in the survivors. In 
82% of the relaparotomies debridement was performed or a septic focus was found. 
Between survivors and non-survivors there was no difference in the incidence of these 
intra-abdominal findings. 
Table 2.5 
Sensitivity, specificity, and predictive values with five scoring systems, and age as an independent 
factor, in 39 patients with AHNP. Between [ ] the values are shown when age as a contributing factor 
was excluded for calculations. 
Score 
APACHE II > 9 
Ranson г 3 
Inule г Э 
SSS 2 20 
MOF г 4 
Age > 55 
Sensitivity 
(%) 
96 [73] 
95 [77] 
82 [68] 
55 
73 
55 
Specificity 
<%) 
59 [65] 
24 [29] 
65 [71] 
76 
76 
88 
Positive 
predictive value 
(%) (death) 
75 [73] 
62 [5η 
75 [75] 
75 
80 
86 
Negative 
predictive value 
(%) (survival) 
91 [65] 
80 [50] 
73 [63] 
57 
68 
60 
Comment 
Prediction of outcome in acute pancreatitis has been extensively reported (1,3-5,11 -1-
4). Some of these studies compared and evaluated different scoring systems (3-5). 
We have found no reports on the evaluation of such scoring systems in the subgroup 
of patients with the most severe form of of the disease: acute hemorrhagic necrotizing 
pancreatitis (AHNP). The present group of AHNP patients was highly selected, 
because of the need for more than 24 hours of mechanical ventilation. Previous 
authors (2) reported 38% mortality in a series of AHNP, but only 12 needed mechani­
cal ventilation for more than 24 hours and developed MOF, and eigth (67%) died. This 
example emphasizes the need for stratification and classification of AHNP patients by 
the use of scoring systems. 
Figure 2.1 
Average MOF score for the first 4 days of ICU-stay versus age in 39 patients with AHNP. 
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Such systems can be useful for predicting mortality, severity of disease and intensity 
of its complications. 
The 56% mortality rate in our series is comparable to the rates in other studies of pa-
tients treated by total pancreatectomy (60-75%) or by excision of necrotic tissue (37-
64%) (8.17,18). 
To illustrate the listed aspects we compiled data of several large series of acute 
pancreatitis, where classification as severe occurred in 16% to 26%, using the Ranson 
and/or Imrie scores (1,3-5,14). Among the patients with severe pancreatitis mortality 
was 31% to 50% and AHNP developed in 18% to 68% (2-5,8,9,14.19). On the other 
hand, only 76% to 79% of proven AHNP cases were originally classified as severe 
(2,14). Of our cases, 87% were classified as severe according to Ranson score, but 
only 62% with Imrie score. Thus, there is a considerable group of patients with 
pancreatitis apparently mild at the onset which later evolves to AHNP. These scoring 
methods gave a reasonable indication of the severity of pancreatitis, but our results 
(24% and 65%) confirmed the poor specificity shown by others (3). 
Peak APACHE II score, recorded during the first 3 post-admission days, was used in 
a recent study of acute pancreatitis (4). When the peak score was more than 9, the 
negative predictive value was very good for survival (95%), but low for death (45%). In 
the present study we used the APACHE II score on ICU admission and at more than 
9 obtained similar prediction of survival (91%), but a higher figure for death (75%). We 
thus can confirm the statement that the APACHE II score provides a higher accuracy 
and better prediction of outcome than Ranson and Imrie scores do (4). The MOF 
score was the most accurate predictor of death (80%), and gave a well equilibrated 
sensitivity (73%) and specificity (76%). The most important difference between the 
MOF score and APACHE II score is the fact that the MOF score includes intensity of 
therapeutic interventions and grades the severity of organ dysfunction. Thus, it is 
possible that an ICU-patient may have a high MOF score but a low APACHE II score. 
Therefore the MOF score is the more informative of the two as regards the severity of 
illness. 
The SSS showed the lowest sensitivity (55%) and the difference with the MOF score 
has already been pointed out. 
It is well known that age is a factor significantly contributing to the prediction of 
outcome in patients with AHNP (1,2). As this factor is an independent variable and 
cannot be influenced, prediction of outcome should be possible irrespective of age 
(1). Moreover, increasing mortality in relation to age is not always due to the specific 
complications of the pancreatitis per se (20). Our results show that, though sensitivity 
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was low (55%), the factor age showed the highest specificity (88%) and positive 
predictive value for death (86%). Age is not included in MOF and SSS scoring, but the 
influence of this variable as part of the APACHE II score, and Ranson and Imrie score 
is clear from table 5. When age was excluded the sensitivity of these scores was 
greatly reduced. 
Our results demonstrate that prolonged ICU-stay was not necessarily an unfavourable 
prognostic factor, as 68% of the non-survivors died during the first 3 weeks in the 
ICU, whereas only two of the 17 survivors could be discharged from the ICU in the 
same period. 
In conclusion, we advocate the APACHE II score for grading the severity of disease 
on admission hospital or ICU. For monitoring the grade of organ dysfunction and 
intensity of supportive treatment the MOF score is well suited. Use of these two 
scoring methods with consideration of the patient's age permits a fairly good predicti-
on of outcome in patients with AHNP. 
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Abstract 
In 56 polytraumatized patients with an ISS г 33 we prospectively collected data of 
seven scoring systems (ISS, TS, TRISS, GCS, PTS, APACHE II, SSS) and sequentially 
determined blood lactate concentrations. These data were analysed in relation to later 
developing Adult Respiratory Distress Syndrome (ARDS) and Multiple Organ Failure 
(MOF). 
Twenty-two patients developed ARDS and 18 MOF. Of the mentioned scoring systems 
only ISS, PTS and SSS were predictive of subsequent ARDS, and only ISS and SSS 
of subsequent MOF. Lactate concentrations at day 2, 3 and 4 were significantly 
different between patients with and without subsequent ARDS and/or MOF. Surprisin­
gly, APACHE II did not correlate with subsequent ARDS and/or MOF, nor showed any 
significant relation with lactate concentration at any time. By stepwise regression 
analysis ISS, SSS and lactate at day 3 were the most significant variables toward the 
development of ARDS and MOF. 
It is concluded that scoring systems directly grading the severity of groups of trauma 
patients have predictive value for late and remote complications such as ARDS and 
MOF, while scoring systems that grade the physiologic response to trauma - though 
clearly related to mortality - have no such predictive value. 
Introduction 
Measuring the severity of illness, the degree of sepsis, the severity of trauma or the 
intensity of organ failure by scoring systems has been subject of many studies. Most 
of these studies had mortality as endpoint. As ARDS and MOF are the major cause of 
prolonged intensive care treatment and put a heavy burden on health care, it is 
imperative to identify markers that predict these syndromes (1,2). In polytraumatized 
patients at risk of death and late and/or remote complications, such as ARDS and 
MOF, almost any of these scoring systems may be applied, depending on the time 
after injury or the topic of interest during the clinical course. 
Multiple trauma often leads to shock with ischemic injury and tissue hypoxia. As soon 
as oxygen supply falls below the critical level, blood lactate starts to rise, reflecting 
anaerobic metabolism as response to the oxygen debt (3-5). A clear correlation 
between blood lactate levels and circulatory shock has frequently been shown and in 
septic shock lactate is one of the most reliable predictors of outcome (3,4,6,7). Regar-
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ding polytrauma only a few reports studied the correlation between the severity of 
injury and plasma lactate concentrations (8-10). 
In the present study we evaluate the relative value of several scoring systems for 
severity of injury or illness and plasma lactate concentrations in relation to the 
development of ARDS and/or MOF in severe polytraumatized patients. 
Scoring systems (see appendix) 
Injury Severity Score 
In 1974 Baker et al. devised the Injury Severity Score (ISS) based upon the Abbrevia-
ted Injury Scale (AIS) by summing the squares of the 3 highest values obtained in five 
body regions, with 0 points for no injury and 5 points for a critical lesion (11). The 
maximal ISS then is 75. ISS scores the severity of anatomical injury in victims of blunt 
trauma and correlates well with mortality (10-14). The Hospital Trauma Index (HTI) is 
an adaptation of AIS, containing both anatomical and physiological elements in six 
body regions (15). As HTI utilizes more objective diagnoses, its use instead of AIS 
was advocated (12). Nevertheless, a very good correlation between ISS-HTI and ISS-
AIS has been shown (13). The main criticism on ISS concentrates on two elements: 1. 
there is a systematical underprediction of death, as ISS fails to identify the patient 
population in which death occurs from head injury (12,16,17); 2. there is no adjust-
ment for age as a risk factor. A solution to this latter problem has been offered by 
Bull's probit method, weighting age and ISS, or by the TRISS method (14,18). ISS is 
the most widely used system for grading the severity of injury. Attempts to improve 
the score by adding biochemical data or varying AIS values have failed until today 
(10). 
Trauma Score 
The Trauma Score (TS) was developed in 1980 by Champion et al. for rapid asses-
sment and field triage of the injured patient (16). The score also can be used for 
reviewing prehospital care. TS measures physiological changes caused by the injury. 
It consists of simple respiratory and hemodynamic information, combined with the 
Glasgow Coma Scale. The score ranges from 1 (worst) to 16 (best prognosis). TS 
has been shown to have a high predictive power as to survival and death (16,19,20). 
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TRISS method 
Physiologic (TS), as well as anatomic characteristics (ISS) and age are combined in 
the TRISS method, which is used to quantify probability of survival after injury (18.20). 
The method was especially developed for evaluating trauma care, but can of course 
be applied to any individual patient to estimate the probability of survival. The formula 
is: 
Ps = 1 / (1 + e-") 
where Ps is the probability of survival, b = bO + M (TS) + b2(ISS) + ЬЗ(А), with A = 
0 if the patient's age is < 54 and A = 1 if the age is > 55; b0...3 are coefficients 
derived from the Walker-Duncan regression analysis applied to data from thousands 
of analyzed polytrauma patients. These coefficients can change over time, as impro­
ved trauma care may lead to a decreased mortality. By substituting the calculated TS, 
ISS, age and the latest published coefficients the probability of survival (Ps) or death 
(1-Ps) can be calculated. More recently the Trauma Score has been replaced by the 
Revised Trauma Score (RTS) and in combination with new coefficients, this led to an 
improvement of prediction (18). At this time calculation of the RTS is reserved for after 
the fact evaluation of trauma care (18). 
Glasgow Coma Scale 
In 1974 Teasdale and Jennet introduced the Glasgow Coma Scale (GCS), a simple, 
reliable and generally applicable method for assessment and recording of the altered 
level of consciousness (21). Three aspects of behavior are scored independently: eye 
opening, best motor response and best verbal response. The scale ranges from 3 
(worst) to 15 (best). One must realise that additional injuries can negatively influence 
brain function as measured by GCS on admission (22). But as approximately 50% of 
the patients with severe head injury die, the information provided by the GCS is 
essential (10,12,20). The GCS also showed a good correlation with functional outco­
me of the survivors (21,23,24). The interobserver disagreement of GCS is very low, 
even in inexperienced or unskilled hands (19,21). Undoubtedly therefore, the GCS has 
been incorporated in other scoring systems, such as the Trauma Score, APACHE II 
and Polytrauma Score. 
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The Polytrauma Score 
The Polytrauma Score (PTS), developed in Hannover, Germany, in 1985, is an 
anatomical injury severity score including an age classification (17). In later publica-
tions the score was revised, with inclusion of the Horrowitz index (Pa02 / Fi02) and 
Base Excess, while the GCS was used to grade the severity of head injury (25). The 
score is thought to be more practicable than the ISS, while featuring an excellent 
correlation with the ISS (17,26,27). A recent study revealed that the interobserver 
disagreement in PTS was significantly less compared to ISS (27). In the present study 
we used the original PTS. 
APACHE II 
In 1985 Knaus et al. presented APACHE II, being a revised version of APACHE (Acute 
Physiologic And Chronic Health Evaluation), a severity of disease classification system 
developed to stratify acutely ill patients admitted to the ICU (28). Increasing scores 
(range 0 to 71 ) closely correlate with subsequent hospital death. The score consists of 
an acute physiologic score (APS), an age score and a chronic health score. APS is 
determined from the most deranged physiologic values during the initial 24 hours after 
ICU admission. While APACHE II was not developed for follow up of the clinical 
course, many studies showed that it is usefull in this respect (using daily APACHE II) 
and for studying the response to treatment (29). 
Sepsis Severity Score 
In 1983 Stevens developed the Sepsis Severity Score (SSS) for grading the severity of 
surgical sepsis (30). The system consists of a 6 point scale in seven important organ 
systems: lung, kidney, coagulation, cardiovascular, liver, Gl tract and neurologic. 
The final score is calculated by adding the squares of the 3 highest values of the 3 
organs with the most severe dysfunction. Several studies showed significantly different 
scores in survivors versus non-survivors and the score correlated well with the length 
of hospital stay in survivors (26,30,31). In fact the SSS scores the degree of multiple 
organ failure (26). In the present study we used a modification of the score by 
summing the points obtained in all 7 organ systems, leading to a maximum score of 
35 points. 
Multiple Organ Failure score 
The Multiple Organ Failure score (MOF score) was developed by Goris et al. in 1985 
to grade the (dys)function of the 7 main organ systems: the pulmonary, cardiovascu­
lar, hepatic, renal, central-nervous, hematologic and gastro-intestinal system (1). It 
consists of a 3 point scale (maximum score is 14). As the MOF score includes the 
intensity of therapeutic interventions necessary to support organ function as well as 
the severity of organ dysfunctions, this system accurately assesses the severity of 
MOF. It is well suited for follow up during ICU treatment and correlates well with 
outcome (1,29). 
Patients and methods 
During a two year period, data from 56 polytraumatized patients were prospectively 
collected as part of a multicentre trial on the evaluation of inflammatory mediators. 
Patients with blunt trauma, were admitted to 3 trauma hospitals in Europe (Innsbruck, 
Nijmegen and Vienna). Patients were included in the study if ISS (HTI) г 33, which 
equals at least two severe lesions in different body regions or one severe and two 
major lesions in three different regions. Extensive data collection was performed on 
admission and further daily during ICU admission. Bloodsampling was done daily in 
the first week and every other day in the second week. Three aspects were subject of 
our study: mortality, ARDS and MOF. 
Late lung failure or AROS was defined as an average Benzer Quotient > 0.45, from 
day 5 to day 14. The "Benzer Quotient" is the alveolar-arterial oxygen quotient: PA02 -
Pa02/ PA02 (32). This Quotient has been shown to differentiate patients with acute 
lung failure (ARDS) from those with other pulmonary dysfunctions like, e.g. obstructive 
airway diseases (32). 
Multiple organ failure (MOF) was defined as an average MOF score г 4 from day 5 to 
day 14. According to this definition, in our study all patients with a MOF score of 5 or 
more (a definition used before) were included, while patients that had only an inciden­
tal MOF score of 5 were excluded (1,29,33). 
Scoring systems were utilized as described above. Table 3.1 gives an overview of the 
time relation of the application of the scores. 
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Table 3.1 
Time table that shows the application of scores, lactate determinations and definition of 
ARDS and MOF. 
ISS 
TS 
TRISS 
GCS 
PTS 
APACHE II 
SSS 
MOF Score 
Benzer Quotient 
| Lactate 
On 
admission 
X 
X 
Within 
24 hours 
X 
X 
X 
X 
X 
Dally 
X 
X 
X 
Average 
day 5-14 
X 
X 
TS and GCS were scored on admission. ISS, PTS and TRISS were calculated from 
data collected on the first day of admission; for APACHE II and SSS we used the 
highest values within the first 24 hours after admission. 
Statistical analyses were performed using the Kruskall Wallis test and Wilcoxon two 
sample test for comparison between groups. Spearman's correlation coefficients were 
calculated to assess correlations between several parameters. A ρ value < 0.05 was 
considered to be significant. 
Results 
Fifty-six patients entered the study, 10 women and 46 men. The mean age was 33 
years (range 14-71). By inclusion criteria all patients had an ISS of > 33. 
Mortality was 14%, as only 8 patients died. Table 3.2 shows the cause of death in 
these patients. ARDS was diagnosed in 22 patients; 29 patients had no ARDS, 
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whereas 5 patients already died before day 5. The mean (± SD) ICU stay of patients 
with ARDS was 29 ± 15 days, and without ARDS 14 ± 12 days (p < 0.0001). 
Table 3.2 
Causes and day of death, ISS, age, GCS on admission and probability of survival (TRISS) of eigth 
patients with severe polytrauma 
patient age day of 
number death 
ISS GCS Probability of 
survival, TRISS (%) 
cause of death 
16 
19 
50 10 1% 
38 30% 
severe thoracic injury 
ruptured lungs 
brain death 
23 
26 
75 
57 
2% 
15% 
severe thoracic injury 
and brain death 
brain death 
50 
6 29 
57 15 70% 
29 
57 
50 
15% 
2% 
coagulopathy, ARDS 
+ acute renal failure 
(= early MOF) 
acute renal failure 
and brain death 
MOF 
37 37 57 1% MOF 
According to the definition utilized, 18 patients developed MOF. The average ICU stay 
of MOF patients was 32 + 18 days, and 15 ± 9 days (p = 0.0003) in 33 patients 
without MOF. 
Table 3.3 shows the mean values (± SD) of seven scores as regards mortality. All 
scoring systems, except PTS and GCS, showed a significant difference between 
survivors and non-survivors. PTS and GCS showed only an indication of significance 
with ρ values of 0.07 and 0.09, respectively. 
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Table 3.3 
Mean values (± SD) of seven scoring systems in survivors (n=48) and non-survivors (n=8). 
ISS 
TS 
TRISS 
GCS 
PTS 
APACHE II 
SSS 
Survivors 
44.3 ± 9.8 
10.3 ± 3.3 
0.53 ± 0.34 
Θ.5 ± 4.8 
39.1 ± 17.0 
15.7 ± 7.7 
10.5 ± 2.9 
Non-survivors 
55.1 ± 10.1 
6.6 ± 3.4 
0.18 ± 0.23 
5.6 ± 4.5 
49.8 ± 17.2 
24.3 ± 7.7 
14.1 ± 4.1 
P-value | 
0.006** J 
0.009** | 
0.004** 
0.09 
0.07 
0.02* 
0.01* 
* = ρ < 0.05 and ** = ρ < 0.01, by Wilcoxon's test. 
In table 3.4 and 3.5 the results of the scores are presented concerning ARDS and 
MOF. Only ISS and PTS showed significant differences between patients with and 
without ARDS. ISS and SSS were the only two scores that significantly differentiated 
between patients with and without MOF. 
Table 3.6 shows the relationship between the scoring systems and later developing 
ARDS (average Benzer Quotient) or multiple organ failure (average MOF score). Again 
significant correlations only existed between ISS and ARDS (r = 0.40) and between 
ISS (r = 0.38), SSS (r = 0.43) and MOF. 
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Table 3.4 
Mean values (± SD) of 7 scoring systems ¡η 51 patients with ARDS (n=22) and without ARDS (n=29). 
| 
I i s s 
I T S 
j TRISS 
GCS 
PTS 
APACHE II 
SSS 
No ARDS 
42.1 ± 7.2 
9.5 ± 3.7 
0.51 ± 0.36 
7.6 ± 4.9 
39.5 ± 14.2 
17.2 ± 8.6 
10.5 ± 3.4 
ARDS 
48.5 ± 11.6 
10.6 ± 3.4 
0.50 ± 0.34 
8.9 ± 4.7 
45.8 ± 18.9 
15.3 ± 8.0 
11.3 ± 3.1 
P-value 
0.04* 
0.22 
0.84 
0.31 
0.03· I 
0.45 
0.21 
* = ρ <0.05, by Wilcoxon's test. 
Table 3.5 
Mean values (± SD) of 7 scoring systems in 51 patients with MOF (n=18) and without MOF (n=33). 
ISS 
TS 
TRISS 
GCS 
PTS 
APACHE II 
SSS 
No MOF 
42.6 ± 8.1 
10.5 ± 3.5 
0.55 ± 0.34 
9.1 ± 4.9 
40.5 ± 18.5 
15.7 ± 7.5 
9.9 ± 2.8 
MOF 
49.1 ±11.5 
9.0 ± 3.7 
0.42 ± 0.36 
6.3 ± 4.2 
38.6 ± 14.3 
17.6 ± 9.8 
12.6 ± 3.5 
P-value 
0.03* 
0.19 
0.11 
0.06 I 
0.97 
0.63 
0.01* 
* = ρ <0.05, by Wilcoxon's test. 
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Table 3.6 
Relationship expressed by Spearman's correlation coefficients (r.) of seven scoring systems and mean 
values of scoring for MOF and ARDS (Benzer Quotient) In 51 patients. 
- - - • ' ~ ~ — 
ISS 
TS 
I TRISS 
GCS 
PTS 
APACHE II 
SSS 
Mean MOF score 
r. 
0.38 
-0.28 
-0.32 
-0.34 
0.01 
0.13 
0.43* 
P-value 
0.005 
0.04 
0.02 
0.01 
0.93 
0.35 
0.001 
Mean Benzer 
Quotient 
r. 
0.40* 
0.04 
0.19 
-0.03 
0.25 
0.12 
0.17 
P-value 
0.003 I 
0.78 I 
0.17 1 
0.80 
0.07 
0.41 
0.21 | 
(* = significant and relevant correlation with r a 0.4 and ρ < 0.05). 
As regards mortality, lactate levels were significantly different between survivors and 
non-survivors at day 2 (p < 0.05). Figures 3.1 and 3.2 illustrate the lactate levels 
during the first week of admission. Lactate levels in patients later developing ARDS 
showed an indication of significance at day 2 (p = 0.08) and were significantly higher 
at day 3, 4 and 5. Lactate levels were significantly higher in patients later developing 
MOF, beginning at day 2 and persistend so at day 3 and 4. Lactate concentrations 
correlated well with the mean MOF score (from day 5 to 14): at day 2 (r = 0.56, ρ = 
0.0001; at day 3 (r = 0.49, ρ < 0.001); and at day 4 (r = 0.45, ρ < 0.005). The corre­
lation between lactate concentrations and mean Benzer Quotient was only relevant at 
day 3 (r = 0.37 ρ = 0.01). 
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Table 3.7 
Relationship expressed by Spearman's correlation coefficients (r.) of seven scoring systems and 
serum lactate concentrations of the first three days of admission in 56 patients after severe poly­
trauma. 
ISS 
1TS 
1 TRISS 
1 GCS 
PTS 
APACHE 
II 
SSS 
Lactate 
day 1 
r. 
0.23 
-0.13 
-0.18 
-0.16 
0.29 
-0.002 
0.15 
P-value 
0.11 
0.39 
0.23 
0.26 
0.05 
0.99 
0.30 
Lactate 
day 2 
r. 
0.23 
-0.18 
-0.22 
-0.27 
0.07 
-0.10 
0.37 
P-value 
0.09 
0.19 
0.09 
0.04 
0.58 
0.48 
0.004 
Lactate 
day 3 
r. 
0.43* 
-0.15 
-0.29 
-0.23 
0.19 
-0.001 
0.43* 
P-value 
0.002 
0.28 
0.04 
0.10 I 
0.18 
0.99 
0.001 I 
(* = significant and relevant correlation with r » 0.4 and ρ < 0.05). 
In table 3.7 the relations between the seven scores and lactate concentrations of the 
first three days are given. Relevant correlations (г г 0.4 and ρ < 0.05) were only 
found between ISS and SSS and lactate concentration of day 3. 
Strikingly, APACHE II (highest value within 24 hours) - although significantly different 
between survivors and non-survivors - had no correlation with subsequent ARDS or 
MOF, nor showed any significant differences between patients with and without ARDS 
and/or MOF. Moreover, it had no significant correlation with any lactate concentration 
measured at any time. 
Finally, stepwise regression procedures showed lactate levels at day 3 and SSS 
(highest value within 24 hours) to be the best predictors of MOF, and ISS to be the 
best predictor of ARDS (p < 0.05). 
Figure 3.1 
Mean lactate levels (+ SD) of 51 polytraumatized patients divided into patients with AHDS (n=22) and 
without ARDS (n=29), (* = ρ < 0.05). 
lactate (mmol/l) 
NO ARDS ARDS 
Figure 3.2 
day 
Mean lactate levels (+ SD) of 51 polytraumatized patients divided into patients with MOF (n=18) and 
without MOF (n=33), ( · = ρ < 0.05). 
10 r 
lactate (mmol/l) 
NO MOF MOF 
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Discussion 
In the present study we evaluated the relevance of several scoring systems and blood 
lactate concentrations in relation to the development of ARDS and/or MOF in polytrau-
matized patients. Evidence is accumulating that a multicascade of inflammatory 
responses to different initiating events, such as trauma, sepsis, pancreatitis, and he­
morrhagic shock, finally may lead to ARDS and MOF (2,34). We were specially 
interested to study mediators and markers (risk factors) of this inflammatory cascade 
to unravel the possible correlations with and predictive values for subsequent ARDS 
and/or MOF. For trauma patients, the primary event in the inflammatory cascade of 
course is the injury and tissue damage itself. Severity of injury scoring systems may 
grade the intensity of this event. Circulatory shock and tissue hypoxia are directly 
associated with polytrauma. In this respect blood lactate level could be an informative 
marker. We will discuss the relevance of injury severity scoring (event-grading) and 
lactate (marker) for subsequent ARDS and MOF (see figure 3.3). 
Figure 3.3 
Schematic diagram illustrating the relations of subsequent events, severity grading and markers for 
the development of Multiple Organ Failure after polytrauma. 
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It should be emphazised that ISS and PTS particularly score the anatomical severity of 
injury, while TS scores the physiologic reactions of the organism to trauma at a certain 
moment. Also the GCS scores the physiologic response of one organ system: the 
central nervous system. TRISS compiles anatomical severity of trauma with the 
physiologic response, considering the patient's age. APACHE II includes no informati-
on on the severity of injury, but grades the physiological dysregulation - whatever the 
intensity of treatment - in combination with prehospital condition and age. In contrast 
to APACHE II, SSS grades not only the degree of physiological dysregulation in 7 
organ systems, but also incorporates the intensity of treatment, necessary to support 
these organ systems. In this aspect it is similar to the MOF score. 
The present study demonstrates that the only relevant scoring systems, accurately 
predicting ARDS and/or MOF in groups of patients with severe polytrauma, are the 
anatomical severity (and quantity) of injury scores (ISS and PTS) on one hand, and 
SSS that grades the intensity of initial organ dysfunction and support on the other 
hand. As SSS in fact is an organ failure scoring system it seems logical that it 
significantly correlates with later developing MOF. 
But the importance of SSS for subsequent ARDS and/or MOF fits within the concept 
that early organ failure, which is partly reversible, is the prerequisite for late MOF (34). 
It must be emphazised, however, that the statistically significant differences found 
between patients at the group level are likely to be very helpful in the individual 
patient, due to the large degree of overlap between the groups (table 4 and 5). The 
same is true for the statistically significant correlations found between scoring systems 
and ARDS/MOF, which actually are weak correlations, especially when considered in 
an individual patient. Nonetheless, despite these limitations the application of these 
scores in groups of patients reveals relevant information. 
Surprisingly, the physiological dysregulations measured initially by TS, GCS or 
APACHE II have no predictive value at all toward ARDS and MOF. These data confirm 
the findings of Cerra et al., who showed that APACHE II had no relevant ability to pre-
dict the development of MOF in postoperative surgical patients (35). A possible 
explanation for this finding in the present study of polytraumatlzed patients concen-
trates on three important aspects of APACHE II: age, chronic health evaluation and 
GCS. We studied relatively young patients with healthy prehospital status. The patients 
had been operatively stabilized before admission to ICU. In this postoperative setting 
it is difficult to score GCS adequately. A recent study showed that GCS soon after 
arrival at the emergency department had no predictive power toward outcome in 
patients after severe head injury (24). These authors pointed out that the GCS 
fiQ 
originally was proposed to be applied at least 6 hours after trauma. But in postope-
rative polytraumatized patients, who are ventilated and heavily sedated, this is hardly 
possible. On the other hand, the GCS on admission may negatively be influenced by 
factors not related to the anatomical severity of brain injury, such as additional injuries, 
shock and hypoxemia (22). Although in the present study 6 of 8 patients that died, 
had a very low GCS (< 5) on admission and 4 of them died because of the severity 
of brain injury, GCS did not identify patients later developing ARDS and/or MOF. 
Next to the severity of the traumatic event, tissue hypoxia as reflected by lactate 
concentrations was studied in correlation to subsequent ARDS and MOF. Some 
studies pointed out a positive correlation of lactate levels with mortality in polytraumati-
zed patients, but only few studies showed a correlation between lactate and later 
developing ARDS and MOF (8-10,33,35). 
It must be realised that the cause of high lactate levels in the initial phase after trauma 
is different from high lactate levels seen in patients with established ARDS and MOF 
(36). The latter probably is the consequence of the inability of the tissues to extract 
oxygen and to use it efficiently (37). This type of hypoxia with elevated blood lactate -
found at the end of the cascade that leads to MOF - closes a vicious cicle as it 
causes more organ dysfunction. The higher lactate levels found at day 5 and 6 in 
patients with ARDS and/or MOF support this concept. Our data further demonstrate 
that persisting high lactate levels in the first three days post-injury not only correlate 
well with the most relevant scoring systems ISS and SSS (table 3.7), but also confirm 
the predictive value of lactate levels toward subsequent ARDS and/or MOF (fig. 3.1 
and 3.2). Moreover, stepwise regression procedures showed that both parameters 
(ISS - SSS and lactate at day 3) independently were of significant importance for the 
development of these two syndromes. 
Finally, we conclude that in polytraumatized patients anatomical injury severity scoring 
systems (like ISS) positively correlate with subsequent ARDS and MOF. Scoring 
systems that grade the degree of early organ failure (like SSS) and serial lactate 
measurements similarly predict ARDS and/or MOF. Because therapeutical efforts to 
improve outcome of established ARDS and MOF have failed until now, the focus must 
be on prevention of these syndromes. As the severity of injury itself cannot be 
changed, agressive early and rapid resuscitation is necessary to diminish the 
accompaning hypoxic injury. 
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Abstract 
We prospectively evaluated several inflammatory mediators or markers (C3, C3a, 
terminal complement complex -TCC-, thromboxane B2 -TxB2-, C-reactive protein -
CRP-, elastase, and neopterin) in 56 patients following severe blunt trauma (ISS г 
33). Major aims of study were the analysis of the relation between inflammatory 
mediators and scoring systems, multiple organ failure (MOF) and mortality. 
Elastase levels showed the best correlation with severity of injury (corr. coefficient at 
day 1 with ISS r = 0.50, with Trauma Score r = -0.63). 
Non-survivors (n=8) had significantly higher C3a and elastase levels on the first post-
injury day, compared with survivors (n=48). No difference between these groups was 
found for TCC, TxB2, CRP, and the neopterin/creatinine ratio. 
Five patients died before day 5. Eigthteen patients developed MOF, which was 
diagnosed from day 5 onwards, leaving 33 patients without MOF. The patients with 
subsequent MOF showed significantly higher (mean ± SEM) levels of C3a (914 ± 190 
ng/ml), TCC (57 ± 17 U/ml), and TxB2 (275 ± 37 pg/ml) at the first post-injury day, 
than the patients without MOF (566 ± 1 1 0 ng/ml, 27 ± 2 U/ml, and 169 ± 14 pg/ml, 
respectively). In patients with MOF elastase levels were significantly higher at day 2, 3, 
4, and 5 post-injury. Neopterin/creatinine ratios, on the other hand, were significantly 
higher in patients with MOF when MOF already had established (at day 8 and 10). 
From the present data it is concluded that in polytrauma patients excessive triggering 
of the inflammatory cascade, as expressed by complement activation and stimulation 
of polymorphonuclear leukocytes producing elastase, plays an important and early 
role in the development of MOF. 
Introduction 
Death after polytrauma occurs either immediately at the scene of the accident or 
within hours after the event when patients are hospitalized (1). These fatalities are 
mainly due to the severity of injury or to direct complications from the primary injury. 
The third possibility then is late death after days or even weeks, because of compli­
cations in remote organ systems not necessarily affected by the primary trauma. In 
the latter group most patients die of adult respiratory distress syndrome (ARDS) and 
multiple organ failure (MOF), syndromes that are thought to have one common 
pathophysiological background (2,3). This group is of special interest, not only 
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because of the great impact these patients have on ICU occupation, but also because 
the mechanisms leading to ARDS/MOF and subsequent death still have to be 
unravelled. 
In polytrauma patients head injury accounts for approximately 50% of the deaths, 
hemorrhage for about 10 - 15% and ARDS, MOF and sepsis for approximately 30 -
35% (4,5). The incidence of MOF after polytrauma varies from 21 - 47% (4-7) and 
mortality within this group from 20 - 30%, depending on patient populations studied 
and definitions used. Unfortunately, there is still no general consensus about the 
definition of this syndrome and therefore conclusions of various reports are difficult to 
compare and can lead to contradictory findings. 
It remains puzzling why in two patients, with equal preexisting condition, similar 
trauma and treatment, one recovers within few days and the other develops ARDS 
and MOF and subsequently dies. One hypothesis on this paradigm is that a varying 
inflammatory reaction following trauma may lead to a sequential autodestructive 
process in various organ systems (2). 
The present study on polytrauma patients was performed to investigate the role of 
mediators and markers of the inflammatory cascades in relation to scoring systems 
for severity of injury and disease, the development of MOF, and mortality. The follo-
wing parts of the inflammatory cascades were studied: complement activation, acute 
phase protein synthesis, thromboxane production, polymorphonuclear leukocyte 
(PMN) and macrophage activation. 
Complement activation 
Complement activation plays a central role in the inflammatory cascade, because of 
the release of anaphylatoxins, that trigger a series of other biological events (8). 
C3 is the initial key component that is activated either by the classical or the alternati-
ve pathway, the latter being the main route after trauma (8). From the activated split 
products we chose C3a for measurement, because other products are more rapidly 
cleared from the circulation (9). C3a and its ratio with C3 (C3a/C3) has been shown to 
correlate positively with outcome after trauma or septic shock (8-10). In addition, we 
measured the Terminal Complement Complex (TCC), which is a complex formed by 
C5b, C6, C7, C8 and C9 and indicates the activation of the terminal complement 
pathway (11). Since the generation of TCC requires activation of C5 to C5a and C5b, 
TCC can be used as an indirect indicator of C5a formation (12). 
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C-Reactive Protein 
The acute phase reaction is a general and non-specific response to most forms of 
infective and non-infective inflammatory processes, trauma, tissue necrosis and 
neoplasias (13). C-reactive protein (CRP) is a fast reacting acute phase protein, 
synthesized by hepatocytes under the influence of humoral mediators, such as 
prostaglandin-E1 or, especially, interleukin-6 (14). It may play a vital role as an 
opsonic protein in the immediate post-injury period when complement is consumed 
(15). It probably acts primarily as a protective mechanism, but in some circumstances 
CRP may also initiate or exacerbate inflammatory lesions (13). Some studies showed 
a positive correlation between the severity of (surgical) trauma and levels of CRP 
(16,17). 
Thromboxane B2 
Eicosanoids, with a broad spectrum of biological activities, represent a class of lipid 
mediators, derived from polyunsaturated fatty acids (18). The major natural source is 
arachidonic acid. Enzymatic catalysation of arachidonic acid leads to either prostag-
landins and thromboxanes by the cyclooxygenase pathway, or to leukotrienes by the 
lipoxygenase pathway. In the present study thromboxane B2 (TxB2), which is the 
inactive metabolite of the main biologically active product thromboxane A2 that is 
known to have strong vasoactive and platelet stimulatory effects (18), was chosen to 
evaluate the cyclooxygenase pathway. Many different inflammatory triggers (e.g. 
allergic reactions, toxic oxygen radicals, endotoxin) and especially septic or circulatory 
shock are associated with enhanced eicosanoid formation (18,19). 
Elastase 
There is plenty of evidence that PMNs play a major part in triggering complications in 
septic or post-traumatic patients (6,9). The enzyme elastase is released from stimula-
ted PMN's at the site of injury, infection or inflammation and can cause tissue damage 
and subsequent organ dysfunction. By measuring the complex of elastase with its 
inhibitor a1-proteinase (Elastase-a1 PI) in plasma, the degree of PMN activation can 
be quantified (20,21). 
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Neopterin 
There is increasing evidence that activated macrophages play a key role in the 
airtodestructive inflammatory response to traumatic or septic events (3). After immune 
stimulation, e.g. by endotoxin or τ-interferon, activated macrophages produce and 
excrete the inactive metabolite neopterin (22). Neopterin is cleared from the circulation 
in a creatinine-like manner and can be measured in blood as well as urine (23,24). To 
correct for possible renal insufficiency, we therefore used the neopterin / creatinine 
ratio to grade macrophage activation. 
Patients and methods 
During a two year period, data from 56 polytraumatized patients were prospectively 
collected as part of a multicenter trial on the evaluation of inflammatory mediators and 
scoring systems (25). Patients with blunt trauma were admitted to 3 trauma hospitals 
in Europe (Innsbruck, Nijmegen and Vienna). Patients were included in the study if 
Injury Severity Score (ISS) (26) calculated from the Hospital Trauma Index (HTI) (27) 
was г 33, which represents at least two severe lesions in different body regions or 
one severe and two major lesions in three different regions. On admission the severity 
of injury was graded by the ISS as well as the Trauma Score (TS) (28). Extensive data 
collection was performed on admission and daily during ICU admission, up to two 
weeks after injury. 
Blood sampling at the ICU was done daily in the first week and every other day in the 
second week. Biochemical measurements were performed as follows: C3a was 
determined by ELISA technique according to Zilow et al. (29), C3 by radio-immuno-
diffusion (NOR-Partigen, Behring Diagnostics, FRG) and TCC according to Deppisch 
et al.(30), CRP by an ¡mmuno-turbidometric assay (Orion Diagnostica, Espoo, Fin-
land), thromboxane B2 by RIA as described by Flynn et al.(31), elastase-a1 proteinase 
inhibitor complex by ELISA (Merck, Darmstadt, FRG) and neopterin was determined 
using a RIA (Henning, Berlin, FRG) with neopterin/creatinine ratio expressed as 
/¿mol/mol. 
Three items were subject of our mediator study: scoring systems, MOF and mortality. 
Survivors were defined as patients discharged from hospital alive; non-survivors were 
patients that died in hospital because of any post-traumatic complication. 
For all patients APACHE II score (32) and MOF score (2,33) were calculated daily. For 
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determination of the MOF score and APACHE II the most deranged values of the 
various contributing parameters of each day were used. 
The MOF score according to Goris et al.(2) grades organ function as normal (0 point), 
moderately disturbed (1 point) or severely disturbed (2 points), with a maximum of 14 
points in seven main organ systems (table 1). MOF was defined as an average MOF 
score г 4, from day 5 to day 14 (25). 
Statistical analyses were performed using the Wilcoxon two sample test for compari­
son between groups. Spearman's correlation coefficients were calculated to assess 
correlations between several parameters. Ρ < 0.05 was considered to be significant. 
Results 
Fifty six patients entered the study, 10 women and 46 men. The mean age was 33 
years (range 14 - 71). The mean (±SD) ISS of all patients was 46 ± 10 (range 33 -
75). Mortality was 14%, as 8 patients died. Table 4.2 shows the cause of death and 
the day after admission these patients died. Mean ISS of survivors was 44 ± 10 and 
of non-survivors 55 ± 10 (p < 0.01). 
As five patients died early (within 3 days) we only provide data concerning inflamma­
tory mediators in relation to mortality of the first day of admission. Differences 
between survivors and non-survivors for the various mediators are shown in table 4.3. 
At day 1 only complement activation, expressed by C3a/C3 ratios, and elastase levels 
were significantly different between survivors and non-survivors. The differences for 
the C3a/C3 ratios were mainly caused by significantly increased levels of C3a in the 
non-survivors. TCC showed a tendency towards higher levels in non-survivors compa­
red to survivors (p = 0.07). 
Correlation analyses of mediators during the first four post-injury days and injury 
severity scoring systems (ISS and TS) are shown in table 4.4. ISS correlated signifi­
cantly with TCC on day 1, 2 and 4 and with elastase on the first three days post-inju­
ry. No significant correlations were found between ISS and the other mediators during 
this period. TS on the other hand, showed significant correlations with C3a/C3 ratios 
almost continously during the whole observation period, mainly because of signifi­
cantly inverse correlations between TS and C3a. (The higher levels of activated 
complement correlate with a worse (lower) Trauma Score). The same was true for TS 
and elastase. Except for a significant correlation between TS and CRP levels on day 3 
and 4, no other mediators showed significant correlations with TS in the early post­
eo 
injury period. 
Table 4.2 
Injury Severity Scores (ISS), cause and day of death in the eight patients that died. 
patient nr. 
2 
3 
4 
5 
ISS 
50 
38 
75 
57 
57 
57 
50 
57 
day 
1 
3 
3 
3 
3 
6 
9 
37 
cause 
severe thoracic injury 
ruptured lungs 
brain death 
severe thoracic Injury 
and brain death 
brain death 
coagulopathy, ARDS 
+ acute renal failure 
(= early MOF) 
acute renal failure 
and brain death 
MOF 
MOF 
Table 4.3 
Inflammatory mediators (mean ± SD) in survivors (η=4θ) and non-survivors (n=8) determined on the 
first day after injury. * = ρ < 0.05 and * · = ρ < 0.01, by Wilcoxon. 
C3 (mg/ml) 
C3a (ng/ml) 
C3a/C3 χ 1000 
TCC (U/m!) 
CRP (mg/l) 
TxB2 (pe/mi) 
Elastase (ng/ml) 
Neop/creat (^mol/mol) 
Survivors 
0.67 (0.31) 
604 (571) 
0.96 (0.79) 
36(34) 
55 (51) 
194 (92) 
539(337) 
837 (488) 
Non-survivor· 
0.71 (0.28) 
1331 (619) 
3.23 (4.24) 
53(28) 
33(24) 
237 (155) 
1006 (287) 
906 (476) 
ι · ~ ' " 1 
P-value 
0.32 
0.01* 
< 0.001*· 
0.07 
0.41 I 
0 , 9 
0.03. I 
I 
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Table 4.4 
Spearman's correlation coefficients between several mediators and two Injury severity grading 
systems applied on admission: Injury Severity Score (ISS) and Trauma Score (TS), during the first four 
days of admission (* = ρ < 0.05 and ** = ρ < 0.01). 
(4.4 a) ISS 
MEDIATOR DAY 
СЭ 
C3a 
СЗа/СЗжЮОО 
I т с с 
j CRP 
I Elastase 
Neop/creat 
1 TxB2 
1 
0.15 
0.19 
0.10 
0.53** 
-0.01 
0.50* 
0.16 
0.28 
2 
0.19 
0.30* 
0.25 
0.3B* 
0.11 
0.53* 
0.15 
-0.11 
3 
0.05 
0.12 
0.18 
0.25 
0.19 
0.43* 
0.14 
-0.02 
4 
-0.05 
0.15 
0.20 
0.44** 
0.14 
0.28 I 
0.009 
-0.15 
(4.4 b) TS 
MEDIATOR 
C3 
C3a 
C3a/C3x1000 
TCC 
CRP 
Elastase 
Neop/creat 
TxB2 
DAY 
1 
0.01 
-0.29 
-0.36* 
-0.05 
-0.12 
-0.63* 
-0.23 
-0.04 
2 
0.09 
-0.39* 
-0.46** 
-0.08 
0.17 
-0.62*· 
0.007 
-0.11 
3 
0.05 
-0.29* 
-0.41** 
-0.06 
0.36* 
-0.35* 
0.14 
-0.06 
4 
0.22 
-0.22 
-0.35* 
-0.09 
0.47** 
-0.72** 
0.15 I 
0.09 I 
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Significant correlations (r > 0.3 and ρ < 0.05) were found in the early post-injury 
period between APACHE II and complement activation (expressed by СЗа/СЗ) (day 1 : 
r = -0.40; day 2: r = -0.48) and elastase levels (day 1: r = 0.39; day 2: r = 0.33), but 
not between APACHE II and TCC, CRP, TxB2 or neopterin/creatinine. 
Since five patients died before day 5, 51 patients were left for classification of 
subgroups with or without MOF. Of these 51 patients, MOF was diagnosed in 18 
cases. Figure 4.1 (a+b) shows the mean values (± SEM) of six mediators during the 
two week study period in patients with and without MOF. On day 1 TCC, TxB2 and 
C3a were significantly higher in patients with MOF, while CRP was lower on day 1 and 
2. The most protracted differences between patients with and without MOF were 
found for elastase: practically the whole first week post-injury the levels were signi­
ficantly higher in patients with MOF. Neopterin/creatinine ratios did not show any signi­
ficant difference between both groups during the first week. However, significantly 
higher neopterin/creatinine ratios were found in patients with MOF at day 8 (p = 0.04) 
and day 10 (p = 0.005), while there was an indication of significance at day 12 (p = 
0.06). 
Discussion 
In the present report we prospectively evaluated inflammatory mediators in relation to 
scoring systems for severity of injury and disease, subsequent MOF and mortality. 
It should be emphasized that we studied a homogeneous group of severely traumati­
zed patients, who at least had two severe or one severe plus two major lesions in 
different body regions (= ISS > 33). This is in contrast to most other reports, that 
evaluate a much wider range of "multiple" injured patients, even including those with 
an ISS of less than 18 points (7,9,12,34). This might implicate that in the present study 
differences between groups will become less easily evident. On the other hand, if 
differences between groups occur, they could be pathophysiologically more relevant. 
Complement and PMN activation, expressed by C3a or C3a/C3 ratios and elastase 
levels, respectively, appeared to be the most significant mediators for differentiation 
between survivors and non-survivors. This is in line with other studies, not only repor­
ting on trauma patients, but also about patients after major elective surgery and 
sepsis (8,10-12,20,21,35,36). 
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Figure 4.1 (a) 
Mean (± SEM) values of C3a, TCC, CRP, TxB2, Elastase and Neopterin/creatinine ration during a two 
week ICU observation period in 51 multiple trauma patients with MOF (solid line, η = 18) and without 
MOF (broken line, η = 33). Ρ values are indicated by asterisks: (*) = 0.05 s p < 0 . 1 0 , * = p < 0.05 
and ** · ρ < 0.01, by Wilcoxon. 
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Previously we reported that ISS and TS both could significantly discriminate between 
survivors and non-survivors, but that only ISS - mainly grading the anatomical severity 
of injury - showed a good correlation with subsequent ARDS and MOF (25). For TS 
however - scoring the physiologic reaction of the organism to injury at a certain 
moment - this relation could not be demonstrated. However, both anatomical (ISS) 
and physiological (TS) scoring systems showed reasonable correlations with comple-
ment activation and elastase levels, but not with CRP, TxB2 or neopterin/creatinine 
ratio. Good correlations have been demonstrated between the severity of trauma and 
elastase (6,9,37) and between complement activation and tissue trauma (11,12,34). 
The importance of the activation of the complement system and PMNs in the post-
traumatic course is further underlined by the moderate correlations found with the 
APACHE II scoring system. This latter scoring system, originally meant for disease 
classification, gives information about the physiological derangement and necessity of 
treatment (32). 
The most important observation is, that we found significantly higher levels of 
complement activation (C3a and TCC), as well as TxB2 levels at the first post-injury 
day in patients with subsequent MOF compared to those without subsequent MOF, 
while elastase levels were significantly elevated practically the whole first week in the 
former patients. 
CRP concentrations, on the other hand, were initially higher in patients without MOF. 
This latter finding is not in agreement with a previous report, that showed a similar rise 
of CRP levels in both patient group with and without MOF during the first four days 
post-injury, with a significant elevation in MOF patients from day 5 onwards (6). We 
also could not demonstrate a positive correlation between severity of injury (expres-
sed by ISS and TS) and CRP, while other reports clearly showed that the magnitude 
of (surgical) trauma correlated well with the levels of CRP production (15-17). A 
possible explanation could be that the patients in the present study all had such a 
severe trauma that this led to similar CRP levels according to the "all or nothing 
phenomenon" theory of Colley et al. (38). On the other hand, it remains questionable 
to what extent liver damage and insufficiency may contribute to the initial lower CRP 
production in patients developing MOF. 
The role of the prostanoid TxB2 in the development of ARDS and MOF remains 
unclear. Some authors reported a positive correlation with subsequent ARDS (19,39), 
while others could not confirm this (40). We could only demonstrate a significantly 
higher level of TxB2 on the first post-traumatic day in patients with subsequent MOF. 
Neopterin concentrations in blood and urine have been shown to predict outcome of 
8fi 
patients with viral infections (including AIDS), autoimmune diseases and graft vs host 
reactions (41). Also, in multiple trauma and sepsis patients it was demonstrated that 
increased levels of neopterin are associated with poor outcome (6,7,41). Since 
neopterin is exclusively eliminated by the kidneys in a creatinine-like manner (23,24), it 
remains questionable whether the plasma neopterin concentrations may be used as 
an independent parameter. Nast-Kolb et al. (6) concluded in their study on 69 multiple 
trauma patients that neopterin was a reliable parameter in predicting subsequent 
organ failure from day 2 to 5, but after this period elevated neopterin levels were 
mainly caused by retention due to renal insufficiency (6). In the present series we 
therefore used the corrected neopterin concentrations during the whole observation 
period. We could only demonstrate a significant rise of the neopterin/creatinine ratio in 
MOF patients in the second week. This is in line with the finding of Nathan (42) who 
concluded that it apparently takes several days for macrophages after activation to 
fully develop their inflammatory capacity. 
The good correlation between neopterin/creatinine and APACHE II during the second 
observation week indicates that ongoing macrophage activation is related to physiolo-
gical derangement and organ dysfunction. 
The present data support the view that complement activation plays a central and 
early role in the inflammatory cascade leading to complications and poor outcome in 
multiple trauma patients. Complement activation is fundamental for bacterial opsonisa-
tion and recruitment of inflammatory cells by chemoattraction and elicits the release of 
lysosomal enzymes, like elastase, and oxygen radicals by PMNs, thus contributing to 
the defense against microorganisms, but also leading to cell and tissue damage, that 
ultimately may result in organ failure (11,35). 
Elastase indeed appears to be not only a marker of severity of injury and a mediator 
leading to proteolysis of a great variety of normal tissue substances, but also a factor 
significantly correlating with final outcome. 
The present study therefore underlines the importance of the complement system and 
PMN activity in the early post-traumatic phase, not only towards mortality, but also 
towards the major complicating syndrome: MOF. 
Finally, these data support the hypothesis that MOF is the result of an excessive 
uncontrolled autodestructive activation of inflammatory cells and mediators (2). 
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Abstract 
Adult respiratory distress syndrome (ARDS) and multiple organ failure (MOF) following 
severe trauma, hemorrhagic shock or ischemia-reperfusion injury are thought to be 
the result of an excessive uncontrolled activation of inflammatory cells and mediators. 
In the present study we investigated the plasma patterns of the cytokines TNFa, IL-1В 
and IL-6 during these events. 
Of 28 multiple trauma patients, 20 patients admitted in shock because of a ruptured 
abdominal aortic aneurysm (AAA) and 18 patients undergoing elective AAA repair, 
arterial blood was serially sampled on admission or at the start of the elective 
operation, after 6 hours and on day 1, 2, 3, 4, 5, 7. 9, 11, and 13 at the ICU. 
Twenty-two patients died, 15 within 48 hours and 7 after several weeks, due to 
ARDS/MOF. On hospital admission and after 6 hours these non-survivors had 
significantly higher plasma TNFa and IL-1B levels than the survivors, while the 
differences in IL-6 levels did not reach statistical significance. At the same measuring 
points TNFa and IL-13 were significantly more elevated in patients with ruptured AAA 
compared with the patients with trauma. On the contrary, IL-6 was significantly higher 
in the patients with trauma. 
Ten patients developed ARDS/MOF and 41 had an uncomplicated course in this 
respect. The patients with ARDS/MOF exhibited significantly different cytokine patterns 
in the early post-injury phase. TNFa and IL-1ß were higher mainly the first day of 
admission, while IL-6 appeared to be significantly elevated in patients with ARDS/MOF 
from the second day onwards. The latter cytokine showed a very good correlation 
with the daily MOF score during the whole two week observation period. 
It is concluded that in the early post-injury phase higher concentrations of the 
cytokines are not only associated with increased mortality, but also with an increased 
risk for subsequent ARDS and MOF. These data therefore support the concept that 
these syndromes are caused by an overwhelming autodestructive inflammatory 
response. 
Introduction 
Evidence is accumulating that the adult respiratory distress syndrome (ARDS) and 
multiple organ failure (MOF) are the result of a severe generalized autodestructive 
inflammation, in which micro-organisms may or may not be involved (1). Trauma, 
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shock and infection initiate a complex inflammatory response, in which the pro­
inflammatory cytokines TNFa, IL-13 and IL-6 are thought to play a pivotal role (2,3). 
The role of these cytokines has almost exclusively been studied in relation to the 
pathogenesis of infection and septic shock. Only a few studies deal with cytokinemia 
following trauma or hemorrhagic shock (5-10). Most of these - clinical and experimen­
tal - studies have mortality as endpoint. However, ARDS and MOF represent an 
important part of morbidity in the intensive care unit (ICU), being responsible for more 
than 70% of the ventilator days spent on the ICU (1,11,12). In addition, ARDS and 
MOF are the main cause of late death in surgical ICU patients and put a very heavy 
burden on health care (12). Therefore, unraveling the pathophysiology of these 
syndromes should be a major objective of study. We have investigated the role of 
circulating cytokines (TNFa, IL-1B and IL-6) in relation to the development of ARDS 
and MOF in patients with essentially a non-bacterial challenge: severe blunt trauma, 
hemorrhagic shock and major vascular surgery. 
Patients and methods 
Sixty-six patients were studied prospectively, including 1 β patients undergoing elective 
aortic surgery (16 abdominal aortic aneurysms and 2 thoraco-abdominal aortic aneu­
rysms), 20 patients with hemorrhagic shock because of a ruptured abdominal aortic 
aneurysm (AAA) and 28 patients with severe blunt trauma (Hospital Trauma Index -
Injury Severity Score [HTI-ISS] > 25) (13,14). All patients or their relatives gave 
informed consent to draw blood for analyses. 
Arterial blood was withdrawn from the patients undergoing elective aortic surgery at 
the time of incision, when they had already been anaesthesized (Oh) and after 6 hours 
and 24 hours. Subsequently, samples were collected daily during the first week and 
every other day during the second week, as long as patients were at the ICU with a 
maximum of two weeks. For the other patients, the first sampling point (Oh) was 
immediately after hospital admission. Thereafter, the same schedule was followed as 
for the patients undergoing elective surgery. 
Definitions 
An APACHE II score (15) was calculated for all patients at the time of hospital and 
subsequent ICU admission and further daily throughout the ICU stay. In order to 
ОЯ 
grade the intensity of organ failure a daily MOF score was calculated (1). Patients 
were diagnosed to have MOF, if the average MOF score between days 5 and 14 was 
>4 (16). ARDS was diagnosed when patients had bilateral diffuse infiltrates on the 
chest radiography, and progressive hypoxemia requiring mechanical ventilation 
resulting in a Pa02 / Fi02 ratio < 175 with PEEP > 10 cm H20 and - in case of prior 
cardiac disease - did not have a pulmonary artery wedge pressure exceeding 18 mm 
Hg (17). 
A shock score was defined to grade the severity of hemodynamic derangement after 
admission (16). For this purpose the Allgöwer shock index (heart frequency / systolic 
blood pressure) (18) and the systolic blood pressure were used: (0) no shock: index 
< 1.0 and systolic blood pressure > 100 mm Hg, (1) mild, compensated shock: index 
> 1.0 and systolic blood pressure > 100 mm Hg, (2) moderate shock: systolic blood 
pressure 80-100 mm Hg, (3) severe shock: systolic blood pressure < 80 mm Hg, (4) 
severe, prolonged shock: more than one hour systolic blood pressure < 80 mm Hg. 
Blood analysis 
Arterial blood was collected in sterile 4 ml tubes containing 0.048 ml EDTA-K, 
(Vacutainer Systems, Becton and Dickinson, Rutherford, New Jersey, USA) and 250 μ\ 
aprotinin (final concentration 625 kallikrein inactivating units per ml; Bayer, Lever­
kusen, Germany). After centrifugation at 2000 g for 10 minutes the resulting platelet-
poor plasma was transferred into sterile 1.5 ml tubes and samples were stored at -
20°C until further analysis. The samples were analyzed by fluidphase radio-immuno-
assay (RIA) for TNFa and IL-18, as described by Van der Meer et al. (19) and Cannon 
et al. (20). Prior to the IL-18 measurement the plasma was extracted with chloroform 
according to Cannon et al. (20). Detection levels in the assays were: TNFa, 60 pg/ml 
and IL-1B, 200 pg/ml. 
Arterial blood for IL-6 assay was collected in sterile 4 ml tubes and processed as 
described above. IL-6 was quantitated by ELISA technique. Microtiter flatbottom plates 
(Costar) were coated with anti-IL-6 monclonal (Moab) BE-8 (7 ^g/ml) in phosphate 
buffered saline (PBS) pH 7.4 (ΙΟΟμΙ/well). After 24 hour incubation at 4 °C, plates were 
washed with PBS with 0.02% (v/v) Tween-20, followed by a 60 minute/room tempera­
ture incubation of PBS with 5% bovine serum albumen (BSA) (200/*l/well). After was­
hing serial dilutions of standard recombinant human IL-6 (kind gift of Dr. L Aarden, 
CLB, Amsterdam) or serum samples were added to the plates and incubation 
proceeded for 1 hour at 37°C. After washing, 100 μ\ PBS/BSA with biotinilated anti-IL-6 
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Moab BE-4 (2¿tg/ml) was added to the wells. BE-4 and BE-8 recognize different 
epitopes. Following a 60 minute incubation and a washing step, 100 μΙ strepavidin 
horseradish peroxidase in PBS/BSA was added, followed by 45 minutes incubation. 
After washing a citric-acid buffer pH 5.2 with 0.003% H20 and ortho-phenyl diamine 
was added. The reaction was terminated with 4 mol/l H2S04 and the absorbance was 
read at 495 nm in an automated ELISA reader (Titertek). The detection level of this 
assay was 20 pg/ml. 
Arterial blood lactate was measured in deproteinized samples (0.6 mol/l perchloric 
acid) by enzymatic conversion of lactate into pyruvate. 
Statistical analysis 
The Kruskal-Wallis test and Wilcoxon two sample test were used to examine differen­
ces between patient groups when indicated. Pearson's correlation coefficients were 
used for correlation analysis. Ρ values of less than 0.05 were considered to be signi­
ficant. 
Results 
Demographic data of the 66 patients are presented in table 5.1. We differentiated 
between early (the first or second day of admission) and late mortality. Fifteen patients 
(8 with trauma and 7 with ruptured AAA) died early. Of the remaining 51 patients, 
ARDS/MOF developed in ten. Two patients with trauma developed ARDS without 
subsequent MOF and survived. One patient with a ruptured AAA had ARDS without 
MOF and survived as well. The remaining seven patients all had MOF (six including 
ARDS) and they succumbed between days 28 and 60 at ICU. Thus, total mortality was 
22 of 66 patients (33%). The 41 survivors who did not develop ARDS/MOF were 
considered as patients with an uncomplicated clinical course. 
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Table 5.1 
Demographic data of the study population. Data are expressed as mean ± SD. 
Elective 
Ruptured 
Trauma 
total 
N 
18 
20 
28 
66 
Age 
64±11 
70±7 
31±14 
Sex 
F/M 
3/15 
1/19 
6/22 
10/56 
APACHE 
II 
(ICU) 
6.2+4.0 
11.6±5.4 
9.9+7.0 
ISS 
-
-
38+11 
• ' • — 
Early 
death 
0 
7 
β 
15 
ARDS 
MOF 
3 
5 
2 
10 
Late 
death 
3 
4 
0 
7 
Uncom· I 
pli­
cated 
15 
θ 
18 
« I 
The course of the cytokine concentrations during the first two days in the three 
separate patients groups is depicted in Figure 5.1. On admission IL-1B and after 6 
hours TNFa were at a significantly higher level in patients with ruptured AAA compa­
red with the patients with trauma (p = 0.03 and 0.02, respectively). In this early post-
injury period (Oh), however, IL-6 was significantly more elevated in the patients with 
trauma compared with both vascular patient groups (p < 0.001). On day 1 and 2 the 
differences between groups concerning TNFa and IL-13 disappeared, but now IL-6 
was increased in the vascular patient groups, while in the patients with trauma a 
decrease could be observed. 
Figure 5.2 illustrates the course of cytokine concentrations during the first day of 
admission in relation to mortality. The corresponding p-values of these measurements 
are listed in table 5.2. Non-survivors had significantly higher TNFa and IL-1B concen­
trations, both on admission and 6 hours later. With respect to IL-13, this difference 
was mainly caused by the contribution of the late non-survivors who died of ARDSA 
MOF; in the case of TNFa both early and late non-survivors appeared to contribute 
equally to the observed difference with survivors. The differences in IL-6 concentrati­
ons between non-survivors and survivors did not reach statistical significance (p = 
0.07 and 0.08 at 6h and 24h, respectively). 
In addition, we did not find any significant difference in cytokine concentrations 
between early and late non-survivors. 
Table 5.2 
P-values of Wìlcoxon two sample tests for analysis of differences between cytokine concentrations of 
survivors and non-survivors (including early and late non-survivors). Corresponding cytokine 
concentrations are demonstrated In figure 5.2. 
IL-1B 
TNFo 
Κ­
Ι 
Time (hr) 
0 
6 
24 
0 
6 
24 
0 
6 
24 
All Non-
Survivors (NS) 
0.04* 
0 . 0 0 1 " 
0.02* 
0.003** 
0.002** 
0.67 
0.75 
0.07 
0.08 
Early NS 
(N = 15) 
0.32 
0.26 
0.15 
0.01* 
0.06 
0.12 
0.44 
0.006** 
0.18 
LateNS 
( N « 7 ) 
0.007** 
0.004** 
0.10 
0.08 
0.01* 
0.15 
0.17 
0.86 I 
0.29 
( · ш ρ < 0.05 and ** = ρ < 0.01). 
Figure 5.3 shows the course of the cytokine concentrations during the first two weeks 
at ICU in the group of 10 patients with ARDS/MOF and the 41 patients with an 
uncomplicated course. IL-1ß was increased in patients with ARDS/MOF at 6 hours and 
at day 1, but the difference did not reach statistical significance (p = 0.056 and 0.087, 
respectively). This difference completely disappeared between day 2 and 4 because 
the patients with an uncomplicated course showed a rise of IL-13. In the subsequent 
period IL-1 ß levels went down again in the "uncomplicated" group, while the levels 
remained elevated in patients with ARDS/MOF. 
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Figure 5.1 
Plasma cytokine concentrations in three patient groups during the first two days of admission. Data 
are expressed as medians in box plots ranging from the 25th to 75th percentile. Bars indicate 5th and 
95th percentile. Dotted lines indicate the detection limit of the various cytokine assays. 
I patients with ruptured AAA; trauma patients; 
'•'//\ patients after elective AAA repair. 
(*) = 0.05 < ρ < 0.10; * = 0.01 s ρ < 0.05 and ** = ρ < 0.01 
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Figure 5.2 
Plasma cytokine concentrations on the first day of admission in survivors and non-survivors. Data are 
expressed as medians in box plots ranging from the 25th to 75th percentile. Bars indicate 5th and 
95th percentile. Dotted lines indicate the detection limit of the various cytokine assays. 
" Ί survivors; | , .·' ' L non-survivors. 
(*) = 0.05 < ρ < 0.10; * = 0.01 s ρ < 0.05 and ** = ρ < 0.01 
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TNFa showed a somewhat similar picture. There was a significant difference in TNFa 
levels at 6 hours (p < 0.005) and an almost significant difference at day 1 and 2 (p = 
0.055 and 0.051, respectively). In the second week, TNFa levels rose in patients with 
ARDS/MOF and tended to normalize in the "uncomplicated" group. 
IL-6 levels showed a completely different course. At all measuring points the IL-6 
concentrations were significantly higher in the patients with ARDS/MOF than in the 
patients with an uncomplicated course, except for the first 24 hours, due to the large 
variation. 
A good correlation was found between ISS and IL-6 on admission, as well as 6 and 
24 hours later (r = 0.52, 0.43, and 0.53, respectively; all ρ < 0.05). A highly significant 
correlation (r = 0.83, ρ < 0.001) was found between IL-6 and lactate concentration at 
24 hours. Further correlation analysis between cytokines and ISS, shock score, lactate 
concentrations or APACHE II score did not show any consistent pattern of significant 
correlations. 
In all patients a daily MOF score was calculated and we correlated these values with 
the cytokine levels measured at different days. In the second week IL-1B and TNFa 
showed very good correlations with the MOF score, for instance: IL-13 at day 9 and 
MOF score at day 9 (r = 0.63, ρ = 0.02); IL-1B at day 11 and MOF score at day 13 (r 
= 0.68, ρ = 0.02); TNFa at day 7 and MOF score at day 7 (r = 0.77, ρ = 0.005); and 
TNFa at day 9 and MOF score at day 11 (r = 0.84, ρ = 0.001). 
Finally, striking correlations (all ρ < 0.01) were found between IL-6 concentrations and 
MOF scores from the second day onwards: day 2 (r = 0.64); day 3 (r = 0.53); day 4 
(r = 0.60); day 5 (r = 0.77); day 7 (r = 0.77); day 9 (r = 0.59); and day 11 (r = 0.63). 
Correlation analysis between the cytokine concentrations of all samples at various 
time points did not reveal any significant correlation. 
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Figur· 5.3 
Plasma cytokine concentrations during the first two weeks of ICU admission in 10 patients with 
ARDS/MOF (—0—) and 41 patients without ARDS/MOF (—*—). Data are expressed as mean ± SEM. 
(*) = 0.05 s ρ < 0.10; * = 0.01 s ρ < 0.05 and ** = ρ < 0.01 
1Yno(daye) 
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Discussion 
In the present study we found intriguing differences in cytokine profiles between three 
different patient groups representing different pathogenic conditions associated with 
an increased risk for subsequent ARDS/MOF: severe trauma, hemorrhagic shock 
(ruptured AAA) and ischemia-reperfusion injury (elective AAA). On admission and after 
6 hours, TNFor concentrations were significantly higher in patients after hemorrhagic 
shock than after trauma. In the former patients, higher IL-1 ß concentrations were also 
found on admission. These findings are in accordance with animal experiments 
showing that the induction of TNFa release after trauma is significantly enhanced 
when hemorrhagic shock is also present (4). Apparently, shock is the main factor 
leading to production and release of TNFa by macrophages. Experimentally, it has 
also been demonstrated that intestinal ischemia and reperfusion injury leads to 5 to 10 
fold increases of circulating TNFa (21), and that hypoxia alone is a major stimulus for 
human peripheral blood monocytes to produce and secrete IL-1 В and TNFa (22). 
The ischemia and reperfusion injury is likely to be responsible for the elevated levels 
of TNFa and IL-1 ß found in patients after elective aortic aneurysm repair. However, it 
remains unclear why in some of these patients after induction of anaesthesia and at 
the start of the operation increased TNFa and IL-1 β concentrations were found. The 
use of specific medication, like cyclooxygenase inhibitors, or the presence of chronic 
heart failure has been shown to lead to raised levels of circulating TNFa (23,24). 
However, only one patient (TNFa < 60 pg/ml) regularly used cyclooxygenase 
inhibitors, while one other patient exhibited signs of mild chronic heart failure (TNFa = 
110 pg/ml). Certainly, the role of anaesthesia in relation to the release of these cytoki­
nes needs further investigation. 
Our observations of increased IL-1ß concentrations after major trauma are in agree-
ment with the findings of Baigrie et al. (25), who demonstrated short-lived IL-1B 
responses to major surgical injury. It is more difficult to explain how our data relate to 
those of Faist et al. (9), who showed that the elevated number of circulating mono-
cytes found post-injury were not able to produce adequate amounts of IL-1B within 
the first eigth to ten days following trauma. This process was attributed to elevated 
concentrations of PGE2, downregulating TNFa and IL-1ß synthesis (8,9). However, it is 
currently unclear to what extent circulating monocytes contribute to ¡η-vivo production 
of cytokines. Bitterman et al. (10) could only detect TNFa and IL-6, but no IL-1ß 
activity, in a rat model of major surgery and shock. An explanation could be that we 
used chloroform extraction (20) to show IL-1B activity. In addition, there may be diffe-
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rences between the cytokine responses in rats and humans. 
We found quite a different profile for IL-6. Trauma patients exhibited the highest 
concentrations of IL-6 directly post-injury and 6 hours later. These data support the 
idea that IL-6 production is more closely tied to soft tissue trauma than other cytoki-
nes (4). The IL-6 profiles observed are also in agreement with the reports describing a 
relation between post-operative concentrations of IL-6 and the magnitude of surgical 
trauma (26.27). The delay in the IL-6 peak in the patients with ruptured and elective 
AAA might be explained by the fact that here IL-6 was mainly released by the surgical 
trauma of the vascular reconstruction, and also because IL-6 levels tend to follow 
TNFa and IL-1B peaks with some delay (2,25). It is of interest that the occurrence of 
shock apparently did not contribute significantly to the release of IL-6, since we found 
no difference between patients undergoing acute or elective major vascular surgery. 
The role of translocating bacterial endotoxin in the production and release of the 
cytokines in the present patient population remains unclarified. In 28 individuals (11 
patients with trauma, 10 with ruptured AAA and 7 undergoing elective AAA repair) we 
were able to look for blood endotoxin concentrations at 0, 6, 24 and 48 hours (16,28). 
In 15 patients (4 with trauma, 6 with ruptured AAA and 5 after elective AAA repair) 
endotoxemia could be detected (mostly at 0 or 6 hours) and all but two patients 
exhibited circulating TNFa at the same moment (data not shown). On the other hand, 
in 10 of the 13 patients without detectable circulating endotoxin we also found 
increased TNFa concentrations at one or more of the same time points. Thus, 
endotoxemia may be indicative for the presence of subsequent circulating TNFa, but it 
surely is not a prerequisite. Endotoxemia has been shown to occur after hemorrhagic 
shock, intestinal ischemia and reperfusion injury and even after elective aortic 
aneurysm repair (16,21,28-30), but it was only rarely detected in multiple trauma pa-
tients (31). There is ample evidence that endotoxin induces the production and 
secretion of TNFa, but it is clear that endotoxin is not the only factor responsible for 
the cytokine production in our patients. A great variety of microbial and non-microbial 
factors is known to be able to lead to cytokine production. 
The present data demonstrate that patients who succumb eventually exhibit much 
higher levels of TNFa, IL-1ß and IL-6 in the early post-traumatic phase than survivors. 
But the finding of increased cytokine levels in non-survivors was probably not an inde-
pendent phenomenon. The fact is that the large standard deviations indicate that the 
finding of elevated cytokine concentrations can hardly be expected to better predict 
prognosis in an individual patient than for instance the ISS or APACHE II score would 
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do. Nevertheless, the present data may help to elucidate the mechanism of inflamma-
tory response to trauma and shock. 
Finally, our data demonstrate a good correlation between cytokine levels and the 
development of ARDS and MOF. On the first two days after admission, TNFa was 
significantly elevated in patients with subsequent ARDS/MOF. This is in agreement 
with previous reports, in which TNFa levels were found to correlate with subsequent 
sepsis or septic episodes in post-injury patients (8,32,33). From these studies, 
however, it is not clear whether this phenomenon was linked to bacterial or non-
bacterial sepsis, since the presence of bacteria was not obligatory for the definition of 
sepsis in these studies. Such obscure use of the term sepsis and septic syndrome 
has already led to a lot of confusion in the discussion about the relation between 
bacterial sepsis (infection) and MOF. It would, therefore, probably be better to utilize a 
term like Systemic Inflammatory Response Syndrome (SIRS) as recently proposed by 
Bone et al.(34). 
With respect to the IL-1B levels, there only was an indication of a significant elevation 
in patients with subsequent ARDS/MOF on the first day after admission. An interesting 
finding was the rise of chloroform extractable IL-1 ß between days 2 and 4 in the 
patients with an uncomplicated clinical course. A similar phenomenon was observed 
during the recovery phase in patients with meningococcal infections (35). This finding 
might suggest a protective effect of IL-1B necessary in the course of reconvalescence, 
which is in line with the proposition that several cytokines not only synerge but also 
counterregulate each other (2,36). However, this observation might also be influenced 
by the assay method used and therefore this phenomenon is presently investigated 
further. Patients with ARDS/MOF, on the other hand, showed a trend of sustained 
elevated TNFa and IL-1 ß levels in the second week. This protracted cytokine release 
is probably associated with the organ damage observed in those patients. 
The presence of significantly increased IL-6 concentrations in the patients with 
subsequent ARDS/MOF is remarkable. This is also reflected by the striking correlation 
between IL-6 and the MOF score during the two weeks studied. While the patients 
with an uncomplicated clinical course showed a normalization of IL-6 in the second 
week, the release of IL-6 in the patients with ARDS/MOF remained abnormally high 
during this period. The same has been demonstrated in patients after major thermal 
injury (6) and septic shock (37). 
We could not demonstrate any relevant correlation between the concentrations of the 
three cytokines. This finding has also been reported previously (23,38) and therefore 
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our data support the concept that the production of these cytokines is regulated 
independently (38). 
In conclusion, after major trauma, hemorrhagic shock due to a ruptured AAA and after 
elective aortic aneurysm repair increased concentrations of the cytokines TNFa. IL-10 
and IL-6 are a common finding. The higher concentrations found in the early post-
injury time course are not only associated with increased mortality, but also with an 
increased risk for the development of ARDS and MOF. The present study therefore 
supports the concept that ARDS and MOF are syndromes caused by an excessive 
uncontrolled activation of endogenous inflammatory cells and mediators (1). 
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Chapter 6 
SERUM LIPOFUSCIN IS INCREASED AFTER MAJOR VASCULAR 
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AND IS RELATED TO SUBSEQUENT ARDS AND MOF. 
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Abstract 
Toxic oxygen radical damage is thought to play an important role in events like 
trauma and sepsis, where ARDS and multiple organ failure (MOF) are the major cause 
of late mortality. Serum lipofuscin has been proposed as a parameter to assess lipid 
peroxidation caused by toxic oxygen radicals. 
Serum lipofuscin levels were measured in 75 healthy controls of various ages and 
sequentially in 66 patients: the latter include 18 patients after elective major vascular 
surgery, 20 with a ruptured abdominal aortic aneurysm and 28 with severe blunt 
trauma. 
Fifteen of the 66 patients died early (within two days). Ten of the remaining 51 patients 
developed ARDS and/or MOF and 41 patients had an uncomplicated postoperative 
course. Serum lipofuscin concentrations in controls showed a positive correlation with 
age. Compared with controls all three patient groups showed significantly increased 
lipofuscin concentrations during the first day after major vascular surgery, trauma or 
shock, respectively. In addition, the 10 patients who subsequently developed ARDS 
and/or MOF showed significantly enhanced lipofuscin levels on day 1, compared with 
the 41 patients with an uncomplicated clinical course. 
Thus, we conclude that serum lipofuscin, which compound may act as a simple and 
valuable measure for grading the oxidative stress in human studies, is positively 
related to subsequent ARDS and/or MOF in patients at risk for these syndromes. 
Introduction 
It is well known that cell damage caused by toxic oxygen radicals takes place in many 
disorders, especially when inflammatory reactions or ischemia and reperfusion play a 
key role (1-3). Events such as severe trauma, shock and sepsis, trigger the activation 
of polymorphonuclear leukocytes, resulting in an respiratory burst with the generation 
of large quantities of toxic oxygen radicals (4-6). The release of these toxic oxygen 
radicals in vivo is thought to cause peroxidation of membrane lipids, resulting in cell 
damage (7,8). Because free radicals are highly reactive and have an extremely short 
half-life, unequivocal evidence that lipid peroxidation caused by radicals occurs in 
humans, is technically very difficult to obtain (9,10). The present evidence is mainly 
based on the measurement of degradation products of lipid peroxidation such as 
conjugated dienes and malondialdehyde in blood or tissue, or penthanes and ethanes 
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in expired breath. However, these assays all have their limitations and specific 
problems (9). 
Lipofuscin is a pigment which is formed as an end result of in vivo lipid peroxidation in 
organelles (11). Lipofuscin is defined as being a yellowish brown, lipid-soluble, 
cytoplasmic granular pigment having an intense yellow autofluorescence when 
exposed to ultraviolet light. The fluorescence measurement of these lipofuscin pig-
ments has been used as a parameter of lipid peroxidation in vitro as well as in vivo 
(11). 
Both adult respiratory distress syndrome (ARDS) and multiple organ failure (MOF), 
which syndromes are thought to have one common underlying pathophysiological 
pathway (12), are probably associated with a significant increase in oxidative stress 
(6). So far, limited data are available on lipid peroxidation in patients at risk for these 
syndromes. Patients after severe trauma or undergoing major elective or acute 
vascular surgery represent three different etiologic entities: tissue trauma, ischemia-
reperfusion injury and hemorrhagic shock, respectively. Therefore we studied the 
course of serum lipofuscin concentrations in these three patient groups and investiga-
ted its relation with clinical symptoms, in particular with respect to the development of 
ARDS and MOF. 
Patients and methods 
Normal values of serum lipofuscin were measured in healthy humans of different ages. 
For this purpose, venous blood was collected of 75 persons (22 females and 53 
males), who had no acute disease and were otherwise considered in good condition. 
In order to investigate the correlation in lipofuscin levels between arterial and venous 
blood, samples of both were withdrawn simultaneously from 14 hospitalized patients, 
who had indwelling arterial and venous catheters. 
Day to day variation in serum lipofuscin was examined in venous blood from five 
healthy volunteers collected on four consecutive days. 
Sixty six patients were studied prospectively, including 18 patients after elective aortic 
surgery (16 abdominal aortic aneurysms and 2 thoraco-abdominal aortic aneurysms), 
20 with hemorrhagic shock because of a ruptured abdominal aortic aneurysm and 28 
with severe blunt trauma (ISS-HTI > 25) (13,14). 
From the patients undergoing elective operation arterial blood was withdrawn at the 
time of incision (Oh), when patients had already been anaesthesized and after 6h and 
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24h. Subsequently, samples were collected daily during the first week and every other 
day during the second week, as long as patients were admitted to the ICU. From 
patients with a ruptured aneurysm and with trauma the first samples were obtained 
immediately after hospital admission (Oh). Thereafter, the same schedule was followed 
as for the patients undergoing elective surgery. Informed consent was obtained from 
all subjects or their relatives prior to the study. 
Definitions 
An APACHE II score was established in all patients at the time of hospital admission, 
of ICU admission and further daily throughout the ICU stay (15). In order to grade the 
intensity of organ failures a daily MOF score was calculated (12). Patients were 
diagnosed to have MOF, if the average MOF score between days 5 and 14 was >4. 
ARDS was diagnosed when patients had bilateral diffuse infiltrates on the chest radio­
graphy, and progressive hypoxemia requiring mechanical ventilation resulting in a 
РаО
г
 / Fi02 ratio < 175 with a PEEP > 10 cm H20 and - in case of prior cardiac 
disease - did not have a pulmonary artery wedge pressure exceeding 18 mm Hg (16). 
The Pa02 / Fi02 ratio was calculated daily in order to grade the pulmonary gas 
exchange. 
Lipofuscin assay 
Serum lipofuscin was measured essentially according to Tsuchida et al (11). Five ml 
ethanol/ether (3:1, v/v) were added to 150 μ\ serum and the mixture was shaken 
vigorously. After centrifugation (5 min. at 3000 g) the supernatant was discarded and 
the sediment washed once with 5 ml ethanol/ether. The final sediment was dissolved 
in 3 ml 67 mM phosphate buffer, pH 7.0. The fluorescence intensity of the solution 
was measured at excitation and emission wavelengths of 345 and 430 nm, respec­
tively, in a Hitachi F-3000 fluorescence spectrophotometer. A quinine sulphate 
solution, 1 mg/ml 0.1 M H2S04 and further diluted with phosphate buffer, was used to 
construct a standard curve (0.05 - 40 /*g quinine sulphate/ml). The lipofuscin concen­
trations are expressed as arbitrary units relative to the fluorescence of quinine 
sulphate. All samples were measured in duplicate, which showed less than 5% 
variation. 
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Statistical analysis 
The differences between the lipofuscin levels measured and the levels predicted (see 
methods section) for each patient group were tested by the Wilcoxon two sample test. 
The Kruskal-Wallis test was used to examine differences between patient groups. 
Pearson's correlation coefficients were used for correlation analysis. Ρ values of less 
than 0.05 were considered to be significant. The formula of Bayes was used to 
calculate the predictive value from sensitivity, specificity and prevalence. 
Figure 6.1 
Relation between age and serum lipofuscin concentration. The latter is expressed as arbitrary units 
relative to the fluorescence of quinine sulphate (Pearson's correlation coefficient r = 0.39, ρ < 0.01). 
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Figure 6.2 
Relation between lipofuscin concentrations in venous and arterial serum sampled simultaneously from 
14 different ICU patients (Pearson's correlation coefficient r = 0.51, ρ < 0.001). 
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Results 
Sera from healthy controls contained significant levels of lipofuscin. Values measured 
in persons of different ages are shown in figure 6.1. The Pearson correlation coeffi­
cient was r = 0.39, ρ < 0.01, indicating that the serum lipofucsin concentration 
increases significantly with age. The regression line of this equation was: y = 244 + 
2.5 χ. The day to day variation, as measured on four consecutive days in five controls, 
was small: the coefficients of variation ranged from 1.6% to 6.5% (mean 3.6%). Figure 
6.2 illustrates that a satisfactory correlation existed between arterial and venous lipo­
fuscin concentrations (r = 0.51, ρ < 0.001). The regression line through the origin 
was: y = 0.95 χ . 
As a consequence of these findings we concluded that the serum lipofuscin levels in 
our patients should be corrected for age using the regression line calculated above. 
Since venous samples were used to construct this line and patient samples were 
obtained from arterial catheters the regression line was corrected for the venous-
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arterial difference reported above. Thus, each patient is expected to show an arterial 
lipofuscin level of: [232 + 2.4 χ age] units/150μΙ serum. A deviation from this expected 
value then indicates enhanced (or suppressed) production of lipofuscin compared 
with healthy controls. Accordingly, we calculated for each patient the difference 
between the serum lipofuscin concentration actually measured and the concentration 
predicted. These data were used for statistical analysis. 
Table 6.1 
Demographic data of the study population. Data are expressed as mean ± SD. 
Elective 
Ruptured 
Trauma 
total 
N 
18 
20 
28 
66 
Age 
64+11 
70+7 
31±14 
Sex 
F/M 
3/15 
1/19 
6/22 
10/56 
APACHE 
II 
(ICU) 
6.2±4.0 
11.6±5.4 
9.9±7.0 
ISS 
-
-
38±11 
Early 
death 
0 
7 
8 
15 
ARDS 
MOF 
3 
5 
2 
10 
Late 
death 
3 
4 
0 
7 
Uncom­
pli­
cated 
15 
8 
18 
41 
I 1 
Table 6.1 shows the demographic data of the three patient groups. We differentiated 
between early mortality (the first or second day after admission) and late mortality. 
Fifteen patients died early, ten within the first 6 hours. Late mortality - in all cases due 
to ARDS and MOF - was seen in seven patients, which died between day 28 and 60 
at the ICU. In ten patients ARDS and/or MOF was diagnosed. Two trauma patients 
developed ARDS without subsequent MOF and survived. One patient with a ruptured 
aneurysm had ARDS without MOF and survived as well. The remaining seven patients 
all had MOF (six including ARDS) and none survived. Survivors who did not develop 
ARDS or MOF were considered as patients with an uncomplicated clinical course. 
We found no significant difference of lipofuscin levels on the first two days of admissi­
on between patients that died early and all other patients. 
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Figure 6.3 
Serum lipofuscin concentrations in the three patient groups during the first two days after admission. 
The numbers within the bars represent the number of patients in the various group. Concentrations 
are expressed (in arbitrary units) as the difference between the level measured and the level predicted 
and the mean ± SEM is given. For each group the difference between values measured and values 
predicted was tested for significance using a Wilcoxon two sample test: 
(*): 0.05 < ρ s 0.10; *: 0.01 < ρ s 0.05; **: 0.001 < ρ s 0.01; ***: ρ s 0.001. 
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Figure 6.3 shows the course of the lipofuscin concentrations, represented as the 
difference between the value actually measured and the value predicted, on the first 
two days in the three patient groups. No significant differences between the three 
groups were found at any of the sampling points. Six hours after the start of operati­
on, elective patients showed a significantly increased lipofuscin concentration. Both 
patient groups with trauma and ruptured aneurysm showed significantly increased 
lipofuscin levels at 6h and at 24h. Although all patients showed enhanced levels at 
time 0, the difference with the predicted values was only significant in the trauma 
group. Betweeen the three patient groups mutually no significant differences were 
found at any of the sampling points (Kruskal-Wallis). 
The APACHE II score on hospital admission in patients with ARDS/MOF (12.1 ± 4.6) 
was significantly higher (p < 0.01) than patients with a subsequent uncomplicated 
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recovery (7.9 ± 4.5); the same was true for the APACHE II score at ICU admission 
(13.1 ± 5.4 versus 7.2 ± 4.9). 
Figure 6.4 
Serum lipofuscin concentrations In patients with and without ARDS/MOF. The numbers above/below 
the bars represent the number of patients in the various group. Concentrations are expressed (in 
arbitrary units) as the difference between the level measured and the level predicted and the mean ± 
SEM is given. For each group the difference between values measured and values predicted was 
tested for significance using a Wilcoxon two sample test: (*): 0.05 < ρ s 0.10; *: 0.01 < ρ s 0.05; " : 
0.001 < ρ s 0.01; " * : ρ s 0.001. 
Differences between groups were tested for significance using a Wilcoxon test: #: 0.01 < ρ s 0.05; 
# # : 0.001 < ρ s 0.01. 
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In figure 6.4 the course in serum lipofuscin levels is compared between patients with 
an uncomplicated clinical course (n=41 at day 1) and patients who developed ARDS 
and/or MOF (π=10). Compared with controls in the patient group without complicati­
ons serum lipofuscin levels were significantly elevated after 6h and 24h, but signifi­
cantly lower between day 3 and 7. During the second week serum lipofuscin levels 
tended to normalize to baseline levels. The patients with subsequent ARDS/MOF also 
showed significantly increased lipofuscin levels at 6h and 24h compared with controls, 
but also higher levels than the patients with an uncomplicated clinical course. In 
addition, the patients with ARDS/MOF did not exhibit the decrease observed between 
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days 3 and 7, but their serum lipofuscin levels showed a renewed tendency to 
increase to supranormal levels in the second week, although these differences from 
predicted did not reach statistical significancy. Figure 6.5 illustrates the course of 
lipofuscin concentrations in three different patients: one trauma patient (S) with head 
injury, who had an uneventfull recovery and another trauma patient (B) who develo­
ped ARDS in the second week without MOF and who finally could be discharged rom 
ICU at day 26. The third patient (R) with a ruptured AAA developed ARDS and MOF 
and finally died on the ICU at day 31. 
Evaluation of sensitivity and specificity showed that the cut off point of 100 age-
corrected lipofuscin units/150μΙ serum at 24 hours after admission appeared to be the 
best predictive value towards subsequent ARDS/MOF. Eigth of ten ARDS/MOF 
patients had lipofuscin levels above the discrimination value of 100 units and 32 of the 
41 patients with an uncomplicated course below this cut off point. This resulted in a 
sensitivity of 80%, with a specificity of 78% and an overall accuracy of 78%. As the 
prevalence of ARDS/MOF in this patient population was 20% (10/51) the positive 
predictive value for the development of ARDS/MOF of > 100 units lipofuscin difference 
from predicted was 47% and the predictive value for an uncomplicated course was 
94% (calculated by the formula of Bayes). 
Finally, correlation analysis showed that lipofuscin concentration significantly correla­
ted with APACHE II score, not only on the first day of ICU admission, but also on day 
three, four, five and seven (day 1 : r = 0.50, day 2 r = 0.21, day 3 г = 0.74, day 4 r = 
0.60, day 5 r = 0.69 and day 7 r = 0.52, all ρ values < 0.01, except day 2). In 
addition, lipofuscin concentration showed a significantly negative correlation (r = -
0.38, ρ < 0.01) with PaOj / FiO, ratio on the first day of ICU admission, indicating the 
pulmonary (dys)function of that day. 
Discussion 
Toxic oxygen radicals are the major cause of neutrophil-mediated cell damage, which 
has been documented to occur after trauma, shock, cardiopulmonary bypass surgery 
and ischemia and reperfusion injury (6,10,17,18). The plasma membrane, especially 
that of the endothelial cells, is the critical site of toxic oxygen radical reactions (3). The 
end products of their reaction with polyunsaturated fatty acids are lipid peroxidation 
products like conjugated dienes, malondialdehydes, 4-hydroxynonenals and fluores­
cent products like lipofuscin (3,6,11). 
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Figure 6.5 
Course of serum lipofuscin concentrations in three individual patients during two weeks of ICU 
admission. Dotted line is the predicted value of the patient. 
Patient S, aged 20 years, polytrauma with headinjury, ISS = 34 and APACHE II day 1 (ICU) - 20; the 
patient had an uneventfull recovery with a mean MOF score of 3.0 and stayed 17 days at ICU; 
survivor. 
Patient B, aged 55 years, polytrauma with an ISS = 41 and APACHE II day 1 (ICU) = 21 ; the patient 
developed ARDS in the second week without subsequent MOF (mean MOF score = 3.8). Discharge 
from ICU at day 26; survivor. 
Patient R, aged 74 years, ruptured AAA admitted in shock, APACHE II day 1 (ICU) = 16; the patient 
developed ARDS and subsequent MOF (mean MOF score = 9.2) and died In ICU on day 31; non-
survivor. 
0 OH I 2 3 10 ti 12 13 
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Involvement of toxic oxygen radicals in the pathogenesis of ARDS is suggested by the 
finding of increased levels of Н2Ог in the expired breath and increased hydrocarbon 
exhalation in patients with ARDS (9,19) and by significant malondialdehyde elevation 
in trauma patients dying of ARDS and sepsis (10). Furthermore, experimental 
administration of agents liberating free radicals, induces a syndrome which closely 
resembles ARDS and MOF (20,21). Fluorescent substances like lipofuscin have been 
shown to be significantly elevated in an animal model of in vivo lipid peroxidation 
induced by carbon tetrachloride (11). 
It is known that the cellular lipofuscin content increases with age. However, the 
consideration that lipofuscin is an age pigment is primarily based on histological 
observations (22). So far, no data are available on the age dependent nature of serum 
lipofuscin concentrations. The present data show that serum lipofuscin concentration 
indeed increases with age, although the positive correlation is admittedly a weak one. 
The present study is the first to show that the serum lipofuscin concentration is 
markedly increased after trauma and hemorrhagic shock and even after major elective 
surgery such as aortic aneurysm repair. The latter group of patients were perioperati-
vely hemodynamically stable, but must have sustained some form of reperfusion injury 
after declamping of the aorta. The role of (the induction of) anaesthesia in the 
explanation of the initial elevation (at 0 hours) of lipofuscin concentration remains 
unclear. 
It is remarkable that patients who subsequently develop ARDS and MOF initially show 
significantly higher lipofuscin levels than patients whose clinical course over the next 
period will be uncomplicated. This finding suggests that in patients with subsequent 
ARDS and MOF, free radical damage initially may take place on a larger scale, leading 
to early cell damage, which is the prerequisite of later organ failures (6). This concept 
is underlined by the finding of an inverse correlation between pulmonary gas exchan­
ge and lipofuscin concentration on the first day of ICU admission. 
Moreover, we found a cut off point of lipofuscin concentration at 24 hours after 
hospital admission that predicts reasonably well the absence of subsequent 
ARDS/MOF (94%). However, the prediction of the occurence of ARDS/MOF was weak 
(47%). Nonetheless, since the prevalence of ARDS/MOF in this patient population was 
20%, the lipofuscin concentration could give additional information for the prediction of 
subsequent ARDS/MOF. Of course the number of patients is to small to draw a 
definitive conclusion about the predictive value of the present lipofuscin cut off point. 
Furthermore we demonstrated a significant decrease of lipofuscin concentration in 
patients with an uncomplicated course during the second half of the first week. 
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Patients with subsequent ARDS and/or MOF did not show such a bifasic lipofuscin 
course, but - on the contrary - showed an elevation of lipofuscin levels again in the 
second week of admission, when ARDS and MOF were established. 
Oxidative stress with subsequent cell damage and the disturbance of the equilibrium 
between oxidants and anti-oxidants plays an important role in (the development of) 
ARDS and MOF (6,23). For instance, in critically ill patients significantly depressed 
levels of vitamin E, an exogenous anti-oxidant, were demonstrated and these levels 
were shown to be significantly decreased in patients with ARDS if compared to non-
ARDS patients (23). Glutathione is one of the most important endogenous oxygen 
radical scavengers; its biosynthesis occurs mainly in the liver (24). The anti-oxidant 
capacity is correlated with the total glutathione content of cells (25). In an ischemia-
reperfusion acute lung injury model in rats glutathione was shown to be decreased 
and oxidized glutathione to be significantly elevated (24). Nakagawa et al. showed that 
the amount of lipofuscin-like pigments induced by chloroquine administration in mice 
was roughly inverse to the glutathione content in liver and kidney (26). In mice fed 
diets containing different amounts of vitamin E, the serum fluorescence intensity varied 
inversely with the level of vitamin E administered in the diet (11) and in a study on 
diabetic rats an inverse relation between vitamin E and lipofuscin contents of erythro-
cytes was demonstrated (27). 
We therefore hypothesize that a traumatic insult can lead to such an oxidative stress 
that the balance between oxidants and anti-oxidants is disturbed, resulting in lipid 
peroxidation with increased lipofuscin production. Patients that have the capability to 
restore this balance, either because the insult is not so severe or by a compensatory 
mechanism of supply and/or production of anti-oxidants, like vitamin E and glutathi-
one, are those who subsequently will show an uneventfull clinical course. If, however, 
the triggering event is to intense (as indicated in our patients by APACHE II score at 
day 1) or the capacity to supply and/or produce enough compensatory anti-oxidants 
is insufficient, the balance turns to increased oxidative stress with more cell damage, 
resulting in enhanced levels of serum lipofuscin and finally complications like ARDS 
and MOF. 
We conclude that lipofuscin measurements could serve as a valuable parameter in the 
evaluation of the oxidative stress in patients at risk for ARDS and MOF. However, 
much work remains to be done to unravel the exact biochemical background of lipo-
fuscin substances. Additional studies are required to investigate the relation of free 
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radical damage, plasma lipofuscin concentration and outcome of patients after severe 
trauma and shock. 
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Abstract 
Endotoxemia has been associated with syndromes like ARDS and MOF. Translocation 
of endotoxins from the gut has been demonstrated to occur experimentally in animals 
after splanchnic ischemia. We investigated endotoxemia in eleven patients with 
hemorrhagic shock due to a ruptured abdominal aortic aneurysm and in five patients 
after elective abdominal aortic aneurysm repair. Endotoxin was measured quantitative-
ly using a limulus assay with a detection limit of 12.5 pg/ml. 
In 7 of the eleven patients admitted to the hospital with an acute condition endotoxin 
was present on admission (range 15-25 pg/ml), even before resuscitation and 
operation were started. In patients treated electively endotoxin was noticed after 
cross-clamping of the aorta in four of five patients (mean ± SEM: 18.9 ± 4.6 pg/ml). 
After reperfusion endotoxemia increased and was present in all patients (mean ± 
SEM: 22.8 ± 2.8 pg/ml). All five patients treated electively had an uneventful recovery 
without specific organ failures or infectious complications. 
It is concluded that systemic endotoxemia as monitored by the Limulus assay is a 
common finding in patients after major vascular surgery. Hemorrhagic shock resulting 
in splanchnic ischemia may lead to endotoxemia. Ischemia and especially reperfusion 
after aortic cross-clamping also result in endotoxin translocation. However, the low 
concentrations of systemic circulating endotoxin found were not related to subsequent 
adverse effects in either the patients treated for acute conditions or in the electively 
treated patients. 
Introduction 
Adult respiratory distress syndrome (ARDS) and multiple organ failure (MOF) are the 
main causes of late hospital death after major vascular surgery (1,2). The gut, which 
contains large quantities of endotoxin, has been implicated to play a major role in the 
etiology of MOF (3). Endotoxin can cause an inflammatory cascade with a deleterious 
effect on endothelial cells, which results in increased microvascular permeability 
leading to ARDS and MOF (4,5). Recently we have demonstrated that intestinal 
permeability is markedly increased in patients after acute and elective aortic aneurysm 
repair (6). O'Dwyer et al. showed that intravenous endotoxin administration in healthy 
human subjects significantly increased gut permeability (7). In addition, endotoxemia 
was demonstrated to occur rapidly after intestinal ischemia caused by superior 
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mesenteric artery occlusion in cats and after colon devascularization in dogs (8-10). 
The present study was done to determine whether endotoxemia occurs in human 
beings after acute and elective major vascular operation and, if so, to investigate its 
relation to possible adverse effects in these patients. 
Patients and methods 
Two patient groups were enrolled in the study. Informed consent was obtained from 
all patients or their relatives before the study. The first group consisted of 11 male 
patients (69 ± 6 years of age), admitted to the hospital in hemorrhagic shock caused 
by rupture of an abdominal aortic aneurysm. Arterial blood was withdrawn under 
sterile conditions immediately after hospital admission (0 hours) and after 6, 24 and 48 
hours. The second group consisted of five male patients (71 ± 5 years of age) who 
underwent elective repair of an aneurysm of the infrarenal aorta. From these patients 
arterial blood was withdrawn under sterile conditions at eigth standardized time 
points: (I) before anaesthesia was induced; (II) immediately after skin incision; (III) 
after manipulation of the intestines and before cross-clamping of the aorta; (IV) 15 to 
20 minutes after cross-clamping of the aorta; (V) 2 to 3 minutes after reperfusion 
following declamping of the aorta; (VI) at the end of the operation; (VII) 4 hours after 
the initial incision and (VIII) six hours after the incision. 
Blood for endotoxin determinations was collected in special storage tubes (Kabi 
Diagnostica, Mölndal, Sweden), centrifuged, and immediately frozen at -20"C as 
described by Redi et al. (11). Endotoxin was measured quantitatively after dilution 
(10%) and heat pretreatment by a limulus assay with chromogenic substrate (Coatest 
Endotoxin, Kabi Diagnostica, Mölndal, Sweden). Each assay was run in duplicate. The 
detection limit of this assay is 12.5 pg/ml. 
Postoperatively, after admission to the ICU, the APACHE II score was determined in all 
cases (12). As long as patients were admitted to the ICU, a daily MOF score was 
calculated (13). A patient was diagnosed as having MOF, if the average MOF score 
from day 5 to 14 was > 4. 
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Results 
Three patients with a ruptured aneurysm died within six hours of hospital admisión. 
The mean APACHE II score on ICU admission of the remaining eight patients from 
this group was 14.5 ± 6.9. 
Table 7.1 
Demographic data and endotoxin concentrations at 0 and 6 hours after hospital admission In eleven 
patienis with hemorrhagic shock caused by a ruptured abdominal aortic aneurysm. At 24 and 48 
hours no circulating endotoxin could be detected in any patient. (*): patient died before 6 hours after 
hospital admission; #: no detectable endotoxin with a detection limit of 12.5 pg/ml. 
PATIENT 
1. 
2. 
3. 
4. 
5. 
6· 
7. 
8. 
9. 
10. 
11. 
AGE 
(years) 
82 
69 
60 
62 
64 
65 
73 
64 
76 
66 
74 
APACHE II 
score 
17 
21 
3 
6 
14 
11 
12 
18 
30 
13 
14 
ENDOTOXIN 
concentration (pg/ml) 
Oh 6 h 
25 
# 
20 
21 
# 
# 
15 
24 
15 
# 
24 
(*) 
# 
(*) 
16 
# 
# 
# 
# 
25 
# 
(*) 
ICU 
stay 
(days) 
0 
59 
0 
3 
46 
Э 
30 
48 
3 
30 
0 
MOF 
-
yes 
-
no 
yes 
no 
yes 
no 
no 
yes 
-
DEATH 
early I 
late 
early 
-
late 
-
late 
-
late 
early I 
Table 7.1 presents the circulating endotoxin concentrations of all eleven patients. 
Seven patients had measurable endotoxin levels (range 15 to 25 pg/ml) immediately 
after hospital admission, before operation was started. At 6 hours only two of the 
remaining eigth survivors still showed circulating endotoxin levels. At 24 and 48 hours 
no systemic circulating endotoxin could be detected in any of the patients. In four of 
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the eight initial survivors MOF developed and none of these patients survived. From 
table 7.1 it is evident that the patients with MOF did not exhibit a different initial endo-
toxin pattern compared with that of the patients who did not have MOF. 
The APACHE II score of the five patients treated electively for aneurysm was 5.8 ± 2.3 
on ICU admission. Table 7.2 shows the endotoxin concentrations in all five patients at 
the eigth defined sampling points. The course (mean ± SEM) is graphically represen-
ted in figure 7.1. 
No systemic circulating endotoxin could be discovered before operation (point I) in 
any patient. After manipulation of the intestines, but before cross-clamping of the aorta 
(III) a slight elevation of endotoxin was noticed in two patients. After infrarenal cross-
clamping of the aorta (IV), four of five patients showed measurable levels of endo-
toxin, with a slight increase after reperfusion when the aortic clamp was removed (V). 
At this point, endotoxin was detectable in all patients. Endotoxemia was present until 4 
hours after the initial incision (VII) in all patients and still detectable in four of five 
patients at 6 hours from incision (VIII). 
All five patients undergoing elective operation stayed in the ICU less than 2 days and 
were discharged from hospital between 11 and 14 days postoperatively after an 
uneventfull recovery, without any infectious complications. 
Discussion 
Bacterial endotoxins, lipopolysaccharide components of the outer membrane of Gram-
negative bacteria, are thought to be responsible for the detrimental changes observed 
in patients with Gram-negative septic shock, which is still associated with a high 
mortality in patients admitted to a surgical ICU (14,15). Although there are many 
reports on a variety of effects of endotoxin in experimental circumstances, relatively 
few studies document endotoxemia in human diseases. 
Endotoxemia has been documented in patients with Gram-negative sepsis, with in-
flammatory bowel disease, with liver failure, after colonoscopy or colectomy and with 
burn wounds (5,16-20). In severely traumatized patients endotoxemia was only 
exceptionally found after severe hemorrhagic shock (21,22). Surprisingly, hardly any 
data are available on the evaluation of endotoxemia in patients after major vascular 
surgery. Van Deventer et al. investigated endotoxemia in a series of 21 patients 
without liver disease including nine patients who had undergone aortic bifurcation 
implantation (23). 
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Table 7.2 
Endotoxin concentrations in five patients during elective aortic aneurysm repair. See text for the 
definition of the sampling points I to VIII. #: no detectable endotoxin with a detection limit of 12.5 
pg/ml. 
PATIENT 
A. 
B. 
С 
D. 
E. 
• 
# 
# 
# 
# 
# 
II 
# 
16 
# 
# 
# 
III 
16 
26 
# 
# 
# 
IV 
30 
20 
20 
25 
# 
V 
24 
17 
23 
34 
16 
VI 
31 
17 
27 
# 
37 
VII 
21 
16 
1Θ 
13 
28 
Ш | 
,7 
20 
20 
# 
26 
Figure 7.1 
Mean (± SEM) endotoxin concentrations in five patients during elective aortic aneurysm repair. See 
text for the definition of the sampling points I to VIII. Dotted line represents detection limit of endotoxin 
assay (12.5 pg/ml). 
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In only two of those nine patients portal and peripheral endotoxemia was detected 
after aortic cross-clamping with subsequent reperfusion. 
The reticuloendothelial system of the liver effectively removes small amounts of 
endotoxin that have been absorbed into the portal circulation (5). However, it has 
been shown experimentally, that also the thoracic duct is also a potential route for 
endotoxin to enter the systemic circulation, thus bypassing the liver (5). 
From the present data, we conclude that systemic endotoxemia is a common finding 
in patients after elective aneurysm repair. This already occurs in the period of bowel 
ischemia but is quantitatively more important during the reperfusion period. This major 
contribution to endotoxemia of the reperfusion period was also demonstrated 
experimentally in cats (10). That hemorrhagic shock leading to splanchnic ischemia 
plays a role in the translocation of endotoxin is demonstrated by the finding of 
systemic endotoxemia in patients admitted to the hospital with a ruptured aortic aneu-
rysm, even before resuscitation and emergency operation. Of course, in this period 
intestinal perfusion must have been impaired. 
The direct relation of endotoxemia with the increased intestinal permeability that has 
been demonstrated to occur between 24 and 36 hours in patients after major vascular 
operation in previous studies remains unclear (6,24). Endotoxemia was detected 
mainly before, but not at the very moment of the documented gut permeability itself, 
which indicates that endotoxemia and increased gut permeability may be independent 
phenomena (24). On the other hand, endotoxemia could have contributed to a rise in 
the already enhanced intestinal permeability (7). 
Recently endotoxemia was noticed in 20% of patients one hour after cardiopulmonary 
bypass surgery (25). This endotoxemia was without relation to subsequent complicati-
ons. Another study documented a significant increase of plasma TNF concentrations 
after release of the aortic cross-clamp, a phenomenon that could be prevented by 
dexamethason administration (26). It is well known that endotoxin is one of the most 
important inductors of mediator release, such as TNF (27,28). In experimental circum-
stances, intestinal reperfusion injury led to portal vein endotoxemia with subsequent 
systemic plasma TNF levels, resulting in acute lung injury, which suggests a pathoge-
netic role for these substances (28). On the other hand, in an animal model of experi-
mentally induced MOF, caused by a severe systemic inflammatory response induced 
by intraperitoneal zymosan, it was shown that endotoxin sensitivity and thus probably 
endotoxin itself was not essential in the pathogenesis of subsequent MOF, in as much 
as the clinical outcome and mortality rate were not different between endotoxin-
responsive mice and endotoxin-hyporesponsive mice (29). 
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Though the number of patients in this study is limited, we conclude from our observa­
tions that endotoxin in low concentrations, as found in the initial period of shock in 
patients with acute conditions, was not related to the development of subsequent 
MOF or associated with adverse effects in the patients undergoing elective operation. 
We, therefore, do not support the hypothesis that endotoxin plays the key role in the 
pathogenesis of ARDS and MOF. 
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Introduction 
Today multiple organ failure (MOF) represents the number one cause of death in a 
surgical intensive care unit (ICU). However, the basic pathophysiology of this syndro-
me still remains to be elucidated (1). Hypotheses on the pathogenesis of MOF include 
"generalized inflammation" resulting from an excessive activation of endogenous 
inflammatory mediators and cells (2), and "the gut as the motor of MOP', implicating 
the role of translocating gut bacteria and endotoxins triggering the septic state (3). In 
this respect, alterations of intestinal permeability (IP) have been shown to be associa-
ted with translocation of intraluminal^ present toxic substances and micro-organisms. 
The role of splanchnic ischemia, inducing increased IP, has been stressed (4), while 
monitoring intestinal mucosal metabolism (for instance by gastric intra-mucosal pH 
measurements) has been shown to provide for early prognostic information (5,6), and 
for a guideline in therapy, thereby improving outcome in ICU patients (7). 
Since MOF is associated with a generalized permeability problem (2,8), the role of IP 
in relation to this syndrome needs further clarification. IP can be defined as that 
property of the intestinal wall which modifies the permeation of a solute across or into 
the intestine (9). 
In the present review the following questions will be addressed: under what circum-
stances has IP been shown to be altered; what is the relation of IP to bacterial 
translocation and what is the relation of these phenomena to subsequent MOF. 
Measurements of Intestinal Permeability 
Several methods to study IP non-invasively have been described. Intestinal absorption 
can be measured using non-metabolizable substances of different molecular size, like 
polyethyleneglycol polymers (PEG) (10-12). After urinary excretion of PEG, however, 
complex deterministic mathemathical models are required to reflect intestinal absortion 
(12) and the validity of these calculations is questionable (13). 
Another possibility to study IP is the use of the isotope 51 Cr-labelled ethylenediamine-
tetra-acetate (51 Cr-EDTA) (14,15). This radio-active labelled solution is also given orally 
and after absorption, urinary excretion after a standardized period (e.g. 24h) is 
measured by the gamma activity uniformly assessed for 100 seconds in a low back 
ground chamber along with an appropriate standard (9,15). The total excretion then is 
expressed as a percentage of the ingested dose. A great advantage of this test is the 
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opportunity to study IP in vitro: in biopsy specimens of intestine (9). 
A major advantage of using a ratio of two probes like in the dual sugar absorption 
tests (DSA) is the fact that by indexing the excretion of one sugar to that of another it 
is possible to correct for factors unrelated to IP, such as gastric emptying, intestinal 
transit time, mucosal surface area, cardiac output and renal function (9,16,17). Single 
probe tests of IP, like 5' Cr-EDTA and PEG, have as a major drawback a lack in 
correction for the above mentioned factors, thus resulting in a wide variation in urinary 
recovery of these molecules. 
Most of the DSA tests use lactulose and mannitol (other combinations with e.g. 
rhamnose or cellobiose have been described). Since most studies on IP in surgical 
and critically ill patients have been performed using DSA tests, especially with 
lactulose and mannitol as markers, and because of the advantages of the two probes 
tests mentioned above, we will further concentrate on this test. 
IP is graded by the ratio of lactulose to mannitol (L/M ratio), while both sugars 
represent different absorption routes (9,18). Lactulose, the larger molecule (m.w. 342) 
is absorbed passively: paracellularly via the tight junctions and extrusion zones at the 
villous tips (figure 8.1). Alterations in lactulose absorption (mainly increased levels) in 
fact reflect mucosal leakiness, resulting from a disruption of the anatomical barrier. 
Mannitol, the smaller molecule (m.w. 182), passes actively through aqueous pores in 
the cell membrane. This process requires energy and therefore depends on the 
functional absorptive capacity of the mucosa. Thus, decreased mannitol absorption 
reflects decreased mucosal function. 
An abnormal L/M ratio indicating an abnormally increased IP, therefore, can be due to 
increased lactulose absorption (anatomical disruption) or decreased mannitol absorp-
tion (functional impairment) or a combination of both. Considering reports on 
alterations in IP, one should keep in mind these different absorption routes and look 
at conclusions of altered IP with caution. 
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Figure β.1 
Illustration of transport routes of lactulose and mannitol through the intestinal mucosal 
layer. 
MANNITOL 
TRANSCELLULAR 
Quantitative analyses of Lactulose and Mannitol 
The widespread use of the L/M test is limited by the difficulties of analyses for 
carbohydrates in urine at low concentrations (19). At present, three different methods 
are available to quantify these sugars. The enzymatic method for lactulose is based 
on hydrolysis by ß-galactosidase into fructose, which then is enzymatically assayed 
(20). Urinary mannitol can be analyzed by an enzymatic-spectrophotometric method, 
using mannitol dehydrogenase, which can be purified from mycelia of Aspergillus 
parasiticus (21). The other techniques are by gas-liquid chromatoghraphy (22) or by 
high pressure liquid-chromatography, in which anion exchange chromatography and 
pulsed amperometric detection are used (19). The advantage of the latter technique 
compared to the gas-liquid chromatography is that prior derivatization is not necessa-
ry (19). 
Normally, lactulose is not present in human urinary samples, while mannitol may occur 
naturally in human urine (23). Therefore it is advised to take pretest urinary samples to 
correct for the mannitol determinations. Under normal conditions 0.1 - 0.5% of the 
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administered lactulose and 6 - 18% of the mannitol is excreted in 6 hourly collected 
urine (24). Thus, reported L/M ratios of healthy human control groups vary from 0.006 
to 0.035 (24). 
Clinical data on altered Intestinal Permeability 
IP of humans has been studied extensively and was shown to be altered after various 
disorders. Increased IP was documented in patients with several types of gastro-
enterologie diseases, like Crohn's disease (10,12,25,26), celiac disease (27-29), 
gastro-enteritis (30,31), persistent (29) and diabetic diarrhoea (32) and exocrine 
pancreas dysfunction (33). In patients with ulcerative colitis, however, L/M ratios 
appeared to be normal (25,27). Oral administration of chenodeoxycholic acid (34), a 
drug clinically used for dissolution of gallstones, and intravenous administration of 
endotoxin (35) both led to a significant increase of IP. The influence of diets on IP (36) 
has been demonstrated by the fact that IP normalizes in patients with celie disease 
who take a gluten-free diet (28). Total starvation led to significantly higher L/M ratios in 
children with diarrhoea, compared to those who were still enterally fed (30). Allergic 
conditions, such as cow's milk intolerance, food allergy or atopic dermatitis are 
associated with an abnormal increase of IP (29,37). 
Additionally, also patients without gastro-enterologie disorders showed abnormally 
altered IP: patients with AIDS (25), chronic renal failure (11), or critically ill patients 
admitted at an ICU because of various underlying disorders (38). Trauma, like burn 
injury (16,17,39), blunt polytrauma (40). surgery for elective aortic aneurysm repair 
(24) and even long distance running (15) have been demonstrated to be associated 
with increased IP (table 8.1). 
Attempts have been made to correlate the degree of abnormally increased IP, 
expressed by L/M ratio, with other parameters associated with the investigated 
diseases. In this respect L/M ratios could be correlated with the severity of disease in 
a study on patients with Crohn's disease (26). L/M ratios were also related to the 
degree of histological alterations in jejunal biopsies (29) and showed an inverse 
relation to growth in Gambian children (31). 
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Table 8.1 
AUTHOR YEAR PATIENT GROUP TEST 
STUDIED 
COMMENT 
Sundqvist12 19Θ0 Crohn's disease PEG 
Ukabam27 
Cooper32 
Elia" 
1983 
1987 
1987 
Crohn's disease 
Ulcerative colitis 
Diabetic diarrhoea 
Total starvation 
L/M 
L/M 
им 
им 
5,Cr-EDTA 
Erickson3" 1988 Oral chenodeoxy- UM 
cholic acid 
O'Dwyer35 1988 Endotoxin L/M 
administration 
Olaison'0 1988 Crohn's disease PEG 
Ziegler" 
Akinbami2" 
Dupont37 
Isolauri30 
1988 Bum patients UM 
1989 Celiac disease L/M 
Cow's milk intolerance 
Food allergy 
Persistent diarrhoea 
increased absorption of higher 
weights PEG polymers 
sign, increased 
normal 
normal in uncomplicated diabetes 
sign, increased; 
no diff. between lean and obese; 
prevented by low calorie diets 
sign, increased 
sign. Increased in 
healthy humans 
increased absorption of 
higher weights PEG polymers 
from day 2 - 45, related 
to infections 
related to histology 
of jejenal biopsy 
1989 
1989 
Cow's milk sensitive 
enteropathy 
Atopic dermatitis 
Gastro-enteritis 
children 
UM 
L/M 
L/M 
sign, increased after 
provocation test, 
normal under diet 
sign, increased 
sign, different between 
feeded and fasted children 
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Table 8.1 (continued) 
AUTHOR YEAR PATIENT GROUP TEST 
STUDIED 
COMMENT 
Murphy28 1989 Crohn's disease L/M 
Deitch38 1990 Burn patients L/M 
Lunn31 1991 Children with growth UM 
faltering + diarrhoea 
Magnusson" 1991 Chronic renal failure PEG 
Harris31 
Lake8 
1992 Critically ill ICU UM 
1992 Celiac disease UM 
LeVoyer17 1992 Bum patients 
Mack31 
UM 
1992 Cystic fibrosis UM 
Shwachman syndrome 
Oktedale'5 1992 Long distance runners s1Cr-EDTA 
Ott25 1992 AIDS UM 
Crohn's disease 
Ulcerative colitis 
Roumen24·40 1993 Polytrauma UM 
Major vascular surgery 
correlation with activity 
of disease index 
16 - 30 hr. post-injury 
sign, increased 
growth inversely related 
to UM ratio 
relatively more higher weigths 
PEG polymers absorbed 
no correlation with severity of 
disease or sepsis scores 
normalization of UM ratio during 
gluten-free diet 
sign, increased in patients 
with infections 
sign, increased in patients with 
exocrine pancreas dysfunction 
after marathon sign, increased, 
related to gastric mucosal erosions 
sign, increased 
sign. Increased 
normal 
sign, increased at day 1 
sign, increased at day 1, 
no difference between acute 
and elective major 
vascular surgery 
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In some studies on burn patients an association with infectious complications could 
be demonstrated (16,17), although in polytrauma patients and patients with he-
morrhagic shock due to a ruptured aortic aneurysm, no difference in UM ratios was 
found between patients with and without subsequent infections (40). Also, no correlati-
ons could be found between L/M ratios and severity of shock (24,40), injury (24), or 
disease (38), total body surface area burned (17), APACHE II scores (38,40), sepsis 
scores (38) or subsequent ARDS and MOF (24,40). 
From the present data we therefore must conclude that increased IP is a common 
phenomenon seen in many patients, with different conditions and at various time 
points during the course of their diseases. Today, no clear conclusions or predictive 
value towards the severity of disease can be drawn from the severity of increased IP, 
ie. the height of L/M ratios. 
Relation between Intestinal Permeability, Endotoxin and Bacterial Translocation 
Since the first investigators to describe ARDS noticed that these patients often died of 
sepsis (41), a consensus developed that bacterial overgrowth is the cause of ARDS 
and MOF. Later, the frustration in not finding bacteria in obviously septic patients led 
to a concept of 'non-bacterial' clinical sepsis (3). In this setting the gut was hypothesi-
zed to be the source of bacteria and endotoxins and to play the key role in MOF (3). 
Indeed, the gut contains large amounts of intraluminal endotoxin, that may cause 
deleterious biological effects, possibly inducing the clinical and laboratory manife-
stations of septic shock (42). The process in which bacteria, normally confined to the 
gastro-intestinal tract can cross the mucosal barrier and appear in mesenteric lymph 
nodes and other organs has been termed bacterial translocation (43). 
From several studies it is obvious that endotoxemia (or endotoxin translocation), 
bacterial translocation and IP are three associated phenomena. O'Dwyer et al. (35) 
showed that intravenous endotoxin administration in human volunteers significantly 
increased IP. Deitch and coworkers (43) demonstrated that endotoxin administration 
in mice promoted bacterial translocation and Navaratham et al. (44) showed that 
endotoxemia increased mesenteric vascular resistance in sheep and promoted 
bacterial translocation, suggesting a causative role for splanchnic ischemia in this 
process. Fink et al. (45), however, concluded from their experiments with pigs that the 
increased IP, observed after endotoxin administration, could be due to factors other 
than (or in addition to) mesenteric hypoperfusion. Induction of colonic ischemia (46) 
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or hemorrhagic shock (47) in dogs led to significant transmural migration of endo-
toxin, whereas ischemia reperfusion injury after lower limb ischemia has been shown 
to result in increased IP in cats (48). Gathiram et al. (49) additionally showed that 
administration of anti - LPS during the reperfusion period after superior mesenteric 
artery occlusion in rats completely reversed endotoxemia. Rats subjected to he-
morrhagic shock showed bacterial translocation, with a positive correlation between 
the degree of translocation and duration of shock (50,51). These findings were 
associated with shockinduced gut mucosal injury, subepithelial edema and focal areas 
of necrosis (51). On behalf of these observations it was hypothezised that a systemic 
challenge like shock or sepsis, causing splanchnic ischemia, may result in increased 
IP, bacterial translocation and endotoxemia. Endotoxemia on its turn aggravates the 
mucosal permeability, thereby generating a recurrent circle of gut derived infections 
(35). 
However, no single human study has clearly demonstrated that increased IP in itself 
was positively and causatively correlated with endotoxemia and bacterial translocation. 
Observations in 50 polytrauma patients showed that positive blood cultures were 
present in 56% when admission systolic pressure was below 80 mm Hg (52). 
However, in only two of these patients endotoxemia was noticed. Peitzman et al. (53) 
concluded from their study on 25 trauma patients, that bacterial translocation to the 
mesenteric lymph nodes (MLN) was not a common occurrence in acutely injured 
patients and they could not demonstrate a relation between positive MLN cultures, 
later Infectious complications and outcome. In a prospective clinical study on major 
torso trauma, Moore et al. (54) could not confirm portal or systemic bacteremia within 
the first 5 days postinjury, despite an eventual 30% incidence of MOF. In polytrauma 
patients and patients in shock due to a ruptured abdominal aortic aneurysm, IP is 
significantly increased 24 to 36 hours postinjury (40). In some of these patients 
systemic circulating endotoxin could be detected, but only immediately after hospital 
admission and 6 hours later. At 24 hours, when IP was demonstrated to be signifi-
cantly increased, and at 48 hours no endotoxemia could be noticed anymore (40). 
These data from the clinical situations in humans, therefore, do not support the above 
mentioned hypothesis, in which IP, bacterial translocation and endotoxemia are parts 
of a vicious circle ultimately leading to MOF (35). 
Experimental data on Bacterial Translocation 
Alexander et al. (55) elegantly demonstrated that Candida albicans and E. coli trans-
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locate by direct penetration of the enterocyte, a proces different from classical 
phagocytosis. Translocation in between enterocytes was not observed. The same 
observation was done for endotoxin penetration. This finding was also observed by 
others (56,57), indicating that bacterial translocation is a process requiring an 
energetic contribution from the enterocyte. Surprisingly, for some unknown reason, 
the host thus seems to contribute actively to bacterial translocation. In this respect it 
has been suggested that bacterial translocation could be a normal function of the gut 
associated lymphoid tissue (GALT), in which macrophages are very important (56,58). 
In an experimental study on mice, Wells et al. (56) demonstrated that intestinal 
macrophages play the key role in the transport of intestinal particles, including 
bacteria, into extraintestinal sites. 
In a recent study on the effects of ischemia-reperfusion in bacterial translocation in a 
hemorrhagic shock pig model, it was shown that bacterial translocation did not occur 
in the early post shock and post reperfusion period, despite significant evidence of 
lipid peroxidation in gut tissues after resuscitation (58). It should be notified that most 
of the work on bacterial translocation has been performed in rodents, animals that 
essentially differ in their purine metabolism from for instance pigs and humans, who 
are more similar in this respect (58). Also in one study with intravenous endotoxin 
administration in mice, no increased bacterial translocation could be demonstrated 
(59). 
Since Enterobacteriaceae are thought most likely to translocate, selective decontami-
nation (SD) of the gastro-intestinal tract has gained wide popularity as a method to 
selectively kill off these bacteria (60), while leaving intact the more harmless anaero-
bes (61). This method has resulted in an impressive decrease in the incidence of 
nosocomial infections in treated ICU patients (62). However, there are still doubts on 
the clinical relevance of SD in ICU patients, because no significant reduction of ICU 
days and ventilator days was observed, and mortality was reduced only in a few sub-
groups of patients (62). Moreover, untili today, SD has not been conclusively demon-
strated to be effective in preventing MOF (62). 
Experimentally, MOF may be induced by a non-bacterial, non-endotoxic inflammatory 
stimulus, even in germ-free rats (63). This ZIGI (Zymosan-lnduced Generalized 
Inflammation) model has been shown to be a suitable one, not only of MOF but also 
of bacterial translocation and was extensively validated by others (64,65). Conclusions 
from several studies with this model (62,66) are, that, although bacterial translocation 
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was a common finding, the development of MOF did not depent on bacterial translo-
cation. Suppression of bacterial translocation by SD did not prevent MOF, while 
streptomycine significantly reduced mortality, even in the presence of an overgrowth 
by Enterobacteriaceae (67). This latter result could be explained by the beneficial 
effect of streptomycin on the phagocytic activity of macrophages (68). In an experi-
ment with endotoxin-hyporesponsive and endotoxin-responsive mice, bacterial trans-
location was barely seen and the mice were surprisingly resistant to zymosan-induced 
MOF (66). The most likely explanation is that zymosan does not induce macrophage 
activation in these mice, as was shown in vitro (69). Macrophage depletion by the 
administration of liposome-encapsulated dimethylene-diphosphonate prior to zymo-
san, resulted in an important increase in bacterial translocation, but in an almost total 
prevention of mortality from MOF (70). In all these experiments only control or 
modulation of the inflammatory response prevented both bacterial translocation and 
MOF, while these two phenomena were not causatively related. 
Conclusion 
The above described data indicate that IP, measured by the permeation of non-
metabolizable substances, can be altered during many different disordes and 
circumstances. Moreover, it has been demonstrated that it is a phenomenon different 
from bacterial translocation and endotoxin penetration. At present it is still unknown 
whether these processes always occur concomitantly or whether some pathological 
conditions are associated with abnormal IP in the absence of increased translocation 
or vice versa (18). We further conclude that increased permeability is a phenomenon 
not necessarily associated with subsequent MOF. The same conclusion is made for 
bacterial translocation. Since the gut is an organ very susceptible to disturbances of 
homeostasis (4), altered IP merely could be a process that is part of a general 
permeability problem seen in many patients with or at risk of MOF. Finally, we suggest 
that IP, bacterial translocation and endotoxemia should not be bracketed together 
unconditionally, because these processes do not implicate causatively related 
phenemona. 
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Abstract 
After thermal injury, alterations in intestinal permeability have been demonstrated and 
correlated with subsequent infections. We measured intestinal permeability on the 
second day after severe trauma and hemorrhagic shock (ruptured abdominal aneu-
rysm). The mean (± SD) lactulose/mannitol (L/M) excretion ratio was 0.012 ± 0.005 in 
seven healthy control subjects, 0.069 ± 0.034 in eleven severely traumatized patients 
and 0.098 ± 0.093 in eight patients with aneurysm, indicating a significant increase of 
intestinal permeability in both patient groups (p < 0.005). No significant correlation 
was found between L/M ratios and age, severity of injury or shock, lactate levels on 
admission, APACHE II score, daily pulmonary gas exchange parameters or mean 
multiple organ failure scores. No difference in intestinal permeability between patients 
with and without subsequent infections could be demonstrated. In eleven patients we 
looked for endotoxin in the systemic circulation. In six patients endotoxemia was 
present immediately after admission and before the L/M test. However, during the L/M 
test and one day afterward, no circulating endotoxin was observed. The present data 
provide evidence for the hypothesis that increased intestinal permeability and subse-
quent infectious complications are independent phenomena, frequently seen in 
patients after severe trauma or hemorrhagic shock. 
Introduction 
Severe trauma and hemorrhagic shock may initiate a cascade of events, leading to 
septic complications, the Adult Respiratory Distress Syndrome (ARDS), Multiple Organ 
Failure (MOF), and ultimately death. One of these events may be failure of the barrier 
function of the gastrointestinal tract, resulting in increased intestinal permeability and 
associated with subsequent translocation of bacteria and endotoxins from the gut (1). 
Increased intestinal permeability is well documented in humans after thermal injury (1-
3) and correlates positively with septic complications (2,3). In addition, experimental 
administration of intravenous endotoxin in humans results in increased intestinal 
permeability (4). Therefore, the gut may be an important source of infection in patients 
at risk, and may be the "motor of MOF" (5). However, at present no data are available 
on changes in intestinal permeability in patients with severe trauma and/or hemorrhag-
i c shock. 
We investigated intestinal permeability after severe trauma and hemorrhaghic shock 
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and its relation to the severity of injury or shock, to infectious complications, ARDS 
and MOF, and to endotoxemia. 
Patients and methods 
Subjects 
Three groups of subjects were studied. The control group consisted of seven healthy 
volunteers. The trauma group consisted of 11 patients with severe blunt injury, 
resulting in an Injury Severity Score (ISS) (6), calculated from the Hospital Trauma 
Index (7), above 24 points. The third group, admitted in hemorrhaghic shock, consi-
sted of eight patients, who underwent an emergency operation because of a ruptured 
abdominal aortic aneurysm. The study was approved by the local ethical committee 
and informed consent was obtained from all patients or their relatives prior to the 
study. 
Study design 
On admission, severity of injury in patients with trauma was graded with the ISS (6). 
At the time of admission to the ICU, the APACHE II score (8) was determined. On 
admission (0 hours = baseline) and at 6, 24 and 48 hours after admission, arterial 
blood was withdrawn under sterile conditions for determination of lactate and endo-
toxin concentrations. On the second day, 24 to 36 hours after admission to the hospi-
tal, intestinal permeability was assessed by measuring the absorption of two orally 
administered inert markers, lactulose (L) and mannitol (M), and their ratio (L/M ratio) 
(2,9). The patients were followed up for 2 weeks after admission with regard to the 
development of infectious complications, ARDS and MOF. 
Lactulose and mannitol assays 
The test solution consisted of 10 grams of lactulose and 5 grams of mannitol mixed in 
60 ml of distilled water, which was instilled via a nasogastric tube. Until then the 
patients had been fasting. The healthy volunteers received the test solution orally after 
an overnight fast. Before administration, the urinary bladder was emptied and a 
pretest urine sample was taken. During the next 6 hours all urine was collected and 
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pooled. From this pooled urine a sample was taken. Both urine samples were frozen 
at -20°C until analysis. Urinary lactulose and mannitol concentrations were determined 
using capillary gas chromatography (10). Mannitol excretion was corrected by sub-
traction of baseline values determined in the pretest samples. 
Blood analysis 
Arterial blood lactate levels were measured in deproteinized samples (0.6 mol/l 
perchloric acid) by enzymatic conversion of lactate into pyruvate. Blood for endotoxin 
determinations was collected in special storage tubes (Kabi Diagnostica, Mölndal, 
Sweden), centrifuged, and immediately frozen at -20°C as described by Redi et al 
(11). Endotoxin was measured quantitatively using a limulus assay with chromogenic 
substrate (Coatest Endotoxin, Kabi Diagnostica, Mölndal, Sweden). Each assay was 
run in duplicate. The detection limit of this assay is 12.5 pg/ml. 
Definitions 
A shock score was defined to grade the severity of hemodynamic derangement after 
admission. For this purpose the Allgöwer shock index (heart frequency / systolic 
blood pressure) (12) and the systolic blood pressure were used: (0) indicates no 
shock: index < 1.0 and systolic blood pressure > 100 mm Hg; (1) mild, compensated 
shock: index > 1.0 and systolic blood pressure > 100 mm Hg; (2) moderate shock: 
systolic blood pressure 80 to 100 mm Hg; (3) severe shock: systolic blood pressure 
< 80 mm Hg; (4) severe, prolonged shock: more than one hour systolic blood 
pressure < 80 mm Hg. 
ARDS was diagnosed when patients had bilateral diffuse infiltrates on the chest 
roentgenograms, and progressive hypoxemia requiring mechanical ventilation that 
resulted in a PaOj/Fi02 ratio < 175 with PEEP г 10 cm H20 and, in patients with a 
history of cardiac disease, a pulmonary artery wedge pressure that did not exceed 18 
mm Hg (13). The PaOj/FiOj ratio was calculated daily to grade pulmonary gas 
exchange. 
For every patient a daily MOF score was calculated to grade the intensity of organ 
failure (14). A patient was diagnosed as having MOF, if the mean MOF score from day 
5 to 14 was > 4. 
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Infectious complications were defined as follows: 
bronchopneumonia: rectal temp, г 39°C and positive sputum cultures and/or 
infiltrates on the chest roentgenograms; 
septicemia: rectal temp. > 39°C and one or more positive blood cultures; 
wound infection: rectal temp. > 38°C and purulent discharge; 
urinary tract infection: rectal temp, à 38°C and > 10 ' micro-organisms/ml 
urine; 
intra-abdominal sepsis: rectal temp. > 39*0 and positive cultures from abdomi-
nal fluid (using laparotomy or ultrasonographic puncture). 
Statistical analyses 
The Kruskal-Wallis test, Wilcoxon two sample test, and Spearman's rank correlation 
analysis were used as indicated. Differences were considered significant at ρ < 0.05. 
Results 
The demographic data of the study population are given in table 9.1. The mean 
APACHE II score in the aneurysm group was 6 points higher than in the trauma 
group, mainly because of the higher age of the patients with aneurysm (APACHE II 
scores 5 additional points for age between 65-74 years). 
The data on excretion of administered lactulose and mannitol are given in table 9.2. 
Lactulose excretion was higher in both study groups than in the control group, and 
significantly higher in the aneurysm group. Mannitol excretion was significantly lower in 
both study groups. The mean (± SD) L/M ratio in controls was 0.012 ± 0.005; in the 
trauma group 0.069 ± 0.034 and in the aneurysm group 0.098 ± 0.093 (p < 0.005, 
by Wilcoxon's test) (figure 9.1). 
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Table 9.1 
Demographics of the study population. Data are expressed as mean ± SD. 
Control 
Trauma 
Aneurysm 
η 
7 
11 
8 
Sex 
M/F 
7/0 
7/4 
8/0 
Age (yr) 
31 ± 9 
33 ± 15 
69 ± 6 
APACHE II 
on admission 
— 
8.1 ± 3.5 
14.6 ± 7 
ISS (ΗΊΊ) I 
— 
34 ± 5 
— 
Figure 9.1 
Lactulose/mannitol urinary excretion ratios in normal controls and in patients with severe trauma or 
ruptured abdominal aortic aneurysm. Horizontal bars indicate mean values. Differences between 
groups are as follows: control vs trauma: ρ = 0.0006; control vs aneurysm: ρ = 0.003; aneurysm vs 
trauma = not significant, by Wilcoxon's test. 
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Table 9.2 
Lactulose and mannitol excretion In 6 hour urine collection of the study population. Data are 
expressed as mean ± SO. 
I 
Lactulose excreted % 
Mannitol excreted % 
Lactulose / mannitol 
excretion ratio 
Control (n=7) 
0.22 ± 0.09 
21.9 ± 8.3 
0.012 ± 0.005 
Trauma (n=11) 
0.69 ±1.17 
9.2 ± 11.6* 
0.069 ± 0.034 " 
Aneurysm (π=β) 
0.44 ± 0.20 * 
9.6 ± 8.3 * 
0.098 ± 0.093 ** 
* = ρ < 0.05 and ** = ρ < 0.005 versus controls, by Wilcoxon's test. 
In nine patients, 12 infectious complications were diagnosed during the 2-week study 
period, including five cases of pneumonia, four urinary tract infections, two cases of 
septicemia and one intra-abdominal infection (table 9.3). Of the 16 bacterial species 
cultured, seven (44%) probably were of enteric origin and nine (56%) of non-enteric 
origin. 
The mean L/M ratio on day 2 in the nine patients who later developed infectious 
complications was 0.059 ± 0.032 and in the 10 patients without infectious complicati­
ons 0.101 ± 0.080 (not significant, by Kruskal-Wallis test). No significant differences 
were found between infected and non-infected patients with regard to age, APACHE 
II, severity of shock or plasma lactate levels (data not shown). 
The degree of the altered intestinal permeability, expressed by the L/M ratio, did not 
show any significant correlation with ISS, APACHE II score, shock score, plasma lacta­
te levels, Pa02/Fi02 ratios at days 1,2 and 3, or mean MOF scores from days 5 to 14. 
None of the patients died during the two week study period. Four patients with 
aneurysm developed ARDS and MOF, while none of the patients with trauma fulfilled 
the criteria for ARDS and/or MOF. The UM ratios of the four aneurysm patients 
developing ARDS/MOF (0.047 ± 0.038) were not significantly different from those of 
the other patients (0.090 ± 0.065, by Kruskal-Wallis test). 
In 11 patients (5 with aneurysm, 6 with trauma) a complete set of blood samples (at 0, 
6, 24 and 48 hours) was available for endotoxin determination. In 6 patients (5 with 
aneurysm, 1 with trauma) endotoxemia was demonstrated at either 0 h (in 6 patients 
the mean endotoxin level was 21 pg/ml, range 15 to 25 pg/ml) or 6 h (in 2 patients 
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the endotoxin levels were 16 and 25 pg/ml). In the other 5 patients, no circulating 
endotoxin could be detected at any time. In patients with endotoxemia, the mean L/M 
ratio was 0.112 ± 0.100, versus 0.051 ± 0.028 in patients without measurable 
endotoxin. The mean shock score and blood lactate concentration on admission in 
patients with endotoxemia were 2.3 ± 1.2 and 5665 ± 4005 //mol/l, versus 1.4 ± 0.5 
and 3167 ±2218 μηηοΙ/Ι in patients without endotoxemia. Since the groups were 
small, no statistical analysis is provided. 
Table 9.3 
Type of infection in patients after ruptured abdominal aneurysm (patient nr. 1 through 3) and in 
severely traumatized patients (patient nr. 4 through 9), the day the infections became obvious and the 
micro-organisms that were cultured together with the individual data on lactulose and mannitol 
excretion (expressed as %) and their ratio. 
Patient Type of 
nr. 
1 
2 
3 
4 
5 
6 
7 
β 
9 
(sp. 
Infection 
Intra-abdominal 
sepsis 
Septicaemia 
Pneumonia 
Pneumonia 
Urinary tract 
Pneumonia 
Septicaemia 
Pneumonia 
Urinary tract 
Urinary tract 
Pneumonia 
Urinary tract 
= species) 
Day 
14 
4 
14 
5 
8 
10 
10 
8 
11 
8 
3 
5 
Micro-organism 
(Gram stain) 
Bacteroides sp. (-) 
Enterococcus sp. (+) 
S. epidermide (+) 
Ps. aeruginosa (-) 
K. pneumoniae (-) 
P. mirabilis (-) 
Enterococcus sp. (+) 
S. aureus (+) 
Strept. pyogenes (+) 
S. aureus (+) 
H. influenzae (-) 
Enterococcus sp. (+) 
Enterococcus sp. (+) 
S. aureus (+) 
Ps. aeruginosa (-) 
Ps. aeruginosa (-) 
Enteric 
yes/no 
yes 
yes 
no 
no 
yes 
yes 
yes 
no 
no 
no 
no 
yes 
yes 
no 
no 
no 
Lactulose/mannKol 
excretion (% / %) 
0.85/18.8 
0.54 / 4.9 
0.13/8.8 
0.31 / 5.9 
0.25/10.5 
4.35 / 44.9 
0.08/1.0 
0.07/1.8 
0.49 / 7.7 
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Discussion 
The lactiilose-mannitol test ¡s based on the different absorption routes of the two 
sugars. Mannitol, the smaller molecule, passes through aqueous pores in the cell 
membrane, while lactulose, the larger molecule, is absorbed paracellularly via the tight 
junctions and extrusion zones at the villous tips (1). By indexing the excretion of 
lactulose to that of mannitol (using the UM ratio), it is possible to correct for factors 
unrelated to intestinal permeability, such as gastric emptying, intestinal transit time, 
mucosal surface area, cardiac output and renal function (2). 
Alterations in absorption of lactulose reflect mucosal leakiness, whereas decreased 
absorption of mannitol correlates with a decrease in functional absorptive area 
(3,9,15). The UM ratio may be increased because of decreased mannitol absorption 
(functional impairment) as in celiac disease and in malnourished children with 
diarrhoea (9,15), or because of an increased lactulose absorption due to mucosal 
damage (physical impairment) as occurs after burn injury (3). Under normal condi-
tions, 0.1 to 0.5% of the administered lactulose and 6 to 18% of the mannitol is 
excreted in the urine during the first 6 hours after administration, the UM ratios 
reported varying from 0.006 to 0.035 (1-4,15,16). In the present study, the controls 
showed similar excretion and UM ratios. 
Both patients with trauma and aneurysm showed significantly increased UM ratios on 
the second day after the event, the first documentation, to our knowledge, of increa-
sed intestinal permeability in these patient populations. In this respect, the patients 
responded like thermally injured patients (1-3) and experimental animals after 
hemorrhaghic shock (16). 
No significant correlation was found between the severity of injury as documented by 
the ISS or shock as documented by the shock score and lactate levels on admission 
on one hand and the degree of increase in intestinal permeability on the other hand. 
This finding is in agreement with the post-burn injury studies, which did not show a 
burn-size-related effect on intestinal permeability (1-3). 
Since only a few patients in our study developed ARDS and subsequent MOF and 
these patients did not display a significantly different pattern of intestinal permeability 
compared with other patients, we looked at pulmonary gas exchange (РаО
г
 / Fi02) 
and mean MOF scores of all patients. No correlation was found between UM ratios 
and either impaired pulmonary function within the first 3 days of admission or with a 
later increase of mean MOF scores. 
In contrast to other reports (2,3), our data demonstrate that there is no significant 
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difference ¡η intestinal permeability between patients with and without subsequent 
infections. A type II error is unlikely because the direction of the trends in the L/M 
ratios was even opposite to that suggested by the other reports, ¡е., intestines of 
infected patients were less permeable than those of non-infected patients. LeVoyer et 
al. reported an increased intestinal permeability prior to the episode of infection in pa­
tients with burn (3). However, in their series only six of the 13 infections were caused 
by enteric organisms. Ziegler et al. also suggested a correlation between increased 
intestinal permeability and infections (2). However, in the latter study L/M ratios were 
measured after the first postburn week and thus at the time of infection itself. 
In our present study only five (42%) of the 12 documented infections (seven (44%) of 
16 infecting micro-organisms) were caused by enteric organisms. The remaining 
infections were caused by other non-enteric Gram-positive or Gram-negative species. 
Thus, we suggest that increased intestinal permeability and subsequent infections are 
independent phenomena, seen in patients after severe trauma or hemorrhagic shock. 
This hypothesis is supported by the observations that the process of microbial 
translocation occurs by direct penetration of the enterocyte, which is a process 
different from classical phagocytosis (17). Additionally, it has been demonstrated that 
the macrophage may play a key role in this translocation process (18). Thus, increa­
sed intestinal permeability as reflected in the L/M ratio may have little relevance to the 
mechanism of bacterial uptake by the intestinal epithelium. 
In six (54%) out of 11 patients in whom endotoxin was measured, detectable levels 
were found at the time of admission and/or 6 hours later. However, at the time 
increased intestinal permeability was demonstrated, and 1 day after the L/M test, no 
circulating endotoxin was found in any patient. Although the number of patients was 
limited, we found a trend toward higher L/M ratios in patients with prior positive 
endotoxemia test results. This is in agreement with the observations of O'Dwyer et al., 
who showed an increased intestinal permeability after a single dose of intravenous 
endotoxin in healthy humans (4). However, the present study provides no support for 
the hypothesis that endotoxin creates a positive feedback loop, in which damage to 
the intestinal barrier leads to translocation of endotoxins, with infectious complications 
and a septic response (4,5). We found endotoxemia, especially in patients after severe 
hemodynamic derangement (mainly ruptured abdominal aneurysms, with higher 
shockscores and lactate levels). In these patients splanchnic flow and especially liver 
perfusion generally are impaired in the shock phase (19). Therefore, endotoxin that 
entered the systemic circulation either by portal vein route or lymphatic transport 
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could be less rapidly inactivated by the liver, which normally plays a key role in this 
aspect (20). Once endotoxemia has occurred, this leads to an increase of mesenteric 
vascular resistance, resulting in a reduction of mesenteric blood flow of more than 
50% (21). After reperfusion and stabilization of hemodynamics, or in patients with less 
splanchnic flow impairment, endotoxin inactivation by the liver could be such that 
systemic circulating endotoxin levels do not exceed the threshold of detection. This 
effect may explain why in a recent study on major trauma patients no endotoxin could 
be detected in the circulation within the first 48 hours, since the first samples were 
taken no sooner than 6 hours after trauma (22). In one of our patients with trauma 
endotoxemia was found, but only immediately after the injury. After 6 hours this patient 
did not exhibit any detectable circulating endotoxin anymore. Our findings are in 
agreement with the data of Rush et al., who took blood specimens within 3 hours of 
admission in 10 patients with hemorrhagic shock (23). In the latter study only 
significant endotoxin levels were measured in two of these patients, who had very low 
blood pressures on admission (less than 80 mm Hg). 
The finding of increased intestinal permeability without subsequent detectable 
endotoxemia may be explained in several ways. First, after trauma and shock both 
increased intestinal permeability as well as endotoxemia are phenomena that primarily 
occur independently of each other. In patients with endotoxemia, a factor previously 
shown to promote bacterial translocation (19,24), the intestinal permeability can be 
increased or show a sustained elevation. However, increased intestinal permeability 
itself does not necessarily lead to more endotoxemia. Within this concept fits the 
finding that translocation of endotoxin does not require loss of mucosal integrity as 
such, since endotoxin has been shown to translocate directly across the enterocyte 
(17). The second explanation could be that immediately after trauma and shock intes-
tinal permeability is so much elevated that it leads to endotoxemia. Twenty-four hours 
later some reconvalescence of the intestinal mucosa has taken place, but intestinal 
permeability is still significantly increased, although not enough to lead to endotoxemi-
a. The latter proces could be enhanced by the fact that small amounts of entered 
endotoxin are cleared by the liver and do not exceed the detection limit of the 
systemic circulation. 
Conclusions 
In patients with severe trauma or a ruptured aortic aneurysm, intestinal permeability, 
as measured by the lactulose/mannitol test, was significantly increased at day 2. 
1R.4 
However, increased intestinal permeability did not correlate with the severity of injury 
and/or shock, or with subsequent infectious complications, ARDS and/or MOF. 
Endotoxemia was only demonstrated before the measurement of increased intestinal 
permeability, not at the time of measurement or afterward. We therefore hypothesize 
that in the patient population studied, increased intestinal permeability and subse-
quent infectious complications are independent phenomena. 
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Abstract 
In experimental animals increased intestinal permeability has been demonstrated after 
ischemia and reperfusion injury. In this study we determined intestinal permeability in 
patients after elective or emergency aortic aneurysm repair: the latter patients were in 
severe shock on hospital admission. A dual sugar absorption test with lactulose (L) 
and mannitol (M) as markers was used to measure intestinal permeability on the 
second day between 24 and 36 hours after hospital admission. The lactulose/mannitol 
(L/M) excretion ratio was 0.012 ± 0.005 in seven healthy control subjects, 0.118 ± 
0.116 in seven patients undergoing elective operation and 0.098 ± 0.093 in eight 
patients having emergency operation, indicating a significant increase of intestinal 
permeability in both patient groups (p < 0.01). No significant difference was found in 
intestinal permeability between patients of the elective and emergency groups. It is 
concluded that a significant increase in intestinal permeability commonly occurs in 
patients after elective and emergency major vascular surgery. It is suggested that this 
is mainly due to reperfusion injury rather than the ischemic period of the intestine 
itself. 
Introduction 
Late hospital death after major vascular surgery is mainly due to multiple organ failure 
(MOF) (1,2). It has been hypothezised, that the gut may play a leading role in the 
origin of MOF (3). This contribution of the intestine in situations leading to MOF is 
associated with two phenomena: bacterial translocation and endotoxemia (4-6). 
Bacterial translocation has been demonstrated in experimental animals after trauma 
and shock,(4) but in humans with major trauma this could not be confirmed (7). Endo-
toxemia was documented to occur after intestinal ischemia in cats (8). Experimentally, 
bacterial translocation is also promoted by endotoxin administration (5,9), whereas 
intravenous injection of endotoxin in human volunteers increased intestinal permeabili-
ty (6). These findings have led to the hypothesis that injury and shock, endotoxemia, 
intestinal permeability and bacterial translocation are parts of a vicious circle, finally 
leading to remote organ damage and death (6). 
Recently it was demonstrated that intestinal permeability is increased in rats after 
lower limb ischemia and reperfusion injury (10). The present human study was 
undertaken to investigate whether gut permeability is altered after major vascular 
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surgery, in particular after abdominal aortic aneurysm repair. 
Patients and methods 
Subjects 
Three groups were studied. The control group for studying intestinal permeability 
consisted of seven healthy volunteers, all men with a mean (±SD) age of 31 ± 9 
years. The second group consisted of seven patients (6 men and 1 woman: 65 ± 12 
years of age), who underwent elective repair of an aneurysm of the infrarenal aorta. 
The third group consisted of eight male patients (69 ± 6 years of age), who were 
admitted in hemorrhagic shock and had an emergency operation because of a 
ruptured infrarenal aortic aneurysm. The study was approved by the local ethics 
committee, and informed consent was obtained from all patients or their relatives prior 
to the study. 
Study design 
After operation, after admission to the ICU, the APACHE II score was determined in all 
cases (11). On the second day, 24-36 hours after operation, intestinal permeability 
was assessed by measuring the absorption of two orally administered inert markers 
lactulose and mannitol (6,12). 
The test solution consisted of 10 grams of lactulose and 5 grams of mannitol mixed in 
60 ml of distilled water, and was instilled via a nasogastric tube. Until then the patients 
had been fasting. The healthy volunteers received the test solution orally after an 
overnight fast. Before administration, the urinary bladder was emptied and a pretest 
urine sample was taken. During the next 6 hours, all urine was collected and pooled. 
A sample was taken from this pooled urine. Both urine samples were frozen at -20°C 
until analysis. Urinary lactulose and mannitol concentrations were determined, by use 
of capillary gas chromatography (13). Mannitol excretion was corrected by subtraction 
of baseline values determined in the pretest samples. Finally the lactulose/mannitol 
excretion ratios (L/M ratio) were calculated. 
As long as patients were admitted at the ICU, a daily MOF score was calculated (14). 
A patient was diagnosed as having MOF if the average MOF score from day 5 to 14 
was > 4. 
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Statistical analyses 
The Kruskal-Wallis test and Wilcoxon's two sample test were used for comparison of 
groups. Differences were considered significant at ρ < 0.05. 
Results 
The mean (± SD) APACHE II score on ICU admission was 5.3 ± 2.4 in the elective 
group and 8.4 ± 2.5 in the emergency group (p = 0.09, by Kruskal-Wallis). 
The excretion of administered lactulose and mannitol is shown in table 10.1. Lactulose 
excretion was increased in both study groups as compared with the control group 
and significantly so in the emergency group. Mannitol excretion was significantly lower 
in both study groups. The mean L/M ratio in controls was 0.012 ± 0.005, in the 
elective group 0.118 ± 0.116 and in the emergency group 0.098 ± 0.093 (p < 0.01, 
by Wilcoxon's test) (figure 10.1). 
No significant difference in either lactulose or mannitol excretion or in the L/M ratios 
was found between patients of the elective and of the emergency group. 
Mof developed in 4 patients, all from the emergency group. Their L/M ratios (0.047 ± 
0.038) did not significantly differ from other patients, in whom subsequent MOF did 
not develop (0.128 ±0.110). 
Table 10.1 
Lactulose and mannitol excretion in 6 hour urine collection of the study population. Values are 
expressed as mean ± SD. 
Lactulose excreted % 
Mannitol excreted % 
Lactulose / mannitol 
excretion ratio 
Control (n=7) 
0.22 ± 0.09 
21.9 ± B.3 
0.012 ± 0.005 
Elective (n=7) 
0.85 ± 1.52 
7.1 ± 4.9 * 
0.118 + 0 . 1 1 6 " 
Emergency (n=8) 
0.44 ± 0.20 * 
9.6 ± 8.3 * 
0.098 ± 0.093 ** 
* = ρ < 0.05 and ** = ρ < 0.01 versus controls, by Wilcoxon's test. 
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Figure 10.1 
Lactulose/mannitol urinary excretion ratios in healthy controls, patients after elective aneurysm repair 
and patients after emergency repair, because of a ruptured aneurysm. Horizontal bars indicate mean 
values. Differences between groups: control vs elective: ρ = 0.003; control vs emergency: ρ = 0.009; 
elective vs emergency: ρ = 0.52, not significant, by Wilcoxon's test. 
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Discussion 
The lactulose-mannitol test is a generally accepted tool for assessing intestinal 
permeability and Is based on the different absorption routes of the two sugars 
(6,12,15-18). Mannitol, the smaller molecule of the two agents, passes through 
aqueous pores in the cell membrane, whereas lactulose, the larger molecule, is 
absorbed paracellularly via the tight junctions and extrusion zones at the villous tips 
(12). By indexing the excretion of lactulose to that of mannitol (with use of the L/M 
ratio), it is possible to correct for factors unrelated to intestinal permeability, such as 
gastric emptying, intestinal transit time, mucosal surface area, cardiac output and 
renal function (16). 
Under normal conditions, 0.1-0.5% of the administered lactulose and 6-18% of the 
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mannitol is excreted in the urine during the first б hours after administration (18). The 
reported L/M ratios vary from 0.006 to 0.035 and appear to be independent of age 
(18). In the present study the controls showed similar excretion and L/M ratios as in 
the reviewed literature. 
Increased intestinal permeability has been reported to occur in patients with several 
gastro-intestinal disorders, like Crohn's and celiac disease (19) and in malnourished 
children with diarrhoea (17). In like manner, patients after thermal Injury showed a 
marked increase of intestinal permeability (12,15,16). In these latter patients intestinal 
permeability could be related to subsequent infectious complications (15,16). We 
recently also reported such an increase of intestinal permeability in patients after 
severe trauma, but we could not confirm the relation of this increased permeability 
with septic complications (18). 
The present report demonstrates that after major vascular surgery intestinal permea­
bility is markedly increased. We found no difference in intestinal permeability in 
patients with an elective aortic aneurysm repair, compared to those admitted in shock 
and operated on for a ruptured aneurysm. In both patient groups the aneurysm and 
the clamp placed before operation on the aorta were located below the renal arteries, 
so in both groups the flow through the superior mesenteric artery - and thus through 
the small intestines - was affected in a similar way by the operation itself. This finding 
indicates that the factor of hemodynamic instability and shock in patients of the emer­
gency group did not contribute significantly to intestinal permeability. These data 
confirm the hypothesis that the reperfusion injury, that must have occurred in both 
patient groups may be the most important factor leading to gut mucosal damage and 
increased permeability (10). This is in agreement with animal studies that showed that 
the effects of ischemia occurred largely at the time of reperfusion and reoxygenation 
rather than during the ischemic period itself (20). 
Additional human studies are required to investigate whether intestinal permeability is 
changed also after lower limb ischemia and reperfusion as it is in patients who 
undergo femoral artery operation. Furthermore, attempts should be undertaken to 
unravel the role of anti-oxydants and other antagonists of mediators that are released 
after ischemia and reperfusion injury, with emphasis on intestinal permeability chan­
ges. 
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Abstract 
Splanchnic ischemia, leading to intestinal mucosal damage, is thought to be a 
common condition in patients after severe trauma. The adequacy of mucosal oxyge-
nation can indirectly be determined by gastric intramucosal pH (pHi) measurement. 
We prospectively examined the post-traumatic gastric pHi values in 15 multiple trauma 
patients. In all patients gastric pHi was measured using a tonometer applied via the 
nasogastric route. A pHi value s 7.32 was used to differentiate between normal and 
low gastric pHi. 
Six hours after the injury four patients showed abnormally low pHi levels. Four other 
patients with normal initial pHi values exhibited low pHi values during one or more of 
the next measuring periods. Three of these eigth patients developed major complica-
tions (2x ARDS) and two of them subsequently died. The seven remaining patients 
never had abnormal pHi levels and all patients had an uncomplicated recovery. 
Although intestinal ischemia was expected to be a common condition in multiple 
trauma patients, no consistent pattern of abnormal pHi measurements in the direct 
post-traumatic course could be discovered. No correlation was found between initial 
pHi values (at 6h) and ISS, shock and lactate concentrations or APACHE II score on 
admission. It is concluded that monitoring gastric pHi is usefull in severely injured 
patients admitted to ICU. 
Introduction 
Intestinal ischemia is a common condition in critically ill patients (1). It induces a 
spectrum of mucosal injury ranging from subtle changes in capillary permeability to 
gross transmural infarction depending on the severity and duration of the ischemic 
challenge (2). The mucosal damage consists of two components: the injury induced 
by ischemia (hypoxia) and that produced by oxygen free radicals on reperfusion of 
the ischemic tissue (2,3). In previous studies we showed that human intestinal 
permeability is markedly increased 24 to 36 hours after severe blunt trauma (4). In 
another study, significant increases of serum lipofuscin levels at 6 and 24 hours after 
severe trauma were demonstrated, with a predictive value for subsequent ARDS and 
multiple organ failure (MOF) (5). The presence of increased lipofuscin concentration in 
these patients suggests a pathogenic role for lipid peroxidation caused by oxygen 
free radicals (5,6). Thus, one might expect that splanchnic ischemia is a common 
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condition in the direct post-traumatic course of multiple trauma patients. 
Indirect measurement of pH in gut mucosa (pHi) has been shown to provide a 
measure of the adequacy of mucosal oxygenation (1,7,8). By means of an ¡ntralumin-
ally placed balloon catheter permeable to C02 pHi can be measured (9,10). 
The present study was undertaken to investigate the post-traumatic course of 
tonometrically measured pHi in patients after severe blunt trauma. In addition we 
studied the relation between pHi and parameters for severity of injury, shock, lactate 
levels and physiological derangement. 
Patients and Methods 
Fifteen patients with multiple blunt trauma, with an ISS-HTI > 25 (11,12), who had to 
be operated upon because of one or more injuries, were enrolled in the study. 
Informed consent was obtained from all patients or their relatives prior to the study. 
The study was approved by the local ethical committee. 
On hospital admission ISS-HTI, APACHE II (13) (also calculated on ICU admission) 
and a shock score (4) were determined. The latter score was defined to grade the 
severity of hemodynamic derangement on admission. For this purpose the Allgöwer 
shock index (heart frequency / systolic blood pressure) (14) and the systolic blood 
pressure were used: (0) no shock: index < 1.0 and systolic blood pressure г 100 
mm Hg, (1) mild, compensated shock: index > 1.0 and systolic blood pressure 2 100 
mm Hg, (2) moderate shock: systolic blood pressure 80 - 100 mm Hg, (3) severe 
shock: systolic blood pressure < 80 mm Hg. (4) severe, prolonged shock: more than 
one hour systolic blood pressure < 80 mm Hg. During general anaesthesia a 
tonometer (Tonomitor, Tonometries, Inc. Bethesda, Maryland, USA) was inserted via 
the nasogastic route in all patients. The position of the balloon was confirmed 
radiographically. PC02 was assessed by inflating the balloon with physiologic saline, 
precisely according to the instructions of the tonometer users manual. After an 
equilibration period of 30 minutes, a saline sample was withdrawn anaerobically and 
PC02 measured immediately by a standard blood gas analyzer (Corning 278, Ciba 
Corning Diagnostics N.V., Houten, The Netherlands). Arterial blood was withdrawn 
simultaneously for determination of pHa, blood gases and bicarbonate concentration, 
as well as lactate concentration. After correcting the PC02 according to the equilibrati­
on period the pHi was calculated with the modified Henderson-Hasselbalch equation: 
pHi = 6.1 + Log10 { [HC03] / PC02 x 0.03 }. 
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PH¡ and lactate measurements were performed at 6, 12, 24, 36 and 48 hours after 
hospital admission. None of the patients received histamine-receptor-blocking agents 
throughout the study period (15). A pHI value of < 7.32 was considered as an 
indication of inadequate tissue oxygenation (9,10,16,17). Arterial blood lactate was 
measured in deproteinized samples (0.6 mol/l perchloric acid) by enzymatic conversi-
on of lactate into pyruvate. 
Pearson's correlation coefficients were used for correlation analysis. Ρ values less than 
0.05 were considered to be significant. 
Results 
Demographic data and initial pHi values (at 6 hours) of all 15 patients are shown in 
table 11.1. The patients had a mean (± SD) age of 36 ± 7 years and ISS of 35.5 ± 
8.8. APACHE II score was 10.6 ± 4.9 on hospital admission and 7.4 ± 6.4 after 
admission to the ICU. Figure 11.1 illustrates the pHi course of the whole patient group 
during 48 hours. 
Four patients had an initial abnormal pHi value of less than 7.32. Two of these 
patients showed a correction of pHi to normal values in the next measuring periods. 
They had an uncomplicated recovery and were discharged from ICU at day 3 and 5, 
respectively. One patient had a persistently low pHi at 12 hours with normalization in 
later periods; however, there were no specific complications and he was discharged 
from ICU at day 11. The fourth patient showed a further decrease of pHi (lowest pHi 
= 7.08), brain death was diagnosed subsequently and he died of cardiopulmonary 
instability at day 3 in ICU. In four other patients, who initially showed a normal pHi at 6 
hours, a decrease below pHi 7.32 occurred during one of the next measuring periods. 
Two of these patients also had an uncomplicated recovery with discharges from ICU 
at day 3 and 4, respectively. The two other patients, however, developed compli­
cations: one developed ARDS with a prolonged ICU stay (26 days) and the other 
patient -77 years of age- also developed ARDS with subsequent sepsis due to 
acalculous cholecystitis and died at day 12 in ICU. 
Thus, eight of the 15 patients showed one or more abnormal pHi values during the 
first 48 hours after trauma, of whom three patients had a complicated course. In the 
remaining seven patients in whom no abnormal pHi values were measured all had an 
uncomplicated clinical reconvalescence. 
178 
Table 11.1 
Demographic data and gastric intramucosal pH (pHi) values of 15 patients with multiple blunt trauma 
# Indicates an abnormally low pHi value (s 7.32), (+) indicates that the patient died. 
Patient 
1 
2 
3 
(+) 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
(+) 
Age 
(years) 
25 
26 
43 
31 
46 
36 
41 
21 
19 
21 
33 
52 
16 
55 
77 
ISS 
(HTI) 
41 
34 
57 
41 
25 
41 
34 
29 
34 
25 
34 
29 
33 
41 
27 
• • 
Shock 
score 
(CM) 
1 
1 
4 
2 
0 
2 
2 
1 
1 
1 
2 
1 
1 
3 
0 
Lactate at 
6 hours 
(μΐηοΙ/Ι) 
1900 
1738 
10260 
3129 
3917 
3660 
223Θ 
3623 
1500 
1700 
3015 
3121 
2178 
4954 
1200 
pHlat 
6 hours 
7.12 # 
7.23 # 
7.31 # 
7.32 # 
7.34 
7.35 
7.39 
7.41 
7.42 
7.44 
7.46 
7.49 
7.52 
7.54 
7.66 
Next 
loweet 
pHI 
7.11 # 
7.34 
7.08 # 
7.37 
7.46 
7.43 
7.44 
7.18 # 
7.15 # 
7.46 
7.41 
7.34 
7.36 
7.10 # 
7.06 # 
Compii· 
cation 
-
-
brain 
death 
-
-
• 
-
-
-
-
-
-
ARDS 
ARDS-
sepsis 
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Their ICU stay ranged from 2 to 6 days, except for one patient with severe brain 
damage, who stayed in the ICU for 27 days. 
No significant correlations could be found between initial pHi values (at 6 hours) and 
ISS (r = -0.36), shockscore (r = -0.13). lactate concentration on admission (r = -0.25) 
or at 6 hours (r = -0.14) or APACHE II score on hospital and ICU admission (r = 
+0.17 and r = +0.39, respectively). 
Figure 11.2 
Course of pHi values (mean ± SD) in 15 multiple trauma patients at five consecutive sampling 
periods: 6, 12, 24, 36 and 48 hours after the injury. The dotted line indicates the pHi value (7.32) that 
was used to differentiate between normal and low gastric pHi. 
7.60 -
7.48 -
7.36 -
X 
Q. 
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Discussion 
Several -experimental and clinical- reports have demonstrated that monitoring the 
intramucosal pH (pHi) of the gastro-intestinal tract provides reliable information on the 
local anaerobic activity during situations of systemic hypoxia (7,8,18). Gastric tonome-
try data have been shown to correlate with sepsis and mortality in critically ill patients 
(16.17) and to be of predictive value of complications after cardie surgery (9). Sigmoid 
tonometry was of prognostic value in patients after abdominal aortic operations not 
only regarding the development of subsequent colitis, but also towards postoperative 
infections with intestinal organisms (19,20). Experimentally, it has been shown that pHi 
reflects reduced gastro-intestinal mucosal perfusion (21) and the degree of pHi decre-
ase to correlate well with the histologic degree of ischemic mucosal injury (7,8). The 
method also has been demonstrated to be reliable in the setting of tissue acidosis 
induced by endotoxemia (18). 
Recently, Gutierrez et al. (10) reported that therapy guided by gastric pHi measure-
ments could significantly improve survival in critically ill patients. This was true in those 
patients in whom pHi on admission to the ICU was normal (> 7.35), but subsequently 
had levels falling below this level and in whom pHi could be restored to normal by 
treatment aiming at an increase of systemic oxygen transport or reduction of oxygen 
demand (10). We could not find a single study that reported on the phenomenon of 
gastric tonometry in patients after multiple trauma. 
It has been shown that mucosal injury leads to increased intestinal permeability (2,21). 
This phenomenon is thought to play a role in the development of multiple organ 
failure, since the gastro-intestinal tract is an occult reservoir of pathogens and large 
amounts of endotoxins (22). Recently, our group demonstrated a significant increase 
of intestinal permeability, measured by the lactulose/mannitol urine excretion ratio, in 
trauma patients 24 to 36 hours after severe blunt injury (4). Eigth of the present 15 
patients studied, took part in that study on intestinal permeability and all these 
patients showed abnormally increased intestinal permeability (data not shown) (4). 
Only two of these eigth patients had initially low pHi values, whereas all belonged to 
the group of patients with uncomplicated recovery. 
Since practically all severe trauma patients exhibit abnormally increased post-traumatic 
intestinal permeability, we expected to find consistently abnormal pHi levels in the 
direct post-traumatic course. Surprisingly, this was not the case. This discrepancy 
may be explained by the fact that tonometry monitors the metabolic process of the 
mucosal cells. This process may fluctuate in time -depending on the splanchnic blood 
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flow- and abnormal levels can be restored within a short period (21). Intestinal 
permeability measurement, on the other hand, reflects either mucosal barrier damage 
expressed by increased passive lactulose absorption and/or decreased mucosal cell 
function expressed by decreased active mannitol absorption (4,23). Once this 
mucosal surface is damaged it probably takes much more time to be restored than 
the underlying metabolic process that reflects pHi. 
Like other reports we also could not find a sigificant relation between initial pHi values 
and lactate concentrations, severity of previous shock or APACHE II scores (10,16,17). 
Also the severity of injury did not correlate with subsequent pHi levels. Apparently 
these parameters do not significantly influence or reflect splanchnic blood flow. 
Since monitoring and even therapy guided by pHi values clearly has been demonstra-
ted to be of value in critically ill patients, tonometry may also be indicated and useful 
in monitoring patients after severe blunt trauma. This is illustrated by the fact that the 
three patients with a complicated course all had one or more abnormal post-traumatic 
pHi levels. 
The present report, however, shows that tonometry and measurements of intestinal 
permeability are two different methods to study the role of the gut in relation to post-
traumatic complications. Therefore conclusions of such measurements should be 
interpreted with caution. 
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Chapter 12 
GENERAL DISCUSSION 
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The clinical studies presented in this thesis are a part of the clinical and experimental 
work on ARDS and MOF that is performed at the Department of Surgery of the 
University Hospital Nijmegen under the supervision of Prof. Dr. RJA Goris. 
Based on clinical and experimental work this group was the first to formulate the 
hypothesis that ARDS and MOF are one syndrome resulting from an uncontrolled and 
general inflammatory response to a variety of stimuli (1,2). They emphasized the 
importance of the activation of the complement system and the specific role of PMNs 
(expressed by their elastase release) (3). These observations could be confirmed in 
our clinical study on severely traumatized patients. In addition, they demonstrated the 
importance of hypoxia in experimental work on rabbits (4). Since blood lactate is a 
generally accepted parameter of tissue hypoxia (5), the finding that in trauma patients 
elevated blood lactate concentrations during the early post-injury phase are an 
independent and significant determinant of subsequent ARDS and MOF confirms the 
role of tissue hypoxia. 
Nuytinck et al. also were the first to point out that autopsy findings of trauma patients 
and patients succumbed of MOF, frequently show features of a generalized inflamma-
tory process in the lungs, liver, kidneys, heart and spleen (6). This observation was 
made not only in those patients dying late of sepsis and MOF, but also in patients 
who died within hours post-injury, or without any sign of clinical sepsis. 
Also an experimental animal model was developed, in which a MOF-like syndrome 
was induced by means of a non-bacterial, non-endotoxic, local inflammatory stimulus, 
i.e. intraperitoneal injection of Zymosan suspended in paraffin (7,8). The usefulness of 
this animal model has been confirmed by others (9). Morphological studies of lungs, 
liver, kidneys and spleen showed the same features of generalized inflammation as 
observed in the post-mortem studies of Nuytinck et al. (6). 
Another important aspect of this experimental work is that it was demonstrated that 
MOF is not obligatorily dependent on the presence of bacteria or endotoxin. Selective 
decontamination of the gut, although very effective in preventing bacterial trans-
location, did not prevent the development of MOF in this model (10). 
The problem with experimental studies is that the findings and conclusions can not 
simply be extrapolated to the human clinical situation. This is mainly because 1) in 
experimental circumstances one variable is changed throughout the experiment, 
whereas all other variables are kept as constant as possible with a fixed time scale 
and 2) the responses of various species - and even between individuals within one 
species - may show huge variations, 
ad 1). It is clear that in clinical studies we deal with patients of varying ages, with 
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varying preëxistent (pathological) conditions, with different degrees of trauma or insult, 
and who enter the study protocols at various time points. This may explain why the 
clinical significance of several inflammatory mediators varies from series to series. For 
example: cytokines, like TNFa, have a short half-life and therefore peak concentrations 
can be overlooked due to random sampling. Samples may be taken at the "wrong" 
time point, because the disease process has already been established. Moreover, 
circulating levels do not necessarily reflect local tissue levels or biological activity (11). 
ad 2). A few examples may illustrate this point: mutation of a single gene is respon-
sible for the change of an endotoxin-sensitive mouse into an endotoxin-hyporesponsi-
ve mouse (12). Thromboxane B2 production during sepsis and septic shock varies 
significantly between rats, dogs, pigs and humans (13). From studies on cytokine 
responses to endotoxin stimulation it is known that human individuals can be divided 
into high-responders and low-responders (14). Human PMNs generate free radicals at 
a much higher level than bovine, ovine and porcine PMNs (15). 
Nonetheless, animal experiments remain essential and are necessary to discover or 
explain underlying pathophysiological mechanisms. Despite the miscellaneous 
circumstances in clinical practice, clinical studies are required to prove pathophysiolo-
gical theories and to demonstrate their clinical relevance. For instance, bacterial 
translocation is a phenomenon which has been demonstrated to occur in experimen-
tal circumstances (16), but its clinical relevance remains unclear. The studies of 
Peitzman et al. (17) and Moore et al. (18) on trauma patients showed that bacterial 
translocation to mesenteric lymph nodes was not a common occurrence, nor was 
systemic or portal bacteremia. Moreover, in those cases where bacterial translocation 
did occur, no correlation with subsequent complications (such as MOF) could be 
discovered. 
The goal of the present thesis is the search for factors significantly associated with the 
development of MOF in the clinical setting. Bone et al.(19) recently emphasized the 
urgency to achieve uniform definitions, to standardize research protocols and to 
compare information from different clinical studies. The problem resulting from the 
absence of such uniformity can be illustrated by the use of the ARDS definitions in our 
own studies. In chapter 3 we used the alveolar-arterial oxygen quotient (20) to 
describe patients with and without ARDS, while in chapter 5, 6 and 9 the definition 
according to Pepe (21) was used. The use of these different definitions was prompted 
by the fact that the data in chapter 3 were collected from a multi-center study in 
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cooperation with two Austrian trauma hospitals, routinely utilizing the parameter 
mentioned first. 
The role of scoring systems, grading the severity of trauma, diseases and organ 
dysfunction in relation to subseguent ARDS and MOF. 
In our retrospective analysis of patients with acute hemorrhagic necrotizing pancrea-
titis (AHNP), who are most prone to develop ARDS and MOF, we demonstrated the 
usefulness of the MOF score developed by Goris et al. (1) and its accuracy in the 
early prediction of death or survival. In addition, we compared the MOF score with 
other scoring systems, such as APACHE II and SSS (see appendix), in order to illu-
strate that different aspects are graded, thus resulting in different information and 
conclusions. The APACHE II score, which is a generally accepted tool for classification 
of ICU patients and for prediction and comparison of ICU mortality rates (22), is less 
useful for follow up, especially when MOF occurs. It is possible that a patient with a 
high MOF score - indicating the necessity of organ support and intensive treatment -
may exhibit a normal or low APACHE II score, because most parameters have been 
normalized due to effective organ support. 
On the other hand, we could demonstrate that the APACHE II score provides more 
prognostic information in patients with AHNP than the pancreatitis-specific-scoring 
systems developed by Ranson et al. and Imrie et al.(see appendix). 
Another aspect of scoring systems is that they may grade the severity of an insult 
according to objective criteria (such as grading the anatomical severity of lesions), or 
the physiological response of the organism to the insult. The first score is once for all 
fixed and will only be influenced by the accuracy of diagnosis. The latter scoring 
system will yield varying values in time, due to the clinical evolution of the patient and 
to the effects of treatment. This may explain the different predictive values of the Injury 
Severity Score and Trauma Score (see appendix) towards the development of ARDS 
and MOF found in our study on patients with multiple trauma. 
The relation of various circulating biochemical products of the inflammatory cascade 
with subsequent ARDS and MOF. 
The role of hypoxia, expressed by elevated lactate concentrations, was demonstrated 
in multiple trauma patients: significantly higher blood lactate levels were found in those 
patients who subsequently developed ARDS/MOF. 
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Data on increased serum lipofuscin concentrations may also illustrate the important 
role of hypoxia (leading to ischemia) with subsequent reperfusion resulting in oxygen 
free radical production. Since PMNs are known to be an important source of oxygen 
free radical production, serum lipofuscin concentrations might also be an expression 
of the significant role of PMNs in the early post-injury phase. We found that lipofuscin 
levels were not only significantly elevated in patients with subsequent ARDS/MOF, but 
also to have a great accuracy in the prediction of these syndromes. 
The important involvement of PMNs in the early post-injury phase, and more signifi-
cantly so in patients who subsequently developed ARDS/MOF, could be demonstra-
ted in the study on patients with multiple trauma. Elastase-a1 proteinase inhibitor 
complex levels can be used as a marker of the severity of injury and our data support 
the hypothesis that elastase may act as an important mediator in the inflammatory 
cascade leading to ARDS/MOF. In other reports it was even concluded that elastase 
can be a predictor of these complications (23). In the same multicenter study on 
trauma patients we could demonstrate the significant role of complement activation in 
the early post-injury phase, associated with an increased incidence of ARDS/MOF. 
In our final study on inflammatory mediators, i.e. the cytokines TNFa, IL-1B and IL-6, 
we found intriguing differences between the three patient groups investigated 
(patients with multiple trauma, ruptured AAA and undergoing elective AAA repair): we 
observed significantly higher cytokine levels during the early post-injury phase in non-
survivors, as well as in patients who developed ARDS/MOF at a later stage. 
These studies on inflammatory mediators support the view that the basic elements 
involved in the evolution of organ failure are the uncontrolled and persistent immuno-
¡nflammatory response and tissue hypoxia following a traumatic event. In this concept 
the host is not an innocent bystander or victim who is invaded by bacteria and 
products of injured tissue, but is an active participant in this destructive process 
(1.11). 
The role of the gut in relation to the development of ARDS/MOF with emphasis on its 
barrier function (intestinal permeability). 
In the discussion about pathophysiological mechanisms resulting in ARDS/MOF 
endotoxin plays an important role. This might be because of the paradoxical position 
it has. In fact, it is a true exogenous toxin, but we carry along with us an abundancy 
of lethal doses of this toxin inside the lumen of our own intestines. 
Experimental work has provided extensive evidence of the toxicity of endotoxin. 
•іяч 
Intravenous endotoxin administration causes a myriad of biological effects (24) clini-
cally resembling sepsis or a shock-like state and thus potentially resulting in MOF 
(25). At present, endotoxin is thought to be the main denominator of the effects seen 
in gram-negative sepsis (26). It has also been demonstrated that endotoxemia results 
in a significant and consistent cytokine release (TNF, IL-10) (27). Conversely, experi-
mental administration of these cytokines produces a response that largely mimicks the 
response to endotoxin or clinical septic shock (28). Therefore, at present it remains 
unclear to what extent endotoxemia (due to endotoxin translocation from the gut) is 
responsible for some or all effects observed in our patients after a severe trauma or in 
hemorrhagic shock. 
Our study on patients undergoing elective aortic aneurysm repair revealed a consis-
tent systemic endotoxemia after clamping and declamping of the infrarenal abdominal 
aorta. This endotoxemia, however, was without specific adverse clinical effects. Moreo-
ver, in patients admitted in shock due to a ruptured abdominal aortic aneurysm or 
after a severe trauma, systemic endotoxemia could also been demonstrated. The 
concentrations found were not higher than in the elective patients, and did not 
correlate with subsequent MOF. In addition, when systemic circulating endotoxin was 
present, no correlation was found to the presence of TNFa. On the other hand, in 
77% of the patients without measurable endotoxin we were able to demonstrate syste-
mic circulating TNFa. These data may illustrate that endotoxin is not the only factor 
that is responsible for the cytokine release observed in our patient populations. 
This debatable role of endotoxin in the process leading to organ failure brings up the 
role of the barrier function of the gastro-intestinal tract in the pathogenesis of MOF. 
Those who advocated the significant role of infections and sepsis in the development 
of MOF were confronted with the fact that In more than 30% of patients dying of MOF 
no septic focus could be identified (1,23). The demonstration of bacterial and endo-
toxin translocation from the gut may then explain this apparent paradox of negative 
septic foci. The study of O'Dwyer et al., (29) who demonstrated that intravenous endo-
toxin administration resulted in a significant increase of intestinal permeability and the 
reports on the promotion of bacterial translocation by endotoxin application (30), 
made the confusion about the role of intestinal permeability complete. From that time 
on, many reports appeared stating that increased intestinal permeability would 
probably mean increased bacterial and endotoxin translocation. A literature review on 
this subject and our own clinical studies revealed that such is not the case. 
The gut apparently is an organ highly susceptible to disturbances of homeostasis 
resulting in functional and anatomical mucosal damage, that can easily be measured 
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by the absorption and excretion of two orally administered inert sugars (29). However, 
this measure of intestinal barrier function does not implicate that patients with 
increased permeability have a higher chance of developing gut derived infections, 
septic complications or MOF. In addition, our studies demonstrated that there is no 
correlation between the increase in permeability and parameters that grade the 
severity of injury and/or shock. In a study on gastric intramucosal pH measurements 
(pHi) in polytrauma patients, we could confirm that monitoring gastric pHi in ICU 
patients is valuable and can be predictive of subsequent complications, such as MOF 
(31, 32). This fits within the concept that hypoxia - and in this case true tissue hypoxia 
- may aggravate the initial insult as was shown by the study of Nuytinck et al. (3). But 
again we could not demonstrate a correlation between the degree of intestinal 
permeability and gastric pHi values. These observations on the role of the gut suggest 
that the gut is not the key organ or motor of MOF (33), but that the associated 
processes of bacterial translocation, endotoxemia, altered intestinal permeability and 
gut-derived-infections merely are epiphenomena frequently seen in patients at risk for 
ARDS and MOF. 
Notwithstanding the fact that prevention of MOF should have the highest priority, and 
that foci of bacteria and endotoxin should be treated early and vigorously, it appears 
that the inflammatory response of the human body to severe injury, shock and infecti-
ons importantly contributes to subsequent morbidity and mortality. Therefore, future 
studies should address the development of strategies that influence or interfere with 
the potentially harmful inflammatory response of the host itself. 
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SUMMARY 
Adult respiratory distress syndrome (ARDS) and multiple organ failure (MOF), both 
syndromes considered to be the result of one common pathophysiological pathway, 
represent the number one cause of death in a surgical ICU. Despite the increasing 
quality of intensive care treatment, the mortality rates of patients with established MOF 
have not appreciably improved during the last two decades. It therefore is a challenge 
to unravel factors that significantly contribute to the development of ARDS/MOF. 
In this thesis the role of scoring systems, various inflammatory mediators and the gut 
is scrutinized in relation to the development of ARDS/MOF in patients known to have 
an increased risk for developing these syndromes. 
In chapter 1 the definition and clinical presentation of ARDS and MOF are outlined. It 
is demonstrated that in patients with different etiological entities a sequential and 
progressive failure of several organ systems may develop, resulting in a common end 
stage. 
The role of oxygen metabolism and toxic oxygen free radicals, probably produced by 
stimulated PMNs and in various tissues after ischemia and reperfusion injury, is 
discussed. 
Further attention is payed to the role of humoral and cellular systems, to bacterio-
logical aspects and to the role of the gut (containing large amounts of bacteria and 
endotoxin that may translocate). 
Several theories on the mechanisms that may lead to ARDS and MOF are summari-
zed. Finally, the aim of the thesis and the questions that will be addressed in the 
following chapters are outlined. 
Chapter 2 provides a retrospective analysis of patients admitted to the ICU because 
of severe acute hemorrhagic necrotizing pancreatitis requiring mechanical ventilation. 
Several scoring systems are compared: Ranson and Imrie scores (grading the 
severity of pancreatitis), Sepsis Severity Score and APACHE II (grading the severity of 
any disease process), and the MOF score (grading the severity of organ dysfunction 
and intensity of organ support). 
It is concluded that on admission to ICU the APACHE II score is better for grading the 
severity of disease than the so-called disease-specific scoring systems (Ranson and 
Imrie), which should be applied during the first 48 hours of hospital admission. The 
MOF score had the best accuracy and yielded the best prediction of death within the 
first four days of ICU admission. 
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Chapter 3 reports on the evaluation of seven scoring systems in 56 patients, who 
sustained severe blunt trauma, in relation to subsequent ARDS and MOF. It is shown 
that the scoring systems that directly grade the anatomical severity of trauma correlate 
best with subsequent ARDS and MOF. This was not the case for scoring systems that 
grade the physiological response of the organism to the injury. 
In addition, it was demonstrated that lactate concentrations -indicating the hypoxic 
injury- were significantly elevated during the first three days post-injury in patients who 
subsequently developed ARDS/MOF, in comparison with patients who did not develop 
ARDS/MOF. 
Chapter 4 describes the patterns of various inflammatory mediators (complement, 
thromboxane B2, C-reactive protein, elastase and neopterin) in the same 56 patients 
as reported in chapter 3. 
We could demonstrate that non-survivors had significantly higher levels of comple­
ment activation at day 1 post-injury, if compared to survivors. The same was true for 
elastase, indicating enhanced activation of PMNs. Moreover, we found significantly 
higher concentrations of C3a, terminal complement complexes, thromboxane B2, and 
elastase at day 1 in patients with subsequent MOF, compared to those who did not 
develop MOF. Neopterin concentrations, indicating macrophage activation, were 
significantly higher during the second week in patients with established MOF. 
In chapter 5 the cytokines TNFa, IL-13 and IL-6 are studied. Three patients groups 
were enrolled in the study: 28 patients after severe blunt trauma, 20 patients with a 
ruptured AAA and 18 patients undergoing major elective aortic aneurysm repair. Of 
the total of 66 patients 22 died (15 ί 2 days and 7 later). The remaining 51 patients 
were divided in patients who developed ARDS/MOF (n=10) and patients who did not 
develop ARDS/MOF (n=41). 
Intriguing differences between patient groups were found for the various cytokines. IL-
6 appeared to be elevated significantly in trauma patients, compared to the patients 
who presented with a ruptured AAA. These latter patients showed higher levels of 
TNFa and IL-13 on hospital admission. Non-survivors showed significantly higher 
levels of IL-13 and TNFa on hospital admission, whereas the differences in IL-6 did 
not reach statistical significance. 
Most interesting was the finding of significantly different cytokine patterns in the early 
post-injury phase in patients who later developed ARDS/MOF. TNFa and IL-1ß were 
significantly higher on admission and after 6 hours in ARDS/MOF patients, while IL-6 
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levels were significantly elevated in these patients from the second day onwards. 
Chapter 6 describes the data on serum lipofuscin measurements in the same patient 
population as outlined in chapter 5. Lipofuscin has been proposed to be a parameter 
of lipid peroxydation caused by toxic oxygen radical production. 
Additionally, blood was drawn from 75 "healthy" persons, ranging in age from 4 to 90 
years, for determination of normal serum lipofuscin concentrations. It appeared that 
serum lipofuscin levels increase significantly with age. 
Especially 6 hours after the trauma, rupture of an AAA or the elective operation of an 
AAA, serum lipofuscin levels (corrected for age) were significantly elevated in all three 
patient groups, as compared with the controls. 
In the group of patients with subsequent ARDS/MOF significantly higher levels of 
serum lipofuscin could be found during the first 24 hours post-injury, compared to 
patients without ARDS/MOF. 
This might indicate that oxidative stress (leading to increased lipid peroxidation) plays 
an important role in the development of ARDS and MOF ¡η these patient populations. 
In Chapter 7 we report on systemic endotoxemia in patients undergoing major 
vascular surgery (elective and emergency aortic aneurysm repair). Endotoxemia was 
regularly present in patients in shock due to a ruptured AAA on hospital admission, 
even before resuscitation or operation was performed. 
Secondly, in patients undergoing elective surgery of the infrarenal aorta, systemic 
endotoxemia was demonstrated especially immediately after ischemia and reperfusion 
(clamping and declamping of the aorta). However, the concentrations of systemic 
circulating endotoxin were low and were within the same range in both elective and 
emergency patients. We could not find adverse effects of endotoxemia in the studied 
patient population. 
Chapter В contains an overview of the literature on intestinal permeability, the 
methods used to measure it, the clinical data and relevance, and its relation with 
endotoxin and bacterial translocation. 
It is concluded that altered (increased) intestinal permeability is a phenomenon that 
occurs under various circumstances and in many pathological conditions, while it 
cannot conclusively be related to endotoxemia and/or bacterial translocation. 
In Chapter 9 we report on intestinal permeability in patients with severe blunt trauma 
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and with a ruptured AAA. It is shown that intestinal permeability is significantly 
increased 24 to 36 hours post-injury in these patient groups. We could not demon-
strate any difference in intestinal permeability in patients with subsequent infections, 
compared to those who did not develop such infectious complications. Additionally, 
we studied endotoxemia in relation to increased intestinal permeability. Systemic 
circulating endotoxin was only found before the increased intestinal permeability was 
demonstrated. At the very moment of increased intestinal permeability, and one day 
later, no endotoxin could be demonstrated in the systemic circulation anymore. 
In chapter 10 we report on intestinal permeability in patients after major elective and 
emergency AAA repair. No difference was found in intestinal permeability between 
patients operated electively and patients undergoing emergency operation because of 
shock, due to a ruptured AAA. 
This finding suggests that the factor shock did not contribute importantly to increased 
intestinal permeability, whereas the reperfusion injury probably was the significant 
factor in this respect. 
Chapter 11 provides data on gastric intramucosal pH (pHi) measurements in 15 
polytraumatized patients. Although we expected that splanchnic ichemia was a 
common finding in multiple trauma patients, no consistent pattern of abnormally low 
pHi values was present. 
However, in those patients in whom abnormally low pHi values were found, either 6 
hours after hospital admission and resuscitation or later, significantly more complica-
tions developed. Patients that never showed any abnormal pHi values, all had an 
uncomplicated recovery. It is concluded that monitoring gastric pHi in severely injured 
patients admitted to an ICU may be usefull. 
Finally, in chapter 12 the results of the presented studies are discussed. Especially 
the data on circulating inflammatory mediators, such as activated complement, 
elastase, lactate, lipofuscin and cytokines, which products were all significantly 
elevated in the early post-injury phase in patients that later developed complications, 
such as ARDS and MOF, provide evidence that these syndromes are the consequen-
ce of a overwhelming generalized autodestructive inflammatory response of the host 
itself. 
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SAMENVATTING 
Adult Respiratory Distress Syndrome (ARDS) en Multiple Organ Failure (MOF) zijn 
twee syndromen, waarvan men tegenwoordig aanneemt dat er één gemeenschappe-
lijk pathofysiologisch mechanisme aan ten grondslag ligt. Zij vertegenwoordigen de 
belangrijkste vorm van morbiditeit en mortaliteit op een chirurgische Intensive Care 
afdeling. Ondanks een indrukwekkende toename in kwaliteit van intensieve zorg zijn 
de mortaliteitscijfers van patiënten met een volledig ontwikkeld beeld van MOF 
gedurende de laatste decennia niet in gunstige zin veranderd. 
Het is daarom zeker een uitdaging om de onderliggende pathofysiologische mecha-
nismen van het ontstaan van ARDS en MOF te ontrafelen en factoren te identificeren 
die een wezenlijke bijdrage aan dit proces leveren. 
In deze dissertatie wordt onderzoek beschreven met betrekking tot een drietal onder-
scheiden deelgebieden, te weten: 1. de waarde van scorinas-svstemen ten aanzien 
van het ontstaan van ARDS/MOF; 2. de rol van diverse circulerende verbindingen, 
welke onderdeel uitmaken van ontstekingsreacties (de zogenaamde inflammatoire 
mediatoren), in relatie tot het ontstaan van bedoelde syndromen; en 3. de rol die de 
tractus diqestivus in dit geheel speelt. 
Hoofdstuk 1 behandelt, uitgaande van de thans beschikbare literatuur, enkele 
algemene aspecten van ARDS en MOF. De klinische presentatie van ARDS en MOF 
wordt gedemonstreerd aan de hand van een drietal patiënten casus en we gaan in op 
de veelheid aan definities van deze syndromen. 
Voorts wordt de rol van het zuurstofmetabolisme en toxische zuurstofradicalen 
besproken. Deze radicalen worden geproduceerd door gestimuleerde polymorfonu-
cleaire leukocyten en gevormd in diverse weefsels, na doorgemaakte ischemie en 
reperfusie. 
De huidige stand van zaken omtrent de rol van humorale en cellulaire systemen, 
welke geassocieerd zijn met het ontstaan van ARDS/MOF, wordt behandeld. Boven-
dien wordt ingegaan op de discussie omtrent het belang van bacteriën, endotoxinen 
en derhalve ook de tractus digestivus bij het ontstaan van ARDS/MOF. 
Tot slot wordt een overzicht gegeven van de theorien omtrent mechanismen die ten 
grondslag zouden liggen aan beide syndromen, waarna het doel van de studie en de 
basale vragen worden toegelicht. 
Hoofdstuk 2 is een verslag van een retrospectieve studie verricht bij 39 patiënten die 
op de Intensive Care afdeling werden opgenomen in verband met een ernstige acute 
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hemorrhagisch necrotiserende pancreatitis (AHNP) met beademingsnoodzaak. Het 
doel van deze studie was uit te zoeken welke van een vijftal gebruikelijke scorings-
systemen de meest relevante informatie opleverde ten aanzien van de prognose 
(morbiditeit en mortaliteit) van deze patiënten. Het betrof de score volgens Ranson en 
Imrie (beide ontwikkeld om specifiek de ernst en prognose van acute pancreatitis in te 
schatten), de Sepsis Severity Score (volgens Elebute en Stoner) en de APACHE II 
score, welke beide ontwikkeld zijn om in zijn algemeenheid de ernst van ziekte bij ICU 
patiënten aan te geven. Tot slot de in Nijmegen ontwikkelde MOF score, die de ernst 
van orgaanfalen en de intensiteit van orgaan ondersteunend handelen scoort. 
De conclusies van dit onderzoek zijn dat de APACHE II score een betere informatie 
geeft omtrent de prognose quo ad vitam van patiënten met een AHNP dan de score 
volgens Ranson en Imrie, en dat de MOF score (het gemiddelde van de eerste 4 
dagen op de ICU) de best predictieve waarde heeft ten aanzien van overlijden. 
In hoofdstuk 3 doen wij verslag van een evaluatie van 7 scorings-systemen toegepast 
bij 56 multi-trauma patiënten, wederom in relatie tot ARDS/MOF. Er kon worden 
aangetoond dat scoringssystemen die de anatomische ernst van letsel graderen het 
best correleerden met later ontstaan van ARDS en MOF. Dit was niet het geval voor 
scorings-systemen die de fysiologische reactie van het organisme op trauma grade-
ren. Bovendien onderzochten wij lactaatconcentraties, welke een goede maat zijn voor 
de doorgemaakte hypoxie bij deze patiënten. Het bleek dat patiënten die in de 
tweede week ARDS en/of MOF ontwikkelden, reeds gedurende de eerste drie dagen 
na het ongeval significant hogere lactaatspiegels hadden in vergelijking met patiënten, 
die niet aan de criteria van ARDS/MOF voldeden. 
In hoofdstuk 4 doen wij verslag van onze studie van diverse inflammatoire mediatoren 
(in serum) bij dezelfde groep patiënten als uit hoofdstuk 3. Het betrof het comple-
mentsysteem, thromboxaan-B2, C-reactieve proteine, elastase en neopterine. 
Patienten die overleden hadden op de eerste dag na het trauma significant hogere 
waarden voor complementactivatie en elastaseconcentraties, in vergelijking met de 
overlevenden. 
Bij vergelijking van de patiënten die MOF hadden ontwikkeld met diegenen zonder 
deze complicatie, bleek de eerste groep op dag 1 significant hogere serum concen-
traties te hebben van geactiveerd complement (C3a), terminaal complement complex 
(C5 t/m C9), thromboxaan-B2 en elastase. Bovendien hadden deze patiënten in week 
2, dus op het moment van een reeds ontwikkeld MOF beeld, hogere neopterinewaar-
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den, hetgeen een indicatie geeft over macrophagen activatie. 
Hoofdstuk 5 handelt over cytokinen: TNFa, IL-13 en IL-6. Wij bestudeerden drie 
patiënten groepen: a. 28 multi-trauma patiënten, b. 20 patiënten met een gebarsten 
aneurysms van de abdominale aorta (AAA) en с. 18 patiënten die een electief herstel 
van een AAA ondergingen. Van deze 66 patiënten overleden er uiteindelijk 22, 
namelijk 15 vóór de tweede dag en 7 ten gevolge van MOF na ruim één maand ICU 
opname. Er waren derhalve 51 patiënten over voor indeling in een groep met 
ARDS/MOF (n=10) en een groep die wat ARDS/MOF betreft een ongecompliceerd 
beloop had (n=41). 
De volgende opvallende verschillen in cytokine-patronen werden gevonden. IL-6 
concentraties bleken bij trauma patiënten direkt na opname in het ziekenhuis en 6 uur 
later een significant hoger niveau te hebben, dan de patiënten die in shock werden 
opgenomen ten gevolge van hun gebarsten AAA. Deze laatste patiënten hadden juist 
hogere TNFa en IL-13 waarden op deze tijdstippen. 
Vergelijking tussen overleden patiënten en overlevenden toonde bij opname significant 
hogere TNFa en IL-13 spiegels in de groep overledenen. De verschillen in IL-6 
concentraties waren niet significant. 
De belangrijkste bevinding was evenwel dat de patiëntengroep die later ARDS/MOF 
ontwikkelde, reeds op de eerste dagen na het trauma wezenlijk andere cytokine-
patronen had. Patienten uit deze groep hadden significant hogere TNFa en IL-13 
spiegels bij ziekenhuisopname en 6 uur later, terwijl er vanaf de tweede dag voortdu-
rend hogere spiegels IL-6 spiegels werden gevonden. 
In hoofdstuk 6 bespreken wij serum lipofuscine metingen verricht bij dezelfde 
patiëntengroepen als vermeld in hoofdstuk 5. Bovendien was er een controle groep 
gevormd, bestaande uit 75 "gezonde" personen in leeftijd variërend van 4 tot 90 jaar. 
Uit andere in vitro en in vivo studies blijkt dat serum lipofuscine een maat is voor 
lipiden peroxidatie ten gevolge van toxische zuurstofradicalen, en dus voor de 
oxidatieve stress die heeft plaatsgevonden. 
Op grond van analyse van de controle groep bleek dat serum lipofuscine spiegels 
toenemen met de leeftijd. Derhalve werden voor verdere vergelijkingen de gevonden-
waarden voor leeftijd gecorrigeerd. 
Reeds 6 uur na trauma, ruptuur van het aneurysms of de electieve operatie voor een 
AAA bleken de serum lipofuscineconcentraties in alle drie patiënten groepen signifi-
cant verhoogd te zijn in vergelijking met de controle groep. 
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De groep van 10 patiënten die ARDS/MOF ontwikkelde had de eerste 24 uur na 
trauma, ruptuur of operatie significant hogere serum lipofuscinespiegels dan de 
patiënten zonder later ARDS/MOF. 
Er wordt geconcludeerd dat oxidatieve stress in de vroege "post-traumatische" fase 
een rol kan spelen bij het ontstaan van ARDS en MOF. 
In hoofdstuk 7 doen wij verslag van serum endotoxine metingen bij patiënten die 
vasculaire reconstructies van de abdominale aorta ondergingen. Er wordt aangetoond 
dat bij patiënten met een gebarsten AAA reeds systemisch circulerend endotoxine 
aanwezig is bij ziekenhuisopname, nog vóór dat resuscitatie of spoed operatie heeft 
plaatsgevonden. 
Voorts werden monsters genomen op zorgvuldig vastgestelde tijdstippen tijdens 
electieve operatie voor een AAA. Wij observeerden een systematische endotoxemie bij 
deze patiënten ten tijde van de ischemie (met infrarenale afklemming van de aorta) en 
met name ook in de reperfusie fase (na het verwijderen van de aortaklem). De 
gevonden endotoxineconcentraties waren laag en in hetzelfde bereik als bij de 
patiënten met een gebarsten AAA. 
We konden geen klinisch negatieve effecten van endotoxemie waarnemen. 
Hoofdstuk 8 is een overzicht van de recente literatuur betreffende intestinale permea-
biliteit. De meet methoden en de klinische relevantie van abnormale intestinale 
permeabiliteit worden besproken. Verder wordt er ingegaan op de relatie tussen intes-
tinale permeabiliteit, endotoxinen en bacteriële translocatie. 
Wij concluderen dat abnormaal toegenomen intestinale permeabiliteit een fenomeen is 
dat onder zeer uiteenlopende omstandigheden en bij diverse aandoeningen kan 
worden waargenomen, zonder dat er aanwijzingen zijn dat er een causale relatie 
bestaat met translocatie van bacteriën en/of endotoxinen -en dientengevolge infectieu-
ze complicaties-, noch met het ontstaan van MOF. 
Hoofdstuk 9 bevat gegevens over intestinale permeabiliteitsmetingen bij multitrauma 
patiënten en patiënten met een gebarsten AAA. Wij vonden een significant verhoogde 
intestinale permeabiliteit, gemeten met behulp van de Lactulose/Mannitol test, bij 
beide patiënten groepen tussen de 24 en 36 uur na trauma of ruptuur. Alle patiënten 
werden vervolgens verdeeld in twee groepen afhankelijk van het al of niet ontwikkelen 
van infectieuze complicaties. Tussen deze twee groepen werd absoluut geen verschil 
in intestinale permeabiliteit gevonden. Bovendien werden endotoxinemetingen verricht. 
9ПЧ 
Endotoxemie kon alleen waargenomen worden op tijdstippen vóór de permeabiliteits-
metingen, echter niet meer ten tijde van deze metingen of 24 uur later. 
In hoofdstuk 10 doen we verslag van onze intestinale permeabiliteitsmetingen bij twee 
groepen patiënten die een vasculaire ingreep aan de abdominale aorta ondergingen: 
te weten een electieve reconstructie van een AAA of een spoedoperatie wegens een 
gebarsten AAA. In beide groepen werd een abnormaal verhoogde intestinale permea-
biliteit geconstateerd, zonder wezenlijk verschil tussen de groepen onderling. 
Deze bevinding suggereert dat niet shock, maar veeleer reperfusieschade een 
belangrijke rol speelt bij het ontstaan van abnormale intestinale permeabiliteit. 
In hoofdstuk 11 bestuderen we de intramucosale pH (pHi) van de maag (wand) bij 15 
multitrauma patiënten. De pHi is een maat voor de oxygenatietoestand van het desbe-
treffende orgaan, waarin gemeten wordt. Wij verwachtten bij multitrauma patiënten een 
verminderde doorbloeding van het splanchnicusbed, met dientengevolge aanwijzingen 
voor (doorgemaakte) ischemie. 
In onze patiënten groep kon evenwel geen evident patroon van een dergelijk ischemie 
aangetoond worden. Wel bleken de patiënten bij wie eenmaal of vaker een abnormaal 
lage pHi werd gemeten, diegenen te zijn met een later optredend gecompliceerd 
beloop (ARDS, sepsis, overlijden). Patienten bij wie nooit een abnormale pHi waarde 
werd gemeten, hadden allen een ongecompliceerd herstel. 
Intramucosale pHi metingen van de maag kunnen derhalve een zinvol additionele 
vorm van monitoring betekenen bij ICU patiënten. 
Tot slot wordt in hoofdstuk 12 een algemene beschouwing gegeven over de verrichte 
studies en de daaruit getrokken conclusies. 
Met name menen wij te mogen constateren dat de gegevens over de diverse 
circulerende inflammatoire mediatoren, zoals geactiveerd complement, elastase, 
lipofuscine, lactaat en cytokinen - welke allemaal in de vroege "post-traumatische" 
periode significant verhoogd bleken te zijn - een extra ondersteuning zijn voor de 
hypothese dat ARDS en MOF het gevolg zijn van een gegeneraliseerde, uit de hand 
gelopen, autodestructieve ontstekingsreactie van het eigen organisme. 
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APPENDIX 
A. SCORING SYSTEMS 
RANSON score
 m 
On admission: 
Ад > 55 years 
White cell count > 16000/mm3 
LDH > 600 units/I 
ASAT > 120 units/! 
Glucose > 10 mmol/l 
Within 48 hours: 
hematocrit fall > 10% 
Urea rise > 0.9 mmol/l 
Calcium < 2 mmol/l 
РО
г
 < 8 kPa 
base deficit > 4 mEq/l 
Fluid sequestration > 6000 ml 
Sum of the score ranges from 0 to 11. 
0-2 points indicates mild pancreatitis, г 3 points severe pancreatitis. 
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IMRIE score m 
On admission: 
Age > 55 years 
Within 48 hours: 
White cell count > 15 χ 1071 
Blood glucose > 10 mmol/l (no diabetic history) 
Serum urea > 16 mmol/l (no response to i.v. fluids) 
РО
г
 < 8 kPa 
Serum calcium < 2 mmol/l 
Serum albumin < 32 g/l 
LDH > 600 μ/\ 
ASAT/ALAT> 100μ/Ι 
Sum of the score ranges from 0 to 9. 
0-2 points indicates mild pancreatitis, > 3 points severe pancreatitis. 
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APACHE II score
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MULTIPLE ORGAN FAILURE score
 w 
Organ system 
Grade 1 Grade 2 
Pulmonary 
Cardiac 
Renal 
Hepatic 
Hematologic 
Gastro-
intestinal 
Central 
nervous 
mech. ventilation with 
PEEP < 10cmH2O 
Fi02 S 0.4 
hypotension > 100 mmHg 
dopamine s 10^g/kg/min 
nitroglycerine < 20^g/kg/min 
serum creatinine & 2 mg/dl 
serum bilirubin > 2 mg/dl 
or SGOT > 25 U/l 
platelets < 50x1 O*/! 
and/or 
leuco's ä 30x10"/l 
acalculous cholecystitis 
stress ulcer 
diminished 
responsiveness 
mech. ventilation with 
PEEP > 10cmH2O 
Fi02 > 0.4 
hypotension s 100 mmHg 
dopamine > 10/*g/kg/min 
nitroglycerine > 20//g/kg/min 
dialysis 
serum bilirubin г 6 mg/dl 
or SGOT > 50 U/l 
disseminated intravascular 
coagulation 
leuco's < 2.5x10"/l or г 60x10*/l 
perforation gallbladder 
bleeding from ulcer > 2 units 
blood/24 hr 
necrotizing enterocolitis 
pancreatitis 
severely disturbed 
responsiveness and/or 
diffuse neuropathy 
No failure = grade 0; moderate failure = grade 1 ; severe failure = grade 2. 
MOF score is total of 7 organ failure scores, with a maximum of 14 points. 
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;EPSIS SEVERITY SCORE 
according to Elebute and Stoner w 
ТіЫе I: SCORING OF LOCAL EFFECTS OF TISSUE 
INFECTION 
Attribute Score 
Wound infection with purulent discharge/ 
cnlerocutaneous fistula 
Requiring only light dressing changed not 2 
more than once daily 
Requiring to be dressed with a pack, dressing A 
needing to be changed more than once daily, 
requiring application of a bag and/or requiring 
suction 
Peritonitis 
Localized peritonitis 2 
Generalized peritonitis 6 
Chest infection 
Clinical or radiological signs of chest infection 2 
without productive cough 
Clinical or radiological signs of chest infection 4 
with a cough producing purulent sputum 
Full clinical manifestations of lobar/ 6 
bronchpneumonia 
Deep-seated infection (e g subphrenic abscess, 6 
pelvic abscess, empyema thoracis, acute or chronic 
osteomyliiis) 
Tabic II: SCORING OF PYREXIA (ORAL 
TEMPERATURE) 
Attribute Score 
Maximum daily temperature (°C) 
36-37 4 0 
37 5-38 4 1 
38 5-39 2 
>39 3 
<36 3 
Add 
Minimum daily temperature >37 5 °C 1 
If 2 or more temperature peaks above 38 4 °C in 1 day 1 
If any rigours occur in a day I 
Temperature should be recorded ai leut 4 times in 24h The record for the 24b 
period u assessed as above and pyrexia score computed 
ТаЫе HI: 
SEPSIS 
SCORING OF SECONDARY EFFECTS OF 
Attribute 
Obvious jaundice (in the absence of established 
hepatobiliary disease) 
Metabolic acidosis 
Compensated 
Uncompensated 
Renal failure 
Gross disturbance of mental orientation /level of 
consciousness (e g delirium, coma) and/or other 
focal neurological manifestations of pyaemia/ 
septicaemia (having excluded other causes) 
Bleeding diathesis (from disseminated intravascular 
coagulation) 
Attribute 
Blood culture 
Single positive culture 
Two or more positive cultures separated by 24 h 
Single positive culture + history of invasive 
procedure 
Single positive culture + cardiac murmur and/or 
tender enlarged spleen 
Leucocyte count ( x 10*'I) 
12-30 
>30 
< 2 5 
Haemoglobin level in the absence of obvious 
bleeding (g/dl) 
7-10 
<7 
Platelet count ( к I0*/1) 
100-150 
<100 
Plasma albumin level (g/1) 
31-35 
25-30 
<25 
Plasma total bilirubin level in the absence of 
clinically obvious jaundice 
> 25 μτηοΙ/Ί 
Scort 
ТіЫе IV: SCORING OF LABORA TOR Y DA TA 
Scor 
INJURY SEVERITY SCORE <6) 
according to Hospital Trauma Index 
m 
iL· 
\û\ i 
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GLASGOW COMA SCALE
 m 
Eyes open 
spontaneously 
on spoken command 
on pain 
no response 
Best motor response 
to spoken command 
to pain stimulus: 
* localised pain 
* flexion withdrawal 
* flexion abnormal 
* extension 
* no response 
Best verbal response 
oriented + converses 
disoriented + converses 
inappropriate words 
incomprehensible sounds 
no response 
4 
3 
2 
1 
6 
5 
4 
3 
2 
1 
5 
4 
3 
2 
1 
Sum of the score ranges from 3 to 15. 
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TRAUMA score
 m 
Respiratory rate 
10 -24/min 4 
24 - 35 / min 3 
> 36 / min 2 
< 10 /min 1 
0 0 
Respiratory effort 
normal 1 
shallow or retractive 0 
Systolic blood pressure 
г 100 mm Hg 4 
80 - 99 mm Hg 3 
60 - 79 mm Hg 2 
< 60 1 
no pressure 0 
Capillary refill 
normal 2 
delayed 1 
none 0 
Glasgow Coma Scale 
1 4 - 1 5 5 
11-13 4 
8-10 3 
5 - 7 2 
3 - 4 1 
Sum of the score ranges from 1 to 16 
216 
POLY-TRAUMA SCHLÜSSEL ^ 
Schädel 
SHT1 oder GCS 9-12 
SHT 2 oder GCS 6-Θ 
SKT 3 oder GCS 3-5 
Mittelgesichtsfraktur 
Schwere Mittelgesichts­
fraktur 
Abdomen 
Milzruptur 
Lebemiptur 
Ausgedehnte Leberruptur 
Pankreasverletzung 
Magen- Darm- Nieren-
Mesenterialverletzung 
Extremrt fiten 
Oberschenkeltrümmerfraktur 
Oberschenkelfraktur 
Oberarm, Schulter 
Unterschenkelfraktur 
Patella- OSG-Fraktur 
Kniebandruptur, Unterarm-
und Ellenbogenfraktur 
Gefassverletzung 
Oberschenkel 
Oberarm 
Unterschenkel, Unterarm 
2' und 3' offene Fraktur 
Weichteilverletzung 
PaOJFIOT 
< 50 
50 - 99 
100 - 149 
150 - 199 
200 - 249 
250 - 299 
300 - 349 
2 350 
2 
4 
12 
1 
2 
5 
β 
10 
8 
5 
В 
6 
1 
1 
5 
4 
2 
3 
1 
22 
12 
8 
5 
3 
2 
1 
0 
Thorax 
Sternum, Rippenfrakturen(1-3) 
Rippenseríenfraktur 
Rippenserìenfraktur bds. 
Pneumothorax 
Hamatothorax 
Lungenkontusion 
Lungenkontusion bds. 
Aorten ruptur 
Becken 
Beckenfraktur (einfach) 
Beckenfraktur (kombiniert) 
Becken-u. Urogenitalverletzung 
Wirbeifraktur 
Querschnittslähmung 
Beckenquetschung 
Alter 
< 40 
40 - 49 
50 - 54 
55 - 59 
60 - 64 
65 - 69 
70 - 74 
i 75 
Base excess 
s -16 
-14..-15,9 
-12 .. -13,9 
-10..-11,9 
- 8 .. - 9,9 
- 6 .. - 7,9 
- 4 .. - 5,9 
2: -3.9 
1 
4 
10 
2 
1 
3 
5 
16 
2 
5 
8 
2 
8 
12 
0 
1 
1 
2 
3 
5 
8 
17 
26 
20 
14 
9 
5 
3 
1 
0 
SEPSIS SEVERITY SCORE 
according to Stevens
 (U) 
Levels of Dysfunction In Seven Organ Systems for Determining SSS* 
System 
Lung 
Kidney 
Coagulation 
Cardiovascular 
Uvar 
Gl tract 
Neurologic 
1 
0 , by mask 
CL, 1 5-2 5 mg/dL 
Ecchymoses, PT, PTT, 
and plateM count, 
normal 
Slight hypotension 
LOH and SQOT InciMead, 
bilirubin, normal 
Mild Ileus 
Obtundsd 
2 
Intubated, no PEEP 
CL, 2 -Э 5 mg/dL 
PTT, 45-451, 
PT, 12-14 β 
Livedo, moderate 
hypotension 
Bilirubin. 
1 5-2 5 mg/dL 
Moderate Ueus 
Disoriented 
Rating of Dysfunction 
Э 
PEEP, 0%-10% 
CL, > 3 β mg/dL, 
adequata urina votums 
Platelets, 20.000-
100,000/cu mm, PTT, 
>50 s, PT, >14 β 
Vasopressors, 
moderata doses 
ВИІгиЫп, 
2 6-4 0 mg/dL 
Severa Usus 
Irrational 
4 
PEEP, >10%, 
Po,. >50 mm Hg 
CL, > 3 β mg/dL, 
urine volume, 
20-50 mL/hr 
Platelets, 
20,000/cu mm, 
elevated PT and PTT 
Vasopressors, 
large doses 
Bilirubin, 
4 9-8 0 mg/dL 
Bleeding due to 
erosive gastritis 
Hyporeactive 
S 
Maximal PEEP, 
Po* < 5 0 m m Hg 
CL, >3 β mg/dL, 
urine volume, 20 mL/hr 
Increased FSP snd 
eugtobuUn, bleeding 
Profound BP decrease 
despite vasopressors 
Precome bilirubin, 
>β 0 mg/dL 
Mensenteric venous 
thrombosis 
Coma 
"SSS indícales septic severity score, CL, creatinine level, PT, prothrombin Urne, Gl, gastrolnteetlnsl, PTT, partial thromboplastin Urns, PEEP, positive end-
nplratory pressure, LDH, lactate dehydrogenase, and FSP, fibrin spirt products Sum of the squares of the three highest dysfunction ratings equals SSS 
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В. LIST OF ABBREVIATIONS 
AAA Abdominal Aortic Aneurysm 
AHNP Acute Hemorrhagic Necrotizing Pancreatitis 
AIS Abbreviated Injury Scale 
AL(A)T ALanine (Amino)-Transferase (=SGPT) 
APACHE II Acute Physiology And Chronic Health Evaluation 
APS Acute Physiology Score 
ARDS Adult Respiratory Distress Syndrome 
AS(A)T Aspartate (Amino)-Transferase (=SGOT) 
BUN Body Urea Nitrogen 
C3(a) Complement factor 3 (activated) 
CNS Central Nervous System 
51Cr-EDTA Chrome-labelled EthyleneDiamineTetra-Acetate 
CRP C-Reactive Protein 
E.Coli Escherichia coli 
Elastase-a1 PI Elastase-a1 Proteinase Inhibitor Complex 
ELISA Enzyme Linked Immunosorbent Assay 
FiOj Inspired Oxygen Fraction 
GCS Glasgow Coma Scale 
HTI Hospital Trauma Index 
ICU Intensive Care Unit 
IL-113 lnterleukin-1ß 
IL-6 lnterieukin-6 
IP Intestinal Permeability 
ISS Injury Severity Score 
kPa kilo Pascal 
LDH Lactic DeHydrogenase 
L/M ratio Lactulose/Mannitol ratio 
LPS LipoPolySaccharide (=endotoxin) 
MOF Multiple Organ Failure 
M.W. Molecular Weight 
Neop/creat Neopterin/creatinine ratio 
Pao, Arterial Oxygen Pressure 
PEEP Positive End Expiratory Pressure 
PEG PolyEthyleneGlycol 
pHi 
PMN 
Ps 
PTS 
r 
RTS 
SD 
SEM 
SGOT 
SIRS 
Sp 
SSS 
TCC 
TNFa 
TRISS 
TS 
TxB2 
vs 
Intramucosal pH 
PolyMorphoNuclear (leukocytes) 
Probability of survival 
PolyTraumaSchlüssel 
Correlation coefficient 
Revised Trauma Score 
Standard Deviation 
Selective Decontamination 
Standard Error of the Mean 
Serum Glutamate Oxalo-acetate Transaminase (=ASAT) 
Systemic Inflammatory Response Syndrome 
Species 
Sepsis Severity Score 
Terminal Complement Complex 
Tumor Necrosis Factor a (=cachectin) 
Trauma Score or Revised TS and Injury Severity Score 
Trauma Score 
Thromboxane B2 
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